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What is a scientist after all? It is a curious man looking through a keyhole, the 
keyhole of nature, trying to know what's going on.  
 
Jacques Yves Cousteau (1910-1997) 
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1 Introduction 
The essential metabolic process that occurs in all plant cells is defined as the primary 
metabolism (1). In contrast, secondary metabolites are organic compounds that are not 
necessary for growth, development, or reproduction but are important for the plants 
survival under advert environmental conditions (1,2). Plants produce secondary 
metabolites in response to abiotic and biotic environmental stress. So far more than 
100,000 secondary compounds have been identified in plants (3). In Arabidopsis 
thaliana (A. thaliana) these fall into seven major classes: Indole and indole-sulfur 
compounds, glucosinolates, phenylpropanoids, benzenoids, flavonoids, terpenes, and 
fatty acid derivatives (4) (see Fig. 1 for a schematic summary of the biosynthetic 
pathways). Many of the compounds are derived from related pathways. Some 
metabolites - termed phytochemicals - have been shown to have beneficial effects for 
humans, which include anti-cancerogenic and anti–mutagenic compounds (5). Due to 
these effects, Sporn (1976) and Wattenberg (1985) introduced the idea of 
chemoprevention. The aim is to intervene with cancer development by prevention, 
which includes the uptake of dietary phytochemicals (6,7). It is of great interest today 
to identify novel natural occurring compounds with chemoprotective properties and to 
elucidate their functional mechanism as preventive agents against cancer (8-10). 
Many compounds have been identified in plants with the desired properties. 
Nevertheless, the identified substances are only a fraction of the predicted number of 
compounds in plants, which is estimated between 200,000 to 1,000,000 metabolites 
(11). In the following chapters, the function of secondary metabolites in plants and 
their chemopreventive properties for mammals will be summarized.  
One way of function of phytochemicals is via the induction of phase II and 
detoxification enzymes that are mediated by electrophile response elements (EpRE) 
located in the promotor region of the respective genes. This mechanism will be 
described and the use of EpRE as a reporter system for the detection of 
chemopreventive agents will be summarized in more detail. Current strategies for 
untargeted metabolite profiling will also be presented. The TAMARA (transposable 
element mediated activation tagging mutagenesis in Arabidopsis) population of A. 
thaliana plants, which are analyzed in this work, will be introduced. 
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Fig. 1: General biosynthetic pathway of Brassicacae metabolites. Structures of representative 
compounds are given. Adapted from (4,12). 
1.1 Secondary metabolites in Arabidopsis thaliana 
1.1.1 Indole and indole-sulfur compounds 
Indole and indole-sulfur compounds are derived from the amino acid tryptophan. One 
prominent representative of this group is the phytoalexin camalexin (3-thiazol-2’-
ylindole). Other tryptophan-derived compounds are indole glucosinolates and simple 
tryptophan derivatives (4). The biosynthesis pathways of indole glucosinolates, 
camalexin and auxin (indole-3-acetic acid (IAA)) are closely related as shown in Fig. 
2 (4,13). The enzymes CYP79B2 and CYP79B3 convert tryptophan into indole-3-
acetaldoxime, which is dehydrated to indole-3-acetonitrile (IAN). Dihydrocamalexic 
acid is formed in the next step. This compound is decarboxylated by PAD3 
(CYP71B15, phytoalexin deficient 3), resulting in the production of camalexin. The 
phytohormone auxin is either formed from tryptophan or upon the accumulation of 
IAN. IAN is then hydrolyzed by nitrilases to form auxin. Indole glucosinolates are, 
like camalexin, derived from indole-3-acetaldoxime (13). The general role of 
glucosinolates is described in chapter 1.1.2. Camalexin is involved in plant defense 
responses against various biotrophic and necrotrophic pathogens such as bacteria, 
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viruses, fungi and oomycetes (4,14-17). Upon pathogen attack and by abiotic reactive 
oxygen species (ROS) generating elicitors such as silver nitrate, camalexin 
biosynthesis is induced (2,16,18,19). The beneficial effect of camalexin for human 
health was recently shown by Mezencev et al. (2011), who could demonstrate that 
camalexin induces apoptosis specifically in Jurkat (T-cell leukemia) cells (20).  
indole-3-
acetaloxime 
auxin 
indole 
glucosinolates 
indole-3 
acetonitrile 
indole-3 
acetonitrile 
derivatives 
dihydrocamalexic 
acid camalexin 
tryptophan 
 
 
Fig. 2: Schematic diagram of camalexin biosynthesis from tryptophan. The pathway is closely related 
to the synthesis of auxin and indole glucosinolates due to the common precursors tryptophan, indole-3-
acetaloxime and indole-3 acetonitrile (IAN). Adapted from (13). 
1.1.2 Glucosinolates 
Glucosinolates are amino acid derived nitrogen- and sulfur-containing compounds 
that are mainly found in species of the Capparales order. Around 200 different 
structures are presently known from this group of compounds, 34 glucosinolate forms 
have been detected in seeds and leaves of various A. thaliana ecotypes (21). 
Glucosinolates are activated by myrosinases, which are enzymes that cleave the 
thioglycosidic bond, releasing an unstable aglycone. The aglycone spontaneously 
rearranges and forms the toxic and active isothiocyanate (ITC) (22). The myrosinases 
are stored in myrosin cells (idioblasts), separately from glucosinolates (23,24). Upon 
tissue damage, caused for example by chewing insects or processing of foods, the 
enzymes and glucosinolates come in contact with each other. This leads to the 
generation of the active compounds. Depending on the type of aglycone, the reaction 
temperature, the pH and the presence of ferrous ions, the products of hydrolysis can 
vary. Nitriles, thiocyanates, epithionitriles and oxazolidine-2-thiones are formed 
(22,25). This is also controlled by the presence of protein factors such as nitrile-
specifier proteins or epithio specifier proteins (25-27) The glucosinolate-myrosinase 
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system is often referred to as the ‘mustard oil bomb’ (Fig. 3) (28). Glucosinolate 
hydrolysis products function as repellents against a variety of organisms such as 
insects, nematodes, bacteria and fungi, though they can also be an attractant to some 
insects (29-38). The amino acids alanine, valine, leucine, isoleucine, phenylalanine, 
methionine, tyrosine and tryptophan are the basis for glucosinolate biosynthesis. They 
can be grouped depending on the amino acid, into aliphatic, indole and aromatic 
glucosinolates (Fig. 2 shows that indole glucosinolates are derived from tryptophan). 
The biosynthesis of glucosinolates is divided into the three stages: Side chain 
elongation, core structure development and secondary side chain modifications. 
During the first step, one or more methylene groups extend certain aromatic and 
aliphatic amino acids. Then the core structure of the glucosinolate is formed via 
rearrangement of the molecule. The side chains of the glucosinolate molecule are then 
further modified. During the biosynthesis of glucosinolates, several precursor 
compounds are formed: N-hydroxy amino acids, aldoximes, thiohydroxymic acids 
and desulfoglucosinolates. Cytochrome-P450-dependent mono-oxygenases (CYPs) 
catalyze the production of aldoximes from amino acids. The elongation step and the 
modifications of the side chains are the basis of the structural diversity of 
glucosinolates (39,40). The consumption of cruciferous vegetables, which have a high 
content of glucosinolates, reduces the risk of cancer mainly due to its breakdown 
products (26,41-45). This could be demonstrated in studies on bladder and prostate 
cancers but also in lung cancer and cancer in the gastrointestinal tract (42,46-48). 
Especially the ITC sulforaphane was shown to be an effective component against 
tumorigenesis (44,49-52). Evidence exists that also intact glucosinolates have 
chemopreventive activity, as shown with glucoraphanin (4-Methylsulfinylbutyl 
glucosinolate) and glucoerucin (4-Methylthiobutyl glucosinolate) (53). In comparison 
to the available data about ITCs, little is known about the chemoprotective effect of 
other glucosinolate breakdown products such as thiocyanates, nitriles and 
epithionitriles (26). Though, it could recently be demonstrated that the epithionitriles 
1-cyano-2,3-epithiopropane, 1-cyano-3,4-epithiobutane and 1-cyano-4,5-
epithiopentane induce phase II enzymes in rat liver epithelial cells (54). Also the 
nitrile crambene (1-cyano-2-hydroxy-3-butene), which is a breakdown product of the 
aliphatic glucosinolate progoitrin, has been demonstrated to induce phase II enzymes, 
especially when administered in combination with indole-3-carbinol (I3C) (55-59).  
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The most common indole glucosinolates are indol-3-ylmethylglucosinolate 
(glucobrassicin, I3M), 1-methoxy-I3M (1MO-I3M), 4-methoxy-I3M (4MO-I3M) and 
4-hydroxy-I3M (4HO-I3M). The main indole glucosinolate in leaves is 
glucobrassicin. In roots, the concentration of indole glucosinolates is particularily 
high. The hydrolysis of indole glucosinolates also results in the formation of different 
breakdown products. Unlike ITCs derived from aliphatic or aromatic glucosinolates, 
the indole glucosinolate derived ITCs are unstable. To date the only indole derived 
ITC detected is 1-methoxyindol-3-ylmethyl-ITC, which is derived from 1MO-I3M. 
Also nitriles are formed, depending on the pH, the presence of specifier proteins, and 
Fe(II)ions. IAN is the I3M-derived nitrile. No organic thiocyanates and epithionitriles 
derived from indole glucosinolates are presently known. The glucobrassicin-derived 
indole-3-ylmethyl-ITC immediately converts in reaction with ascorbic acid to 
ascorbigen and upon reaction with water to I3C. Also inorganic thiocyanate ions 
(SCN-) are produced. Substituted indole glucosinolates are broken down in a similar 
fashion as I3M (60). I3C and ascorbigen have been shown to have anti-cancer effects 
(61). In vivo, I3C is further processed to various oligomeric products such as 3,3’-
diindolylmethane and its different derivatives, N-methoxyindole-3-carbinol, and 
indolo[3,2-b]carbazole, which are presumably responsible for the effects of I3C in 
mammals. Among others, I3C and its derivatives act anti-proliferative in tumor cells 
by leading to cell cycle arrest, apoptosis induction, chemosensitization of 
chemoresistant cancer cells, reduction of inflammation and metastasis. Moreover, 
effects of these compounds against deoxyribonucleic acid (DNA)-adduct formation, 
immunomodulation and tumorigenesis have been observed (61-63). On the other hand 
IAN, another breakdown product of I3C, can also induce cancer by a reacting with 
nitrite, which leads to the formation of carcinogens (61).  
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Fig. 3: Schematic and simplified diagram of glucosinolate hydrolysis by myrosinases. In the presence 
of specifier proteins, nitriles, epithionitriles and thiocyanates (not in Arabidopsis) are formed at the cost 
of ITC production. Adapted from (27). 
1.1.3 Phenylpropanoids 
Phenylpropanoids are compounds derived from the carbon backbone of the amino 
acid phenylalanine. They are produced via the phenylpropanoid pathway (see Fig. 4) 
(4,64). Phenylalanine is transformed into cinnamate, which in turn is transformed into 
p-coumaroyl Coenzyme A (CoA). p-Coumaroyl CoA is the precursor of a variety of 
compounds such as coumarins, flavonoids, lignin, etc. This diverse group of 
phenylpropanoids plays a role in the protection against ultra violet (UV)-light, 
response to mineral treatment, structural stability, pathogen defense, and reproduction 
(4,64). Examples of phenylpropanoids found in Arabidopsis are the coumarins such as 
scopolin and scopoletin, present in roots (65). A prominent example of a 
phenylpropanoid with chemoprotective properties is resveratrol. The stilbene 
resveratrol (3,4’,5-trihydroxystilbene) is produced among others in grapes as a 
phytoalexin against fungal pathogens (18,66). Jang et al. (1997) could first 
demonstrate the chemoprotective effect of resveratrol (67). Numerous preclinical 
studies have been performed with this compound. The substance can both prevent the 
development and the progression of cancer (68,69). In a clinical study it could 
recently be shown that resveratrol can modulate enzyme systems involved in 
carcinogen activation and detoxification (70). 
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Fig. 4: Schematic diagram of the biosynthesis of phenylpropanoids. These compounds are derived 
from the amino acid phenylalanine. Related pathways are the synthesis of benzoid acid from cinnamate 
(common precursor) and the synthesis of salicylic acid (SA) from shikimate via isochorismate. 
Adapted from (64). 
1.1.4 Benzenoids 
Benzenoid compounds have various functions in Arabidopsis and are found as 
volatiles, in the stems of inflorescences, bound to the cell wall and in seeds (4). 
Salicylic acid (SA) is one example of an important signaling compound involved in 
plant defense reaction against different biotrophic and necrotrophic pathogens (71). 
Volatile benzenoid compounds such as methyl benzoate and methyl salicylate have 
been detected in floral scents. Another role of methyl salicylate is to attract predators 
of insects feeding on the plants (72). Benzoic acid can be found in form of 
glucosinolate esters in seeds, suggesting a role in storage of glucosinolates (73). An 
important human application of the benzenoid compound salicylate is in aspirin. SA 
has been shown to have anti-inflammatory effects in humans (74). Inflammation is a 
known causal agent of cancer (75). It was shown that sodium salicylate induces 
apoptosis and inhibits proliferation in human cancer cell lines (76). More than one 
pathway is predicted to exist for the production of benzoic acid. The benzenoids are 
probably derived from phenylpropanoids. Alternatively, it has been considered, that 
benzenoids are synthesized via the shikimate-derived isochorismate (Fig. 4). Most 
research in the past has been done on the phenylalanine pathway (72). 
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1.1.5 Flavonoids 
Flavonoids are derived from the phenylpropanoid pathway (Fig. 4). They comprise 
the subclasses of flavanols, flavanones, anthocyanidins, isoflavones, flavones and 
flavonols (77). The most abundant flavonoids in Arabidopsis are the flavonols 
kaempferol glycosides, quercetin glycosides and an anthocyanin. This anthocyanin 
has a cyanidin core attached to four sugars, and the single residues p-coumaroyl, 
sinapoyl and malonyl (4). In plants, flavonoids have functions in auxin transport, 
defense against pathogens, allelopathy, ROS level modulation, flower coloring, and 
absorption of UV-light (78). Recently it was suggested that flavonoids might also 
have a function as an excess energy escape valve under stress conditions such as cold 
stress, acclimation and water deficit. In addition, the increased production of 
flavonoids are an advantage under these stress conditions (79). It has been shown that 
flavonoids can function as defense compounds against fungi, bacteria and insects in 
various plant species. Flavonoids also have signaling functions in symbiosis in many 
legumes and in wheat (80-82). Arabidopsis mutants lacking flavonoids are more 
sensitive to UV-B-light (83). Independent evidences support a role of flavonoids in 
auxin transport. The flavonoids apigenin, kaempferol and quercetin can inhibit auxin 
transport and could function as natural regulators of auxin transport and it has been 
shown that auxin transport is elevated in a mutant that lacks flavonoids (transparent 
testa) (84-86). Flavonoids are beneficial for humans due to their anti-oxidant, anti-
proliferative, anti-tumor, anti-inflammatory and pro-apoptotic effects (87). For the 
phytochemical kaempferol it was recently demonstrated that it has inhibiting effects 
on the development of skin carcinogenesis, on the proliferation of human cancer cell 
lines and the inhibition of neoplastic cell transformation (88-90). Quercetin can also 
inhibit cell transformation and can among others react with ROS and in high 
concentrations initiate apoptosis (91-94).  
 
1.1.6 Terpenes 
A. thaliana produces a variety of terpene compounds. Terpenes represent the largest 
and most diverse class of metabolites in plants. The compounds are composed of C5 
isoprenoid units and are classified by their number (4,95). Two independent pathways 
exist for the biosynthesis of the general C5-isoprenoid precursors isopentenyl 
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diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). These are the mevalonate 
pathway and the methylerythritol phosphate pathway (MEP). The mevalonate 
pathway can be found in most eukaryotes and in prokaryotes and consists of several 
enzymatic steps. The precursor compound of this pathway is acetyl CoA. Via the 
production of mevalonic acid, IPP and DMAPP are formed. The MEP pathway takes 
place in the plastids. Its precursors are pyruvate and glyceraldehyde-3-phosphate 
(GAP). An intermediate of this pathway is 1-deoxy-D-xylulose 5-phosphate (DXP). 
Products of the MEP pathway are among others chlorophylls, carotenoids and 
gibberellins. Fig. 5 illustrates the MEP and mevalonate pathways. Chlorophylls, 
carotenoids, and plastoquinone are terpenes with primary functions in photosynthesis. 
Other terpenes with primary function in the plant physiology are ubiquinone in 
respiration and cytokinins, sterols, brassinosteroids, gibberellins and abscisic acid in 
plant growth and development (95). Terpenes have been found to also function as 
phytoalexins against blast fungus in rice (96), in defense against herbivores and 
pathogens in conifers (97) and in tobacco (98). Volatile terpenes have been described 
that attract pollinators and can have functions in defense (4, 99-102). In addition it has 
been suggested that volatile isoprenoids have anti-oxidant properties in plants (103). 
Lycopene has anti-oxidant properties and has been shown in humans to have positive 
effects in the prevention of prostate, breast, cervical, ovarian, and liver cancer (104).  
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Fig. 5: Schematic diagram of the two terpene biosynthesis pathways. The two independent pathways 
are the mevalonate and the methylerythritol phosphate (MEP). The precursor of the mevalonate 
pathway is acetyl Co-A, while the MEP pathway is derived from pyruvate and glyceraldehyde-3-
phosphate (GAP). Abbreviations: 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA), isopentenyl 
diphosphate (IPP), dimethylallyl diphosphate (DMAPP), farnesyl diphosphate (FPP), 1-deoxy-D-
xylulose 5-phosphate (DXP), 4-diphosphocytidyl-2-C-methyl-D-erythritol (CDP-ME), (E)-4-Hydroxy-
3-methyl-but-2-enyl pyrophosphate (HMBPP). Adapted from (95). 
 
1.1.7 Fatty acid derivatives 
The derivatives of fatty acids are another class of compounds with multiple functions 
in plants. Substituted acids and alkanes are components of surface waxes and suberin. 
Green leaf volatiles, hydroperoxides and ketodienes are oxylipins. Oxylipins are 
formed from fatty acids by lipoxygenase action. (4) Jasmonic acid, an oxylipin, has 
important signaling function in plant defense in response to herbivory, wounding and 
disease (105). Arabidopsis infected with the caterpillar Pieris rapae attract the 
parasitic wasp Cotesia rubecula by emitting volatiles containing among others green 
leaf volatiles (106). Not only oxylipins play a role in plant defense, but also 
unsaturated fatty acids and very long chain fatty acids have been associated with plant 
defense by altering membrane lipid composition and signaling (107,108). Fatty acids 
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are synthesized in the plastids. The compounds are formed via chain elongation of 
acetyl-CoA with malonyl-CoA. Finally, a 16- or 18- carbon acyl chain is released by 
breakage of the thioesterbond between the carbon chain and the acyl carrier protein 
(1). There is also evidence that sphingolipids may play a role in cancer development 
in animals, since it could be shown that the digestion products of the sphingolipid 
sphingomyelin found in milk, ceramide and sphingosine, inhibit colon carcinogenesis 
(109). Fingrut and Flescher could demonstrate the anticancer effects of jasmonic acid 
and methyl jasmonate (76). Jasmonic acid leads to cell death in lymphoblastic 
leukemia cells and suppresses the proliferation of several different human cancer cell 
lines. Cell death of human cancer cells was also caused by methyl jasmonate. The 
compounds did not harm normal human cells (76).  
 
1.2 Development of cancer and EpRE based chemoprevention 
The development of cancer is generally divided into three different stages. The cells 
go through a process of initiation, followed by promotion and progression. Cancer is 
initiated upon uptake of or exposure to a carcinogenic agent, radiation, UV exposure, 
or inherited defect in genes required to prevent cancer such as DNA mismatch repair 
genes. The carcinogenic agent is distributed and transported to organs and tissues, 
where it is metabolically activated (5). The carcinogen covalently interacts with 
genomic DNA leading to the activation of oncogenes and/or inactivation of tumor 
suppressor genes, via DNA mutation. This phase of tumor development is a rapid and 
irreversible process. The next step of tumor development is the reversible promotion 
phase during which the initiated cells proliferate and accumulate. With the final 
progression stage of the cancer, the tumor develops invasive and metastatic potential 
(5). 
In general xenobiotics are processed in the organism via phase I and phase II drug 
metabolizing enzymes. While phase I enzymes catalyze oxidation, reduction and 
hydrolysis of the compound, which can lead to the activation of a carcinogen, phase II 
enzymes catalyze glucuronidation, sulfation, acetylation, methylation, and 
conjugation. Cytochrome P450 monooxygenases are an important family of phase I 
activating enzymes (110). Oxidative stress is also a causal agent of carcinogenesis. 
ROS, such as hydrogen peroxide or superoxide anions are formed in the cells as a by-
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product during aerobic metabolism. For instance, in inflamed tissues, immune cells 
produce ROS and reactive nitrogen species. Other ROS producers are microbial 
infection, UV-radiation, and toxic chemicals (5,75). Phase II detoxifying and anti-
oxidant enzymes, among others glutathione S-transferase (GST), NAD(P)H quinone 
oxidoreductase 1 (QR) and heme oxygenase-1 (HO-1), protect cells against potential 
carcinogens. Anti-oxidant enzymes have a dual role. They inactivate ROS and 
eliminate and detoxify electrophiles. Therefore, they are not clearly distinguishable 
from phase II detoxification enzymes (5). The toxic compounds are converted to less 
reactive and toxic agents, via conjugation with endogenous substrates such as 
glutathione, glucuronide, or sulfate. This leads to an increase in their solubility and 
promotes their clearance from the organism (8). 
Phytochemicals are divided into two categories, depending on their way of 
intervention during cancer development. Those belonging to the category of blocking 
agents induce the detoxification of carcinogens, inhibit their metabolic activation, 
reduce their synthesis, prevent the interaction of carcinogens with DNA and remove 
free radicals, therefore interfering with the initiation stage. The mechanism behind 
this way of function is the induction of the expression of phase II detoxifying and 
anti-oxidant enzymes. The second group consists of cancer suppressing agents that 
interfere with the promotion and progression of cancer. These compounds impact the 
cell proliferation, differentiation, senescence and/or apoptosis (110) (Fig. 6). 
Examples of blocking phytochemicals playing a dual role by inducing 
detoxifying/anti-oxidant enzymes and having anti-oxidant activity themselves are 
phenolic anti-oxidants such as curcumin, and caffeic acid or the stilbene resveratrol 
(67,110). 
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Fig. 6: Schematic diagram of the role of dietary phytochemicals as inducers of cytoprotective and anti-
oxidant enzymes. The three stages of cancer development are initiation, promotion and progression. 
Phytochemicals can function as cancer blocking or cancer suppressing agents. Cancer blocking agents 
block the initiation of cancer by inhibiting carcinogens from damaging DNA, which would lead to 
mutations, or they induce detoxifying and anti-oxidant enzymes. This results in the inactivation of 
carcinogens, which are then less reactive and can be further processed by the organism. Adapted from 
(110). 
 
The induction of phase II enzymes is mediated through a common mechanism, 
controlled by an electrophile response element (EpRE). EpRE is present in the 
upstream promotor region of genes encoding phase II enzymes. A member of the NF-
E2 family of basic leucine zipper transcription factor, the nuclear factor-erythroid-2-
related factor 2 (Nrf2) plays an essential role in the induction of phase II detoxifying/ 
anti-oxidant enzymes. Nrf2 is negatively regulated via the Kelch-like ECH-associated 
protein 1 (KEAP1), which is an actin-binding protein. KEAP1 prevents the nuclear 
accumulation of Nrf2 and enhances its proteasomal degradation. A treatment with 
chemoprotective substances delays the degradation of Nrf2. Two known mechanisms 
of induction of phase II enzymes are by Nrf2 stabilization and phosphorylation. The 
protein KEAP1 contains 27 cysteine residues, some of which are necessary for the 
interaction with the N-terminal Neh2 domain of Nrf2. A modification of the cysteine 
residues by chemoprotective substances can disrupt the KEAP1/Nrf2 complex. 
Activation of Nrf2 can also take place through phosphorylation by mitogen activated 
protein kinases, protein kinase C, phosphatidylinositol 3-kinase, and ribonucleic acid 
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(RNA)-dependent protein kinase-like endoplasmatic reticulum kinase. Some 
chemopreventive agents induce the expression of these enzymes (8,111) (Fig. 7). In 
addition, it could be observed that the phytochemicals allyl-ITC, I3C and parthenolide 
lead to an increase of Nrf2 protein levels but do not affect its degradation rate (8). 
A number of phytochemicals have been shown to induce both CYPs and detoxifying 
enzymes. These compounds are known as bifunctional inducers. Monofunctional 
inducers on the other hand increase the expression of cytoprotective enzymes only. 
Two examples of monofunctional inducers are tert-butylhydroquinone and 
sulforaphane. Belonging to the bifunctional inducers are !-naphthoflavone and I3C. 
In general it is assumed that the effect of bifunctional inducers is stronger on the 
detoxifying enzyme induction in comparison to phase I enzyme induction (110).  
 
Nrf2 
 
KEAP1: Kelch-like ECH-associated protein 1; Nrf2: nuclear factor erythroid 2-related factor 2; 
maf: transcription factor; EpRE: electrophile response elements; GST: glutathione-S-transferase 
GCS: !-glutamylcysteine synthetase; QR: NAD(P)H quinone-oxidoreductase-1 
chemoprotectives 
Nrf2 maf 
induction 
EpRE 
detoxifying enzymes (GST, GCS, UGT,  
N-acetyl transferase, QR, etc.)  
KEAP1 KEAP1 
 
 
Fig. 7: Overview of the induction of detoxifying and anti-oxidant enzymes via chemoprotective 
compounds. Phase II and anti-oxidant enzymes have EpRE in their promotor region. The expression of 
these enzymes is regulated by the transcription factor Nrf2. Nrf2 is present in a complex with the 
transcription regulator KEAP1 in the cytosol. Chemoprotective compounds lead to the dissociation of 
the complex. Nrf2 can translocate into the nucleus and induce the expression of the detoxifying 
enzymes such as glutathione-S -transferase (GST) or NAD(P)H quinone oxidoreductase-1 (QR). 
 
Assay systems have been developed that apply the EpRE promotor system to screen 
for chemoprotective agents in human and murine hepatoma cell culture (112,113). In 
these assay systems the reporter genes green fluorescent protein (GFP) and Luciferase 
are downstream of EpRE promotor elements in HepG2-GFP and Hepa1c1c7-Lux 
cells, respectively (Fig. 8). Upon treatment of the cells with phytochemicals the 
reporter genes are induced to different extent.  
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EpRE EpRE GST Luciferase/GFP  
Fig. 8: Schematic diagram of the EpRE construct in human and murine reporter cells. 
 
Different approaches have been used to screen for chemoprotective substances. 
Extracts of mutant and wild-type A. thaliana plants have been tested for QR inducing 
activity (114). Grubb et al. (2001) used the QR inducer potency of leaf extracts as an 
indicator for the total glucosinolate content in mutants (115). Wang et al. (2002) 
developed a simplified bioassay for the detection of glucosinolates by measuring the 
activity of QR in Hepa1c1c7 cells after treatment with excised leaf discs of A. 
thaliana (116). The measurement of QR activity has previously been applied in assay 
systems introduced by Prochaska et al. (117,118). 
1.3 Secondary metabolite profiling in plants 
Mass spectrometry (MS) is an analytical method to determine the molecular weight or 
the mass-to-charge ratio (m/z) of a compound (119). This highly sensitive method 
allows the elucidation of metabolite structures and it is frequently used for metabolite 
profiling (120). A metabolome is defined as a complete set of low molecular weight 
molecules present in a cell or organism. The molecules are part of metabolic reactions 
that are required for the growth, maintenance and function of an organism (121,122). 
The metabolome is influenced by gene expression, which is affected by the 
environment and mutations. Plants produce a large variety of compounds that differ in 
structure, physical and chemical properties, stability and quantity, thereby making 
metabolite profiling in plants very challenging. It is to date not possible to detect all 
compounds in plants with a single method (11,120). In order to analyze plant 
secondary metabolites, different analytical techniques have been developed, such as 
combinations of liquid chromatography (LC) with mass spectrometry (MS), gas 
chromatography (GC)- MS, and capillary electrophoresis (CE)- MS (11,123). The 
analysis of secondary metabolites begins with the sample collection followed by polar 
and semi-polar extraction using ethanol (EtOH) or water, or nonpolar extraction using 
chloroform (11). The pre-fractioning of compounds via GC, LC or CE reduces the 
target sample complexity before MS (119). After the fractioning, the compounds are 
analyzed using mass spectrometry. The MS consists of four different steps. The 
compounds are ionized with soft ionization techniques for example via electro spray 
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ionization (ESI) or matrix assisted laser desorption/ionization (MALDI), so that 
positively (positive mode) or negatively (negative mode) charged ions are produced. 
These are separated in the mass analyzer depending on their mass-to-charge (m/z) 
ratio. The ions can be detected either via their current or as image currents via orbital 
frequencies. Different mass analyzers have been developed such as time of flight 
(TOF), quadruple ion trap (QIT), linear ion trap (LIT), Fourier transform ion 
cyclotron resonance (FTICR), or quadrupole-time of flight (Q-TOF) (119,122). After 
the visualization of metabolite signals in a chromatogram, the peaks are compared 
with metabolite information from standard compounds. Upon assigning a specific 
peak to a metabolite, the detected metabolites of the analyzed samples are listed 
together with their intensity data (11).  Not all metabolites can be identified in this 
way; therefore it is necessary to obtain information on the structure of a substance and 
to have the respective detailed compound libraries. The general MS procedure is 
summarized in Fig. 9. 
Samples 
(extraction in aqueous 
ethanol/water) 
Prefractionation 
(GC, LC, CE) 
 
Ionization  
(ESI, MALDI) 
 
Mass Analyzer 
(TOF, QIT, LIT, 
FTICR) 
Detector 
Data  
Analysis 
 
 
Fig. 9: Schematic diagram of mass spectrometry (MS) used for the identification of metabolites. The 
metabolites are extracted from frozen plant material. After prefractionating of the target samples, via 
gas chromatography (GC), liquid chromatography (LC) or capillary electrophoresis (CE), they are 
subjected to MS analysis. MS consists of the ionization source (electro spray ionization (ESI) or matrix 
assisted laser desorption/ionization (MALDI)), the mass analyzer (time of flight (TOF), quadruple ion 
trap (QIT), linear ion trap (LIT), Fourier transform ion cyclotron resonance (FTICR)) and the detector. 
The collected data is processed with different software and analyzed statistically. Adapted from (119). 
 
CE-MS can detect ionic metabolites for example sugar phosphates and nucleotides 
(11). GC-MS is mainly applied for the detection of primary metabolites (amino acids, 
organic acids, sugars, etc.), while LC-MS analysis can detect secondary metabolites, 
such as alkaloids, saponins, phenolic acids, phenylpropanoids, flavonoids, 
glucosinolates and polyamines (11,124-128). The latter method is performed with the 
high-resolution methods such as TOF, in order to identify new compounds. Ultra 
performance liquid chromatography (UPLC) -ESI-QTOF-MS analysis is applied in 
this work. Using this method, medium polar compounds can be detected in 
Arabidopsis; these include glucosinolates and their breakdown products, indole 
derivatives, phenylpropanoids, flavonoids/polyketides and fatty acid derivatives. It is 
not possible to detect terpenes with this protocol (129). The general workflow is 
summarized in Fig. 10. It begins with the growth of the plants and harvesting of the 
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plant material. After extraction of metabolites using aqueous EtOH, the samples are 
separated in the UPLC. The eluted compounds are detected via QTOF-MS. Different 
software is available for the processing of the LC-MS profiles. The data are further 
analyzed using various statistical methods. 
Q-TOF MS 
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alignment & 
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of MS 
datasets 
Growth & 
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plant material 
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Fig. 10: Schematic workflow of an UPLC-ESI-QTOF-MS analysis for metabolite profiling of plant 
extracts. Adapted from (124). 
1.4 Activation tagging and the TAMARA lines 
Activation tagging is the use of enhancer elements that are located on a transfer-DNA 
(T-DNA) insertion tag. In this way, the expressed genes flanking the insertion site are 
up-regulated in a distance ranging from 0.4 to 8.2 kb. It is possible that even more 
than one gene, on both sides of the insertion, can be affected. Among the activation 
tagged plant populations are also knockout mutants that contain the insertion in the 
coding region of a gene. Typically, the Cauliflower mosaic virus (CaMV) promotor 
enhancer elements of the 35S gene are used (130-132). Walden and colleagues 
introduced this method for gene analysis (133). A number of activation tagged 
Arabidopsis populations have been generated, among others by Wilson et al. (1996), 
Tissier et al. (1999), Weigel et al. (2002), Marsch-Martinez et al. (2002), Nakazawa 
et al. (2003), Schneider et al. (2005) and Robinson et al. (2009) (131,134-140). 
Besides in Arabidopsis, activation tagging has been applied in several other plant 
species, namely poplar, rice, tomato, barley and petunia (132). The method of 
activation tagging has many advantages in comparison to classical loss of function 
mutants. A large part of the Arabidopsis genome consists of duplicated loci (141). 
Due to this circumstance, many of the genes can have redundant function and 
therefore the detection of many gene functions is not possible via loss of function 
mutations. The other extreme is that the loss of function can be lethal for the plant. It 
must also be considered that some phenotypes are only visible under certain 
conditions. The advantages of activation tagging are the dominant mutations, the 
viability of the plant versus a lethal loss of function mutation, it can overcome the 
effect of gene redundancy, positive selection screens can be performed under various 
stress conditions, and the opportunity to study metabolic pathways in plants is given 
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(132). Many compounds have not yet been detected in plants because they are present 
in concentrations below the sensitivity of current detection systems (11,142). 
Therefore, the activation tagged plants can allow the detection of compounds usually 
present at very low concentrations in wild-type plants. In Arabidopsis it has been 
observed that activation tagged genes can reflect the endogenous expression pattern of 
a gene in contrast to the ectopic expression caused by a full CaMV35S promotor 
(136,143,144). Visible phenotypes were observed in 0.1 – 1% of the lines of the 
populations (131). In this work the transposable element mediated activation tagging 
mutagenesis in Arabidopsis (TAMARA), a population of 9471 lines, is used (135). 
The TAMARA population contains approximately 6,000 independent random 
transposon insertions of the T-DNA containing a CaMV35S enhancer element 
tetramer. To ensure a non-specific and high frequent integration of the T-DNA into 
the Arabidopsis genome, the maize En/Spm transposon elements were used to 
generate the activation tagged population. A. thaliana Columbia (Col-0) plants were 
transformed with the TAMARA construct, containing the immobilized Spm 
transposase gene, under the control of the CaMV35S promotor, linked with the 
negative selectable marker SU1 and the mobile element containing the bar gene as a 
positive selection marker, linked to the 4 x 35S enhancer elements and the modified 
defective Spm element (dSpm-Act) (see Fig. 11) (135). The SU1 gene confers 
sensitivity to the pro-herbicide R7402 (DuPont), which leads to the production of the 
herbicide sulfonylurea. These plants are dwarfish, dark green and have reduced apical 
dominance. The bar gene confers resistance to the herbicide phosphinotricin 
(BASTA) (132,145,146). The plants were transformed with the TAMARA construct 
using Agrobacterium tumefaciens (A. tumefaciens). Transposition events were 
selected in the T3-generation, via selection with both R7402 and BASTA. 
 
Fig. 11: Schematic diagram of the TAMARA construct. The TAMARA construct contains the Spm 
transposase gene, under the control of the CaMV35S promotor. The SU1 gene is linked to the 
transposase gene and is controlled by the Rubisco small subunit promotor. The T-DNA contains the 
defective Spm element, the CaMV35S enhancer tetramer, and the bar resistance gene. Picture taken 
from (135).  
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1.5 Aim of this work 
Currently it is postulated that there are many unknown compounds present in 
Arabidopsis in concentrations below the sensitivity of current detection systems 
(11,142). The goal of this work is to identify novel chemoprotective compounds in 
Arabidopsis and to characterize genes involved in the synthesis and metabolism of 
these compounds. In a previous screen with HepG2-GFP cells, 470 independent 
mutant lines showing a high EpRE induction potential were selected. After re-
cultivation and extract preparation of these candidate lines, they will be screened 
using a more sensitive assay system with Hepa1c1c7-Lux cells. From the expected 
positive mutants, the T-DNA insertion sites will be mapped and the expression of the 
genes flanking the insertion sites will be determined in relation to the expression in 
wild-type plants. Selected mutants are then planned to undergo untargeted metabolite 
profiling using mass spectrometry in collaboration with Prof. D. Scheel, Dr. Stephan 
Schmidt, and Dr. Christoph Böttcher (IPB, Halle). Further analyses of mutants 
selected on the basis of available metabolite profiles or the putative gene functions of 
the affected genes are planned. 
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2 Materials & Methods 
2.1 Materials 
2.1.1 Instruments, equipment and disposable materials 
The manufacturer of the instruments and equipment used during the laboratory work 
are specified in the corresponding method parts. Disposable material was supplied by 
VWR (Darmstadt, D).  
2.1.2 Chemicals and kits  
The analytical chemicals were obtained from the companies Biomol (Hamburg, D), 
Difco (Hamburg, D), Duchefa (Haarleem, NL), Fluka (Buchs, CH), Merck AG 
(Darmstadt, D), Roth (Karlsruhe, D), Sigma-Aldrich (Deisenhofen, D) and Serva 
(Heidelberg, D). The applied kits and ready to use solutions are listed in Table 1. 
Media and solutions for animal cell culture are listed in Table 2. 
 
Table 1: List of kits  
Name Supplier 
BigDye " Terminator V3.1 cycle sequencing kit Applied Biosystems, (Foster city, USA) 
E.Z.N.A." gel purification kit Omega Bio-Tek, Inc. (Norcross, GA, USA) 
Quantum prep " plasmid miniprep kit BioRad, (München, D) 
BCATM protein assay kit Pierce, (Rockford, USA) 
MinElute Gel Extraction Kit  Qiagen, (Hilden, D) 
QIAquick Gel Extraction Kit  Qiagen, (Hilden, D) 
Superscript II Reverse Transcriptase Kit  Invitrogen, Life Technologies (Karlsruhe, D) 
SYBR GREEN PCR mix Applied Biosystems, (Darmstadt, D) 
SensiMixTM SYBR" kit Bioline Reagents Ltd., (London, GB) 
Brilliant SYBR" Green QPCR Core Reagen kit Agilent Technologies (Böblingen, D) 
 
Table 2: Ready-to-use media and solutions for animal cell culture 
Name Supplier 
DPBS  Gibco", invitrogen 
Geneticin G418  Gibco",invitrogen 
L-Glutamine  Gibco",invitrogen 
Pen-Strep  Gibco",invitrogen 
Recovery freezing media  Gibco", Invitrogen 
RPMI 1640  Gibco", invitrogen 
#-MEM  Gibco", invitrogen 
accutase  PAAThe cell culture company  
trypsin-EDTA  Invitrogen 
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2.1.3 Enzymes 
The enzymes for molecular biological work were obtained from the companies MBI 
Fermentas GmbH (St.Leon-Rot, D), Roche Molecular Biochemicals (Mannheim, D), 
Qiagen GmbH (Hilden, D) and New England Biolabs (Frankfurt/Main, D). The 
enzymes and suppliers are specified in the corresponding method chapters. 
2.1.4  Vectors 
The vectors used for cloning and protein expression are listed in Table 3.  
 
Table 3: List of vectors 
Vector Application and reference 
pENTR-1A Gateway compatible entry clone via classical cloning; kanamycin resistance gene 
(Invitrogen, Karlsruhe, D).  
pENTR-4 Gateway compatible entry clone via classical cloning; kanamycin resistance gene 
(Invitrogen, Karlsruhe, D). 
pDONR207 Gateway donor vector via BP-reaction; gentamycin resistance gene (Invitrogen, 
Karlsruhe, D). 
pGWB2 Expression vector; 35S CaMV promotor for overexpression of a target gene in planta, 
kanamycin and hygromycin resistance genes for selection in plants and in bacteria. 
pGWB3i Expression vector with C-terminal GUS gene for promotor analysis in planta; 
modified version of pGWB3 (147) with a plant intron in the GUS gene to inhibit 
bacterial expression (148). Kanamycin and hygromycin resistance genes for selection 
in plants and in bacteria. 
pGWB5 Expression vector with 35S CaMV promotor and production of C-terminal GFP fusion 
protein. Kanamycin and hygromycin resistance genes for selection in plants and in 
bacteria (147). 
pGWB6 Expression vector with 35S CaMV promotor and production of N-terminal GFP fusion 
protein. Kanamycin and hygromycin resistance genes for selection in plants and in 
bacteria (147).  
pAMPAT Gateway compatible expression vector with 35S CaMV promotor. 
Ampicillin/Carbenicillin resistance gene for selection in bacteria. Bar gene for 
selection with BASTA" in planta. Derivative of pAMPAT-MCS binary vector (Lipka 
V, Rademacher T, Panstruga R, 2003). 
 
2.1.5 Antibiotics 
Table 4 lists the antibiotics used for the selection of transformed Escherichia coli (E. 
coli) and A. tumefaciens, as well as for the selection of transgenic A. thaliana plants. 
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Table 4: List of antibiotics and concentrations 
Antibiotic Concentration Solvent Supplier 
amphotericin 5 !g/mL (A. thaliana) H2O Sigma 
carbenicillin 100 !g/mL Tris HCl pH 8.0 Serva, Duchefa 
chloramphenicol 10 !g/mL (E. coli DB3.1) EtOH Duchefa, Roth, 
Sigma 
 75 !g/mL (A. tumefaciens)   
gentamycin 25 !g/mL (A. tumefaciens SV-0) H2O AppliChem 
 10 !g/mL (E. coli)   
hygromycin 50 !g/mL H2O Duchefa  
 50 !g/mL (A. thaliana)   
kanamycin  50 !g/mL 
50 !g/mL (A. thaliana) 
H2O Duchefa 
phosphinothricin 10 !g/mL (A. thaliana) H2O Dr. Ehrenstorfer 
GmbH 
BASTA 250 mg/L  Bayer 
rifampicin 20 !g/mL (A. tumefaciens SV-0) DMSO  
 50 !g/mL (A. tumefaciens GV3101 
pMP90, GV3101 pMP90RK) 
 Duchefa 
 150 !g/mL (A. tumefaciens P19)   
ticarcillin 160 !g/mL (A. thaliana) H2O Duchefa 
 
2.1.6 Oligonucleotides 
The oligonucleotides (primers) were supplied by Metabion GmbH (Martinsried, D) 
and Sigma-Aldrich" (Deisenhofen, D). For cloning purposes the primers were 
designed using Vector NTI" software (Invitrogen, Karlsruhe, D). The 
oligonucleotides for Real time PCR (polymerase chain reaction) were designed using 
the software primer Express" (Applied Biosystems, Darmstadt, D). The complete list 
of oligonucleotides can be found in the appendix. 
2.1.7 Organisms 
2.1.7.1  Plants 
The leaves of the tobacco plants Nicotiana benthamiana (N. benthamiana) were used 
for subcellular localization studies via transient expression of GFP fusion proteins. A. 
thaliana L-Heyn cv. Columbia-0 (Col-0) (Nottingham Arabidopsis Stock Center  
(NASC)-Nr. N1093) functioned as a background for the overexpression of target 
genes and the study of loss of function mutations. Table 5 is a list of A. thaliana 
mutants used in this work.  
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Table 5: List of A. thaliana mutants 
Mutant Species, ecotype Origin 
TAMARA lines A. thaliana, Col-0 Schneider et al. (2005) (135) 
WiscDsLox461-464F2 
pyk10-1 
A. thaliana, Col-0 Nottingham Arabidopsis Stock Center  
myb11/myb12/myb111 A. thaliana, Col-0 Stracke et al. (2007) (149) 
MIM858 A. thaliana, Col-0 Todesco et al. (2010) (150) 
hig1-1 A. thaliana, Col-0 Gigolashvili et al. (2007) (151) 
2.1.7.2 Bacterial strains 
Table 6: Bacterial strains 
Strain Genotype, reference 
DB3.1 (E. coli) 
cultivation of plasmid containing ccdB 
F- gyrA462 endA1 "(sr1-recA) mcrB mrr 
hsdS20(rB-, mB-) supE44 ara-14 galK2 lacY1 
proA2 rpsL20(SmR) xyl-5 #- leu mtl1  
(Invitrogen, Karlsruhe, D) 
DH5# (E. coli) 
cultivation of plasmid DNA 
F- $ 80dlacZ"M15 "(lacZYA-argF)U169 deoR 
recA1 endA1hsdR17(rK- mK+) phoA supE44 #- 
thi-1 gyrA96 relA1  (152) 
GV3101 (A. tumefaciens) 
stable plant transformation 
pMP90, RifR, GentR (153) 
GV3101 (A. tumefaciens) 
stable plant transformation with vector pAMPAT 
pMP90RK, RifR, GentR, KanR 
P19 (A. tumefaciens) 
anti-silencing strain 
C58C1-pCH32-35S:p19, RifR, KanR (154) 
SV0 (A. tumefaciens) 
transient expression in leaves and cultured cells 
LBA4404.pBBR1MCS virGN54D RifR, ChlorR 
(155) 
TOP10 (E. coli) 
cultivation of plasmid DNA 
F-mcrA "(mrr-hsdRMS-mcrBC) $ 
80dlacZ"M15 "lacX74 recA1araD139 "(ara-
leu)7697 galU galK rpsL (StrR) endA1 nupG 
(Invitrogen, Karlsruhe, D) 
2.1.7.3 Human and murine cell culture 
Prof. Dr. William E. Fahl (University of Wisconsin, USA) provided HepG2 cells 
containing the EpRE-TK-GFP construct. The human liver epithelial cells are derived 
from a hepatocellular carcinoma of a 15-year-old Caucasian boy. The Hepa1c1c7 
cells were provided by the American Type culture collection (Manassas, VA, USA). 
The Mus musculus derived hepatoma cells are liver epithelial cells. The Hepa1c1c7-
Lux (EpRE(mGST-Ya)-LUX) cells were kindly provided by Dr. Aarts (Wageningen 
University, Netherlands). The cells contain the EpRE-LuX construct. 
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2.1.8 Computer software 
Table 7: Computer software 
Software Manufacturer 
Edit view Applied Biosystems 
Fluorescence microscope, binocular Intas GDS 
Gel documentation Intas GDS 
i-control 1.4 Tecan Group Ltd. Infinite 200 
Magellan6 Tecan Group Ltd. Infinite 200 
primer express Applied Biosystems 
SDS software Applied Biosystems 
Vector NTI Invitrogen 
ZEN lite 2009 Zeiss 
 
2.2 Microbiological methods 
2.2.1 Preparation of media 
Lysogeny broth medium (LB-medium) from Sambrook & Russel (2001) (156) 
5 g  yeast extract 
10 g peptone 
10 g NaCl 
(12 g agarose) 
ad 1000 mL with H2Omillipore  
autoclave 
 
Yeast extract and beef medium (YEB-medium) 
5 g bacto peptone 
1 g yeast extract 
5 g beef extract 
5 g saccharose 
0.5 g MgSO4 x 7H2O 
(15 g agarose) 
ad 1000 mL with H2Omillipore 
autoclave 
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Super optimal broth medium (SOB-medium) 
0.5%  yeast extract 
2% tryptone 
10 mM NaCl 
2.5 mM KCl 
10 mM  MgCl2 
10 mM MgSO4 
H2Omillipore 
 
 
 
For the preparation of SOB-medium yeast extract, tryptone, NaCl and KCl were 
suspended in H2Omillipore. After autoclaving, sterile filtered MgCl2 and MgSO4 were 
added to the medium.  
 
Super optimal broth with Catabolite Repression (SOC-medium)  
SOC-medium consists of SOB-medium with 20 mM sterile filtered glucose. 
2.2.2 Cultivation of bacteria 
2.2.2.1  Cultivation of E. coli cells on LB-plates 
E. coli cells were evenly spread on LB-plates containing the appropriate antibiotics 
for selection. The bacteria were incubated for 12-24 h at 37 °C. 
2.2.2.2  Cultivation of E. coli cells in liquid medium 
4 mL of liquid LB medium, containing the appropriate antibiotics, was inoculated 
with E. coli cells from one colony. The bacteria were cultivated at 37 °C on a shaking 
incubator 220 rpm for 24 h (Multitron, Infors GmbH, Einsbach, D).  
2.2.2.3 Cultivation of A. tumefaciens on YEB-plates 
A. tumefaciens cells were spread on YEB-plates containing the appropriate antibiotics 
for selection. The bacteria were incubated, depending on the bacterial strain, for 2 to 5 
days at 28 °C. 
2.2.2.4 Cultivation of A. tumefaciens in liquid medium 
Single colonies of A. tumefaciens were used to inoculate liquid YEB-medium, 
containing the appropriate antibiotics for selecting the bacterial strain and the plasmid. 
Depending on the strain, the agrobacteria could be inoculated in the final needed 
volume of YEB medium (LBA4404, GV3101) or first in 1 mL of YEB (GV3101 
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pMP90RK), which was then used to inoculate larger volumes (50 mL) of YEB 
medium. The bacteria were grown at 28 °C on a shaking incubator at 220 rpm 
(Multitron, Infors GmbH, Einsbach, D). 
2.2.2.5  Long-term storage of bacteria 
For long-term storage of transgenic bacteria, these were grown in the respective liquid 
medium with antibiotics and mixed in equal volumes (0.5 - 1 mL each) with 60% 
glycerol. The mixture was immediately frozen in liquid nitrogen and stored at -80 °C. 
2.2.3 Production of competent bacteria 
For the production of competent bacteria, different protocols were used, depending on 
the bacteria and method of transformation. 
2.2.3.1 Chemically competent E. coli cells (DH5!, TOP10) 
100 - 500 mL Psi broth was inoculated with 200 to 1000 !L of pre-cultured E. coli 
cells. The bacteria were cultured on a shaking incubator at 37 °C and 220 rpm 
(Multitron, Infors GmbH, Einsbach, D), until they reached an OD600 of 0.6 – 0.7. The 
cells were incubated on ice for 15 min and then centrifuged at 4000 x g for 5 min (4 
°C) (Eppendorf centrifuge, 5810 R). The bacterial pellet was resuspended in 0.4 
volume of TfBI. After incubation on ice for 15 min, the cells were centrifuged (4000 
x g, 5 min, 4 °C) and the pellet resuspended in 0.04 volumes of TfbII. Aliquots of 100 
!L each, were prepared, after the cells had incubated on ice for 15 min, and were 
immediately frozen in liquid nitrogen and stored at -80 °C.  
 
Psi 
broth: 
5 g/L  
bacto yeast extract 
TfbI : 30 mM  
potassium acetate 
(CH3CO2K) 
TfbII: 
 
10 mM MOPS 
 
 20 g/L  
bacto tryptone 
 100 mM RbCl  75 mM CaCl 
 5 g/L MgSO4  10 mM CaCl  10 mM RbCl 
   50 mM MnCl2 
 
 15%  
(v/v) glycerol 
   15% v/v glycerol   
 (pH 7.6 NaOH)  (pH 5.8 acetic acid)  (pH 6.5 NaOH) 
 autoclave  filter sterilize 
 
 filter sterilize 
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2.2.3.2 Chemically competent A. tumefaciens 
A. tumefaciens were grown on a shaking incubator (220 rpm, Multitron, Infors GmbH, 
Einsbach, D) for 12-16 h in 5 mL YEB, containing antibiotics The bacterial pre-
culture was used to inoculate 500 mL of YEB medium, which were grown for 4 - 6 h 
until they reached an OD600 0.5-0.6. The bacterial culture was centrifuged at 7000 x g 
at 4 °C for 5 min. The bacterial pellet was resuspended in 25 mL (4 °C) 0.15 M NaCl 
and incubated for 15 min. The cells were centrifuged for 5 min at 7000 x g and 4 °C. 
The pellet was resuspended in a total volume of 5 mL (4 °C) 20 mM CaCl2. Aliquots 
of 50-100 !L were immediately frozen in liquid nitrogen. The competent cells were 
stored at -80 °C.  
 
2.2.3.3  Electro competent A. tumefaciens 
Two flasks, each containing 5 mL of MGL-medium, were inoculated with 
agrobacteria. The agrobacteria were cultivated on a shaking incubator at 28 °C for 24 
- 48 h at 220 rpm (Multitron, Infors GmbH, Einsbach, D). The pre-culture was diluted 
in 100 mL MGL-medium (OD600: 0.04- 0.08). The bacteria were cultivated until they 
reached an OD600 of 0.5. After a centrifugation step for 15 min at 4,000 x g the pellet 
was resuspended in 40 mL 1 mM HEPES buffer (pH 7.0). All steps were performed 
on ice. After another centrifugation step, the bacterial pellet was resuspended in 40 
mL 1 mM HEPES buffer (pH 7.0)/ 10% glycerol. After the next centrifugation the 
pellet was resuspended in 2 mL 1 mM HEPES pH 7.0/ 10% glycerol. The bacteria 
were evenly distributed between two reaction tubes. The two pellets were each 
resuspended in 200 !L 1 mM HEPES pH 7.0/ 10% glycerol. 50 !L aliquots were 
immediately frozen in liquid nitrogen and stored at -80 °C. 
MGL-medium: 5 g/L bacto-tryptone 1 mM HEPES/  1 mM HEPES/  
 2.5 g/L yeast extract KOH pH 7.0 KOH pH 7.0/ 
 5 g/L NaCl  10% glycerol 
 5 g/L mannitol   
 1.16 g/L Na-glutamate   
 0.25 g/L KH2PO4   
 0.1 g/L MgSO4 x 7H2O   
 1 mg/L bithin (stock: 10 mg/mL) 
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2.2.4 Transformation of competent bacteria 
2.2.4.1 Transformation of chemically competent E. coli cells 
Competent E. coli cells were thawed on ice. For transformation 50-200 ng of plasmid 
DNA, BP, LR or ligation reaction (see chapter 2.4.3.1) was added to the cells. The 
samples were incubated on ice for 30 min, before being subjected to a 90 s heat shock 
in a 42 °C water bath. The samples were cooled on ice and 1 mL of LB medium or 
SOC medium was added to the cells. After shaking the bacteria at 37 °C (220 rpm, 
Multitron, Infors GmbH, Einsbach, D) for one hour, 200 – 1000 !L of cells were 
plated onto selective LB-plates. These were incubated at 37 °C for 12 -14 h. 
2.2.4.2 Transformation of chemically competent A. tumefaciens cells 
50-200 ng of plasmid DNA was added to the thawed competent A. tumefaciens cells. 
The mixture of DNA and agrobacteria was frozen in liquid nitrogen and then thawed 
again and subjected to a 2 min heat shock at 42 °C. 800 !L of YEB was added to each 
sample. The bacteria were incubated at 28 °C for 2 h and shaken with 220 rpm 
(Multitron, Infors GmbH, Einsbach, D). Different amounts of agrobacteria were 
plated on several YEB selection plates. 
 
2.2.4.3 Electroporation of competent A. tumefaciens cells 
200 ng of plasmid DNA was pipetted to 50 !L of thawed competent A. tumefaciens 
and incubated on ice for 2 min. The agrobacteria were transferred into a pre-cooled 2 
mm electroporation cuvette (PEQlab, Erlangen, Germany) and subjected to 2 s 
electroporation using the electroporator Genepulser II (Bio-Rad, München, D) with 
the following parameters: 25 !F; 400 %; 2.5 kV; 8 – 9 ms 
Immediately after electroporation 1 mL of YEB was added to the cells and they were 
incubated on the shaker for 2 h at 28 °C and 220 rpm (Multitron, Infors GmbH, 
Einsbach, D). The bacteria were plated on several selective YEB plates in different 
amounts. 
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2.3 Plant cultivation 
2.3.1 Preparation of " MS-medium 
10 g saccharose 
2.3 g Murashige & Skoog Medium with 
modified vitamins (Duchefa, Haarleem, 
NL) 
8 g plant agar/gelrite 
ad 1000 mL  
 
pH 5.6 with KOH  
(autoclave) 
 
with H2Omillipore 
 
2.3.2 Seed sterilization 
For sterilization, the seeds were transferred into a 1.5 mL reaction tube and incubated 
for 2 min in 70% EtOH. The seeds were mixed well with the EtOH. After the seeds 
had settled on the bottom of the reaction tube, the 70% EtOH was removed with a 
pipette. This step was repeated with 96% EtOH. The seeds were dried under the 
sterile hood and transferred onto sterile plates with & MS-medium and selective 
antibiotics.  
2.3.3 Cultivation of A. thaliana on soil 
A. thaliana seeds were germinated in plastic pots with 6 cm diameter (Pöppelmann, 
Lohne). The substrate was a mixture of Einheitserde" type VM and Perligran" (ca. 
100 – 150 g/ 70 L). After the seeds were sown, they were covered with a plastic lid, to 
maintain a high humidity, and stratified for 2 to 3 days in the dark at 4 °C. The pots 
were then transferred into a growth chamber/cabinet or greenhouse. After 
approximately 2 weeks, the seedlings were separated and planted into single 6 cm 
pots or into multi-plates for 77 plants. Transgenic A. thaliana lines containing the bar 
gene were selected with BASTA". The BASTA" solution consisted of 250 mg/L 
BASTA and 0.1% Tween-20. The plants were sprayed with the solution when they 
had developed four leaves. 
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components: 
Einheitserde"  
type VM: 
 
natural clay 
white peat 
sod peat 
 
pH 5.8 
KCl (g/L): 1.0 
N (mg/L): 100 
P2O5 (mg/L): 180 
K2O (mg/L): 180 
S mg/L: 200 
Mg (mg/L): 500 
 
2.3.4 Growth conditions 
2.3.4.1 Green house 
In the green house the plants were cultivated under long day conditions (with 16 h 
light and 8 h of darkness) and a relative humidity of 40%. The temperature during the 
dark was 18 °C, in the light 21 °C. The photon flow density of the photosynthetic 
active radiation varied due to outside conditions.  
2.3.4.2 Plant growth cabinet or chamber 
To reduce the variation between the plants and to increase the reproducibility of the 
results the plants were cultivated in growth cabinets or chambers. The conditions were 
either long day or short day, which 16 and 8 h of light, respectively. During the light 
period the temperature was 21 °C, it was reduced to 18 °C during the dark. The air 
humidity was 40%. The light intensity was 120 !mol m-2s-1. Under high light 
conditions the light intensity was 280 !mol m-2s-1. 
 
2.4 Molecular biology 
2.4.1 Extraction of nucleic acid 
2.4.1.1  DNA extraction  
Genomic DNA was extracted from A. thaliana leaves according to the protocol of 
Edwards et al. (1991) (157). The leaf material was immediately frozen in liquid 
nitrogen after harvest. The leaf tissue was homogenized for 1 min at 20 Hz using the 
tissue lyser (Qiagen, Hilden, D). 400 !L of extraction buffer was added and the 
samples were vortexed for 5 s (VortexGenie 2, Scientfic Industries, Inc, Bohemia, 
NY, USA). After 5 min of centrifugation  (Minispin, Eppendorf AG, Hamburg, D) at 
  
!
Materials & Methods 
!
! !
31 
12,000 x g, 300 !L of supernatant was transferred into a new tube and mixed with 
300 !L 2-propanol. The samples were incubated at room temperature for 2 min and 
then centrifuged for 5 min at 12,000 x g. The DNA pellet was vacuum dried using a 
concentrator (concentrator 5301, Eppendorf AG, Hamburg, D) and resuspended in 
100 !L of TE-buffer. The genomic DNA was stored at -20 °C.  
DNA extraction  200 mM Tris HCl, pH 7.5 1 x TE  10 mM Tris HCl, pH 7.4 
buffer: 250 mM NaCl buffer: 1 mM EDTA, pH 8.0 
 25 mM EDTA   
 0.5% SDS   
 
2.4.1.2 Genomic DNA extraction from inflorescences 
For a high yield of pure genomic DNA, 4 – 6 inflorescences and/ or leaf material was 
collected and immediately frozen in liquid nitrogen. Each sample was homogenized in 
250 !L of extraction buffer using a tissue lyser (Qiagen, Hilden, D). After addition of 
further 250 !L extraction buffer, the samples were mixed with 400 !L of PCI. The 
samples were centrifuged for 15 min at 1,300 x g (Eppendorf centrifuge, 5417R). The 
supernatant was mixed with 800 !L 2-propanol and incubated for 10 min at room 
temperature. The precipitate was pelleted at 1,300 x g, for 10 min. The DNA pellet 
was washed twice in 70% EtOH and centrifuged after each washing step for 10 min at 
500 x g. Succeeding drying of the DNA, the pellet was resuspended in 40 !L of TE 
buffer (pH 8.0). The DNA was stored at -20 °C. The quality of the DNA was checked 
by separation 1 !L of genomic DNA in a 1% agarose gel.  
 
The DNA extraction buffer was prepared shortly before DNA extraction by adding 
the respective amounts of urea (from 12 M urea stock solution) and phenol to the 2 x 
DNA extraction buffer (stock solution). 
DNA 
extraction 
buffer: 
0.3 M NaCl 
50 mM Tris pH 7.5 
20 mM EDTA 
2% (w/v) sarcosyl 
0.5% (w/v) SDS 
4.8 M urea 
5% (v/v) phenol 
2 x Buffer 
for DNA 
extraction: 
0.6 M NaCl 
100 mM Tris pH 7.5 
40 mM EDTA 
4% (w/v) sarcosyl 
1% (w/v) SDS 
phenol/chloroform/isoamylalcohol (25:24:1) (PCI) 
70% EtOH 
1 x TE: 10 mM Tris pH 7.5; 1 mM EDTA pH 8.0 
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2.4.1.3  RNA extraction 
2.4.1.3.1.1  RNA extraction using TRIzol (Invitrogen) or TRIsure (Bioline) reagent 
50 – 100 mg of plant material was harvested and immediately frozen in liquid 
nitrogen. The tissue was homogenized and 800 !L of TRIzol was added to the 
samples. The samples were mixed well and then centrifuged at 18,000 x g for 10 min 
(4 °C) (Eppendorf centrifuge, 5417). The supernatant was transferred into a 2 mL 
reaction tube and the samples were incubated at room temperature for 5 min. 160 !L 
of chloroform was added to the samples, after mixing them thoroughly, they were 
incubated at room temperature for 2 – 3 min. The samples were centrifuged at 12,000 
x g for 15 min, at 4 °C. The aqueous phase was transferred with a pipette to a new 1.5 
mL reaction tube. The RNA was precipitated by the addition of 0.3 mL 2-propanol. 
After 10 min incubation at room temperature, the samples were centrifuged for 10 
min (4 °C and 12,000 x g). The RNA was washed with 600 !L of 75% EtOH 
(H2ODEPC). After centrifuging the samples for 5 min, at 4 °C and 7,500 x g, the RNA 
pellet was dried and resuspended in 30 !L ultra pure RNase free water. The RNA was 
incubated for 10 min at 60 °C. 
2.4.1.3.1.2  RNA extraction using Z6-buffer 
After harvesting of the plant material (50 – 100 mg), it was immediately frozen in 
liquid nitrogen to reduce RNase activity. The plant material was homogenized using 
the tissue lyser (Qiagen, Hilden, D). The powdery material was immediately frozen 
again in liquid nitrogen. 800 !L of Z6-buffer was added to the samples, after they 
were placed on ice. After mixing the samples with the Z6-buffer, they were 
centrifuged for 15 min at 17,950 x g and 4 °C (Eppendorf centrifuge, 5417). The 
supernatant was pipetted into a new 2 mL reaction tube. 500 !L of freshly prepared 
phenol/chloroform/isoamylalcohol (25/24/1) was added to each sample. After mixing 
the samples thoroughly, they were incubated for 2 min at room temperature and then 
centrifuged for 15 min at 12,000 x g and 4 °C. The aqueous phase was transferred into 
a 1.5 mL reaction tube and mixed with 1/20 volume of 1 M acetic acid and 0.7 
volume of 96% EtOH. The RNA was precipitated at -20 °C for 1 h. The RNA was 
pelleted at 18,000 x g for 15 min (4 °C) and washed in 500 !L 3 M sodium acetate 
and in 500 !L 70% EtOH, each step followed by centrifugation (15 min, 18000 x g, 4 
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°C). The pellet was dried using the vacuum concentrator (Eppendorf concentrator 
5301) and resuspended in 25 – 40 !L of H2Oultrapure. The RNA was incubated on a 
shaker at 65 °C until the RNA was completely resuspended. DNA contaminations in 
the samples were digested as described in chapter 2.4.3.6. 
Z6-buffer: 
 
8 M  
guanidinium-
hydrochloride 
1 M acetic acid: 
(H2ODEPC) 
3 M sodium 
acetate:  (H2ODEPC) 
75% EtOH 
(H2ODEPC) 
 20 mM MES  (pH 5.0 acetic acid)  
 20 mM EDTA, 
(pH 7.0) 
   
 0.7% (v/v) !-
mercaptoethanol 
(added shortly 
before use) 
   
 H2ODEPC    
 
0.01% DEPC H2O: 
100 !L DEPC in 1000 mL H2O 
The H2O was stirred using a magnetic stirrer over night and then autoclaved twice. 
2.4.2 Plasmid mini preparation from E. coli 
4 mL of E. coli cells, grown in liquid LB-medium for 12 – 16 h, were centrifuged in 2 
mL reaction tubes (1 min, 12,000 x g) (Minispin, Eppendorf AG, Hamburg, D). The 
supernatant was removed and the bacterial pellet was resuspended in 200 !L of 
solution 1. 200 !L of solution 2 was added to the samples. After inverting the tubes 
several times, 200 !L of solution 3 was pipetted to the samples. The samples were 
incubated on ice for 10 min. After 10 min centrifugation at 12,000 x g the supernatant 
was pipetted onto a column and mixed with 200 !L of binding matrix. Following a 
centrifugation step (30 s, 12,000 x g), the flow through was discarded and the plasmid 
DNA that was bound to the matrix was washed twice using 500 !L of washing buffer. 
After the first washing step, the columns were centrifuged for 30 s and succeeding the 
second washing step the columns were centrifuged for 2 min at 12,000 x g. In the 
final step the plasmid DNA was eluted from the columns by adding 100 !L of H2O, 
TE or EB-buffer to the columns. These were centrifuged for 1 min at 12,000 x g and 
the plasmid DNA was collected in a 1.5 mL reaction tube. The plasmid DNA was 
stored at -20 °C. 
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Resuspension 
solution (1): 
50 mM glucose  
25 mM Tris-HCl  
(pH 8.0) 
Alkaline lysis 
solution 2: 
0.2 N NaOH 
1% SDS 
 10 mM EDTA  
(pH 8.0) 
  
 20 !g/mL RNase A   
    
Binding 
matrix: 
5.3 M guanidine HCl Washing 
buffer: 
20 mM Tris-HCl (pH 8.0) 
2 mM EDTA (pH 8.0) 
 20 mM Tris (pH 8.0)   0.2 M NaCl 
 0.15 g/mL 
diatomaceous earth 
 50% EtOH 
Neutralization 
solution 3: 
5.3 M guanidine-HCl 
0.7 M KAc (pH 5.0) 
 
2.4.3 Nucleic acid analysis and modification 
2.4.3.1 Molecular cloning 
In the course of this work two types of methods were applied to insert a gene or 
promotor sequence into an entry vector. Either via ligation of a DNA-fragment here 
referred to as classical cloning, or via site-specific recombination using the gateway" 
cloning methodology (Invitrogen, Karlsruhe).  
2.4.3.1.1 Classical cloning 
The major steps for classical cloning include the amplification of a DNA sequence 
using a proof reading polymerase (chapter 2.4.3.8.2), the linearization of an entry 
vector via restriction digestion (chapter 2.4.3.3), the preparation of the DNA fragment 
(insert) via restriction digestion and the ligation of the insert into the entry vector 
(chapter 2.4.3.5). Competent E. coli cells (TOP10, DH5#) were transformed with the 
ligated DNA (chapter 2.2.4.1) and positive clones were selected on LB-plates with the 
corresponding antibiotics. E. coli colonies were then tested for the presence of the 
specific insert via colony PCR (chapter 2.4.3.8). After cultivation of the bacteria in 
liquid LB-medium (chapter 2.2.2.2), the plasmid DNA was purified (chapter 2.4.2) 
and digested with restriction enzymes. To check for mutations the insert was 
sequenced and compared to the published gene sequences found among others in the 
public databases such as TAIR (158) and ARAMEMNON (159). In the course of this 
work DNA fragments were cloned into the entry vectors pENTR1A and pENTR4. 
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The restriction enzymes used for cloning in this work were EcoRI, NotI, BamHI and 
NcoI.  
2.4.3.1.2 Gateway 
Entry clones were also produced via gateway" cloning (Invitrogen, Karlsruhe, D). 
This included the amplification of a PCR fragment with primers containing attB sites. 
The attB-site-PCR fragment was then recombined and inserted into an entry vector 
containing attP sites, such as pDONR207. The expression clones (see Table 1), 
constructed in this work, were assembled with the help of the gateway technology via 
LR reactions. During this process the attL sites of the gateway cassette of the entry 
clone recombine and insert into the expression vector, which contains the attR sites. 
The BP or LR reactions were incubated for 12 – 16 h and room temperature. The 
complete reaction mix was then transformed into competent E. coli cells (2.2.4.1). 
 
BP: 
 
10 – 100 ng attB-PCR product  
 
LR: 
 
12.5 – 37.5 ng entry clone 
(pENTR1A, pENTR4, 
pDONR207) 
 37.5 ng donor vector (pDONR207)  37.5 ng destination vector 
(pGWBs, pAMPAT) 
 1 !L BP 5 x clonase buffer  0.5 !L LR ClonaseTM II enzyme 
mix 
 1 !L BP clonase enzyme   
 ad 5 !L with TE buffer (pH 8.0)  ad 2.5 !L with TE buffer (pH 8.0) 
 
2.4.3.2 Determination of nucleic acid concentration 
Nucleic acid concentrations were determined using the NanoDrop® ND-100 
Spektrophotometers (Nanodrop Technologies, Wilmington, US), via determination of 
the optical density (OD). The nucleic acid concentration was determined at a 
wavelength of $ = 260 nm. Calculating the ration between $ = 260/280 nm indicates 
the purity of the nucleic acid. The value of pure nucleic acid should be between 1.8 
and 2.0. The measurements were performed as described by the manufacturer. 
2.4.3.3  Restriction Digestion 
Two forms of restriction digestion protocols were used. Plasmid DNA was digested 
either as a control digestion or for cloning applications. 
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Control DNA digestion:  Preparative DNA digestion: 
0.2 – 1.5 !g plasmid DNA   0.5-3 !g plasmid DNA/PCR fragment 
0.4 !L enzyme I (10 u/!L)  1-1.5 !L enzyme 1 (10 u/!L) 
(0.4 !L enzyme I (10 u/!L))  (1-1.5 !L enzyme 1 (10 u/!L)) 
0.1 vol of 10 x restriction buffer  0.1 vol of 10 x restriction buffer 
H2Obidest ad 20 !L  H2Obidest ad 30 - 40 !L 
 
The digestion reaction-cocktail was incubated for at least 1 h at the temperature 
recommended by the supplier for the specific enzymes. After the restriction digestion, 
the DNA was separated via electrophoresis in a 1 – 1.5% agarose gel (2.4.3.9). 
 
2.4.3.4 Dephosphorylation 
Linearized vectors were dephosphorylated prior to the ligation reaction. This was 
especially important when the restriction sites were blunt end or the vector was only 
digested with one restriction enzyme. The dephosphorylation of the vector ends 
inhibits self-ligation of the vector. For the dephosphorylation reaction the shrimp 
alkaline phosphatase (SAP) was used as described by the manufacturer (MBI 
Fermentas GmbH, St Leon-Rot, D). 
2.4.3.5 Ligation of DNA fragments 
DNA fragments were ligated using the T4 DNA Ligase (MBI Fermentas GmbH, St 
Leon-Rot, D). For cloning purposes the PCR fragments were ligated into the vector as 
recommended by the manufacturer: 
20 – 100 ng linearized vector 
1:1 – 1:5 molar ratio of insert DNA:vector 
2 !L 10 x T4 DNA ligase buffer (5 u/!L) 
1 !L T4 DNA ligase 
H2Obidest ad 20 !L 
 
The ligation reaction-cocktail was incubated for 12 to 16 h at 4 °C and then directly 
transformed into competent E. coli cells (chapter 2.2.4.1).  
2.4.3.6 Genomic DNA digestion using DNase-I in RNA samples 
Genomic DNA contaminations in RNA samples were removed by digestion with 
DNase-I (DNase-free-kit, Ambion", Applied Biosystems, Darmstadt, D) before the 
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RNA was further processed for analysis. The reaction-mixture consisted of the 
following components: 
5 !g RNA 
2.5 !L 10 x buffer DNase-I 
0.5 !L DNase-I (2 u/!L) 
H2Oultrapure ad 25 !L 
 
After 30 min incubation at 37 °C, the DNase-I was inactivated by adding 2.5 !L of 
DNase-I inactivation reagent. The samples were mixed thoroughly during a 2-min 
incubation time at room temperature. The inactivation reagent was removed from the 
samples by centrifugation (1.5 min, 12,000 x g, Minispin, Eppendorf). The 
supernatant was transferred into a new reaction tube. The DNase treated RNA 
samples were stored at -80 °C.  
2.4.3.7 Reverse transcription 
Reverse transcription (RT) is the synthesis of complementary DNA (cDNA) from a 
messenger RNA (mRNA) template. A viral RNA-dependent-DNA-polymerase, the 
reverse transcriptase, is necessary for this process. The RT reactions in this work were 
performed with the BioScriptTM from Bioline, which is derived from the Moloney 
Murine Leukaemia Virus. The oligo dT18 primer is complementary to the poly(A) tail 
of mRNAs. Thus all mRNAs containing a poly (A) tail can putatively be transcribed 
into cDNA. The RT consisted of the following components: 
8 !L DNase-I treated RNA (1.6 !g) (see chapter 2.4.3.6) 
1 !L oligo dT18 primer (0.5 M) 
4 !L 5 x buffer (Bioline") 
0.25 !L BioScriptTM 200 u/!L (Bioline") 
1 !L dNTPs (10 mM) 
% 5.75 !L H2Oultrapure 
 
1) 25 °C & 8 min 
2) 42 °C & 75 min 
3) 70 °C & 15 min 
4) 4 °C & ' 
 
The cDNA was stored at -20 °C until further use. 
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2.4.3.8  Polymerase Chain Reaction (PCR) 
During the PCR, DNA fragments are amplified in vitro using a DNA-dependent-
DNA–polymerase (160, 161). The amplification of a DNA region is among others 
applied as a detection and/or quantification method of a certain DNA region or 
fragment, for mapping of an insertion site and for cloning applications. The DNA 
polymerase extends short double stranded DNA fragments with 3’ hydroxy-termini. 
Therefore, the PCR reaction can only start, when the appropriate primer 
oligonucleotides with free 3’ hydroxy-termini are present. In a standard PCR reaction, 
the samples are heated to 92 – 98 °C, depending on the type of DNA polymerase. 
During this process, the double stranded DNA is denatured and single DNA strands 
are formed. In the next step, the samples are cooled down to the annealing 
temperature of the primers. After the primers anneal to the complementary sites on the 
template DNA, the extension of the primers takes place at 72 °C, which is the optimal 
temperature for the DNA polymerase. The extension time is dependent on the DNA 
fragment size that is to be amplified. This process of denaturation, annealing and 
extension is repeated in 25 – 40 cycles. In a final extension step at 72 °C incomplete 
amplicons are extended. Different types of DNA polymerases exist. In this work 
standard PCR reactions such as colony PCRs for the detection of positive insert 
containing bacterial clones, the analysis of plant genotypes, as well as semi 
quantitative PCRs were performed with dream taq polymerase (MBI Fermentas, 
St.Leon-Rot, D). During mapping of the TAMARA lines taq polymerase from Qiagen 
(Hilden, D) was also applied. For cloning applications, the proof reading polymerase 
from MBI Fermentas was used in order to obtain amplicons with a minimum of 
mutations. 
2.4.3.8.1 Standard PCR reaction 
Reaction mixture: PCR program: 
1 !L template DNA (5 pg- 0.5 !g) 1) 96 °C & 10 min 
0.4 !L primer 1 (10 mM) 2) 96 °C & 30 s 
0.4 !L primer 2 (10 mM) 3) Tm- 5 °C & 30 s 
0.4 !L dNTPs (10 mM) 4) 72 °C & 1 min/kb & 24 – 35 x to step 2 
2 !L 10 x dream taq buffer 5) 72 °C & 10 min 
0.04 !L dream taq (5 u/!L)  6) 16 °C & ' 
% H2Obidest ad 20 !L  
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2.4.3.8.2 PCR reaction with proof reading polymerase 
For cloning purposes it was necessary to obtain amplicons with a minimum of 
mutations. Therefore, a DNA polymerase with proof reading activity (3' => 5' 
exonuclease activity) was applied.  
Reaction mixture: Program: 
50 pg – 1 !g template DNA 1) 95 °C & 1 – 3 min 
5 !L 10 x Pfu buffer with MgSO4 2) 95 °C & 30 s 
1 !L dNTPs (10 mM) 3) Tm-5 °C & 30 s 
2.5 !L primer 1 (10 mM) 4) 72 °C & 2 min/kb & 34 x to step 2 
2.5 !L primer 2 (10 mM) 5) 72 °C & 5-15 min 
1 !L Pfu DNA polymerase (2.5 u/!L) 6) 16 °C & ' 
% H2Obidest ad 50 !L  
 
2.4.3.9 Agarose gel electrophoresis 
The agarose gel electrophoresis is a method for separating of nucleic acids by size. 
Since the nucleic acid is negatively charged, it migrates through the pores of the 
agarose gel towards the anode, once an electric field is applied. Typically a 1 – 1.5% 
agarose gel was subjected to a voltage of 70 – 120 V and a current of ca. 150 mA. The 
nucleic acid was stained with ethidium bromide (EtBr), which intercalates into nucleic 
acids. Upon exposure to UV-light, the EtBr fluorescents, the fluorescence is 
intensified when EtBr is bound to nucleic acid. In this way a nucleic acid band in the 
gel can be visualized. The agarose was suspended in 1 x TAE buffer and heated until 
completely dissolved. After the agarose solution had cooled down to a temperature of 
50 – 60 °C, 0.5 !g/mL of EtBr was added. The agarose was poured into a plastic form 
and the appropriate comb was used to form pockets for samples in the gel. After the 
agarose gel was solid, it was transferred into a gel chamber filled with 1 x TAE 
buffer. The nucleic acid samples, complemented with loading buffer, where pipetted 
into the pockets of the gel. For the determination of the size of the DNA fragments 5 
!L of a ladder of known DNA fragments (Fig. 12) was also separated during 
electrophoresis. The bands were documented with a digital camera (Kaiser RT1, 
INTAS). 
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50 x Tris acetate EDTA-buffer (TAE): 2 M Tris/HAc pH 7.5 
 50 mM EDTA 
10 x loading buffer: 20% (w/v) ficoll 400 
 1% (w/v) SDS 
 0.05% (w/v) xylene blue 
 0.05% (w/v) bromphenol blue 
 40 mM Tris / HAc (pH 7.5) 
 100 mM EDTA 
ethidiumbromide (EtBr) 1% EtBr in H2O 
!
!  
Fig. 12: DNA standards applied for gel electrophoresis 
Left: 1 kb DNA ladder (Invitrogen, Karlsruhe, D), right: gene ruler 1 kb DNA ladder (MBI Fermentas 
St. Leon-Rot, D). 
2.4.3.10 DNA purification from agarose gels 
The purification of DNA fragments from agarose gels was performed using the kits 
E.Z.N.A" gel purification (Omega Bio-Tek, Inc, Norcross, GA, USA), QIAquick gel 
extraction and MinElute Gel extraction (Qiagen GmbH, Hilden, D) as recommended 
by the manufacturer.  
 
2.4.3.11  Ethanol precipitation 
For purifying DNA, 1/10 volume of 3 M sodium acetate (pH 5.2) was mixed with the 
DNA. 2.5 volumes of 100% EtOH (– 20 °C) was added to the samples and the 
mixture was centrifuged for 20 min at 18,000 x g (4 °C) (Eppendorf centrifuge 5417). 
The DNA pellet was resuspended in 250 !L 70% EtOH and centrifuged again for 10 
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min at 18,000 x g (4 °C). The supernatant was discarded and the pelleted DNA was 
air dried before it was resuspended in the necessary buffer-solution. 
2.4.4 Mapping of the insertion site  
The selected candidate mutants from the TAMARA population were mapped using 
the “En flanking”- method adapted from Varotto et al. (2000) (162). This included 
nested PCR reactions and the sequencing of the flanking region of the T-DNA 
insertion site. A high yield of pure genomic DNA was required and therefore the 
DNA was extracted from inflorescences using the protocol described in chapter 
2.4.1.2. 50 – 100 ng of genomic DNA was digested with 2 units of the restriction 
enzymes (0.2 !L) Csp6I and Hind6I, in separate reactions. Alternatively the genomic 
DNA was digested with HindIII/EcoRI and with VspI, at 37 °C for 3 – 4 h. 
Inactivation of the enzymes followed for 10 min at 65 °C. 10 !L of the digested 
genomic DNA was ligated to the adaptors APL1732 (for Hin6I) and APL 1632 (for 
Csp6I) (see 2.4.4.1). 4 !L of the ligation reaction functioned as template for PCR 1, 
using the primer EN205R, which anneals to the adaptor sequence. For PCR 1, the taq 
polymerase from Qiagen was utilized. In a second PCR the PCR 1 product was used 
as template. In PCR 2, the primers En82as and LR26 were applied, thus the 5’ end of 
the T-DNA and the flanking genomic DNA region were amplified. For PCR 2, the taq 
polymerase from Fermentas was used. The DNA bands were separated by 
electrophoresis and eluted from the gel using QIAquick or MinElute gel extraction 
kits (Qiagen, Hilden, D). The DNA fragments were sequenced using the primer LR26 
or EN82as. If the digestion of the genomic DNA for mapping was performed with the 
restriction enzymes HindIII/EcoRI and VspI, then the adaptors Ase, Hind and Eco 
were attached. For PCR 2 the adaptor primer AP1 was combined with EN82as. 
En82as was then also used for sequencing. The mapping procedure is summarized in 
Fig. 13. 
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genomic DNA 
1. Separate digestion with CspI and Hin6I 
fragments of !100-500bp 
/500-1000bp 
2. Ligation with adaptors 
APL1632 for CspI fragments APL1732 for Hin6I fragments 
PCR1 PCR1 
PCR2 PCR2 
3. Primer extension  
specific for adaptor 
4. Amplification of  
fragments using  
dSpm border  
sequences  
 
Fig. 13: Schematic summary of the mapping process. 
 
2.4.4.1 Adaptor production 
The adaptors were produced via annealing the primers LR32 and APL16 (APL 1632) 
or LR32 and APL17 (APL 1732). The primers were diluted 1:10 in annealing buffer 
(10 mM Tris (pH 7.5); 10 mM MgCl2). After a 5-min incubation at 80 °C, the primers 
were cooled down slowly. The adaptors could be stored at -20 °C until further use. 
2.4.5 Sequencing of double stranded DNA 
Sequencing of double stranded DNA, after cloning or for mapping purposes, was 
performed by the Cologne Center of Genomics (CCG). The BigDye" terminator v3.1 
was applied for all sequencing reactions, as recommended by CCG.  
2.5 Human and murine hepatoma cell culture 
2.5.1 Cultivation of human and murine cell lines 
2.5.1.1 HepG2-GFP cells 
For long-term storage, the cells were frozen in liquid nitrogen. To start the cultivation 
of the cells, a cell culture petri dish (cell culture dish 100 mm x 20 mm treated 
polystyrene, Corning Inc., NY, USA) was filled with 10 mL of RPMI (37 °C). The 
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frozen HepG2-GFP cells were rapidly thawed at 37 °C and immediately diluted into 
the RPMI medium. The cells were evenly distributed in the petri dish. For the 
cultivation of the cells, the petri dish containing the cells was incubated at 37 °C, 5% 
CO2 and 95% air humidity (InCu safe MCO-20 AIC, SANYO, München, D). 
Passaging of the cells into new medium was required every 48 – 72 h. For cell 
survival it is necessary for them to attach to the surface of the plastic dish. The cells 
can be passaged up to 20 times, before it is necessary to start a new culture from the 
frozen stock. For passaging the cells, the medium was removed using a vacuum pump 
(Vaccubrand GmbH, Wertheim, D) with a sterile glass tip. The cells were washed 
twice with 10 mL 1x DPBS (37 °C). In the next step the cells were removed from the 
plastic surface by treating them for 20 - 25 min with 1 mL of the enzyme accutase 
(PAA). Alternatively the cells were treated for a minimum of 5 min but maximum 15 
min, with 1 mL of trypsin-EDTA at 37 °C. 3 mL of RPMI was added to the detached 
cells before they were separated by carefully pipetting them up and down. The 4 mL 
cell suspension was divided into &, ' and 1/8 volumes and transferred into new petri 
dishes, each containing 10 mL of RPMI. The cells were distributed evenly and 
incubated at 37 °C, 5% CO2 and 95% air humidity. 
RPMI: 500 mL of RPMI 1640 (Invitrogen) with: 
 15% FBS (90 mL) 
 2 mM L-glutamine (Invitrogen) (6 mL of 
200 mM) 
 100 U penicillin/100 !g streptomycin 
(Invitrogen) (6 mL) 
Dulbecco's Phosphate-Buffered Saline: 
(DPBS) (Gibco",invitrogen) 
1.37 M NaCl 
 
 0.027 M KCl 
 0.08 M Na2HPO4 
 0.015 M KH2PO4 
Trypsin-EDTA (Gibco", invitrogen)  
Accutase (PAA)  
 
2.5.1.2 Hepa1c1c7-Lux cells 
The Hepa1c1c7-Lux cells were passaged as described for the HepG2-GFP cells in 
chapter 2.5.1.1, with the following alterations. The cells were cultivated in #-MEM 
medium. The 4 mL cell suspension was divided into 1/4, 
1/8 and 
1/16 volumes.  
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#-MEM: 500 mL of #-MEM (Invitrogen) with: 
 15% FBS/FCS (90 mL) 
 2 mM L-glutamine (Invitrogen) (6 mL of 200 mM) 
 100 u/mL penicillin/ 100 !g/mL streptomycin (Invitrogen) (6 mL) 
 417 !g/mL Geneticin G418 (Invitrogen) (5mL) 
2.5.2 Production of DMSO stocks of cell culture for long-term storage of 
HepG2-GFP and Hepa1c1c7-Lux cells 
For DMSO stocks, the cells were washed twice in 10 mL 1 x DPBS. The cells were 
detached from the surface via a 5 min treatment at 37 °C with 1 mL of trypsin-EDTA. 
2 mL of medium was added to the trypsinated cells. The following steps were 
performed on ice. After carefully mixing the medium with the cells, they were 
transferred into a 15 mL sterile plastic tube. The plate was washed oncemore with 5 
mL of medium, which was also transferred to the plastic tube. The cells were 
centrifuged at 130 x g (Eppendorf centrifuge 5810R) and the pellet was resuspended 
in 3 mL freeze medium. The aliquots of 1 mL each were pipetted into 2 mL-cryo 
tubes. The cells were frozen for 1 – 2 weeks at -70 °C. In order to freeze the cells 
slowly, they were wrapped in paper and stored in a thick Styrofoam box. Finally the 
cells were transferred from -70 °C to liquid nitrogen for long-term storage. During the 
freezing process to -70 °C, it was necessary that the cells were not moved to avoid 
liquid crystallization within the cells and their disruption. 
 
Recovery freezing medium (Gibco", Invitrogen) 
2.5.3 Screening assays 
2.5.3.1 Preparation of plant methanol extracts 
30 mg of leaf material was harvested and immediately frozen in liquid nitrogen. The 
plant material was homogenized using the tissue lyser (Qiagen, Hilden, D). 300 !L 
80% methanol was added and the samples were homogenized again. The samples 
were centrifuged at 18,000 x g for 20 min (4 °C) (Eppendorf centrifuge 5417). The 
supernatant was transferred into a new reaction tube. The methanol extracts were 
vacuum dried (Eppendorf concentrator 5301) and the completely dried pellets were 
resuspended in 100 !L DMSO. 
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2.5.3.2  GFP fluorescence assay with HepG2-GFP cells 
HepG2-GFP cells were detached from the surface of the cultivation plate as described 
in chapter 2.5.1.1. The amount of cells per microliter was determined using a counting 
chamber (Haemacytometer, NEUBAUER GmbH, Lauda-Königshofen, D). 50,000 
cells were distributed into each well of a black 96-well plate (Costar, 3916, Corning 
inc. NY, USA) and the necessary amount of RPMI-medium was added to reach a total 
volume of 200 !L per well. The cells were incubated for 24 h at 37 °C, 5% CO2 and 
95% air humidity (InCu safe MCO-20 AIC, SANYO, München, D). 2 !L of the 
prepared DMSO plant extracts, diluted 1:5 in RPMI-medium, was added to each well. 
The cells were again incubated for 24 h before the GFP-fluorescence was quantified. 
For the GFP-quantification the medium was carefully removed from each well using a 
vacuum pump. 200 !L of DPBS with EtBr (100 !g/mL) was added to each well. 
After 20 min incubation in the cell culture incubator, the buffer was removed using 
the vacuum pump (Vaccubrand GmbH, Wertheim, D). After a washing step with 200 
!L of DPBS, again 200 !L of DPBS were added to each well and the GFP 
fluorescence was determined using the microplate reader (Infinite 200, Tecan GmbH, 
Crailsheim, D). The cells were stained with EtBr in order to quantify the amount of 
cells per well. The GFP fluorescence was determined at $ = 485/530 nm and the EtBR 
at $ = 485/612 nm. For analysis the data was exported from the software Magellan 
into excel. The GFP fluorescence was divided by the EtBr fluorescence per well.  
2.5.3.3 Luciferase assay with Hepa1c1c7-Lux cells 
2.5.3.3.1 Preparation of the 96 well plates 
The Hepa1c1c7-Lux cells were detached from the cultivation plate as described in 
chapter2.5.1.2. Using the counting chamber to determine the amount of cell per 
microliter, 20,000 cells were distributed into each well of clear 96 well microtiter 
plate (Costar, 3596, Corning inc. NY, USA) and #-MEM medium was added to reach 
a final volume 200 !L per well. The plates with the prepared cells were incubated for 
24 h. 2 !L of 1:5 in medium or DPBS diluted DMSO plant extracts were pipetted into 
each well to induce the cells. After 24 h of incubation the luminescence and protein 
content was determined for each well, as described in the following chapters. 
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2.5.3.3.2  Luciferase assay 
The medium was removed from each well using a vacuum pump (Vaccubrand GmbH, 
Wertheim, D). 200 !L of DPBS was added to each well for washing the cells. After 
removing the buffer with the vacuum pump, 40 !L of 1 x passive lysis buffer 
(Promega, Mannheim, D) was added to each well. The cells were incubated on a 
shaker for 15 min at 600 rpm (MHR23, HLC, Ditabis, Pforzheim, D). The cells were 
pelleted for 15 min at 2900 x g (Eppendorf centrifuge 5810R). 15 !L 2 mM EDTA 
was pipetted into each well of a white 96 well micro titer plate. 10 !L of the 
supernatant of the lysed cells was added into the wells. The luciferase buffer was 
prepared freshly for each screening and stored on ice. The luciferase buffer was 
automatically pipetted using the microplate reader (Infinite 200, Tecan GmbH, 
Crailsheim, D). 100 !L of buffer was added to each well, the luminescence was 
determined. The program I- control settings for the microplate reader were as 
following: 
amount: 100 !L per well; speed: 200 !L/s; wait: 2 s; luminescence; integration: 
10000 ms; attenuation: none 
luciferase-assay 
buffer: 
1 x Luciferase-assay 
buffer  
2 x luciferase 
assay buffer: 
100 mM Tris-
HCl (pH 7.8) 
 15 mM DTT   20 mM MgCl2 
 1 mM ATP   2 mM EDTA 
 0.5 mM Luciferin    
2.5.3.3.3 BCA-assay 
The BCATM protein assay kit (Pierce, Rockford, IL, USA) was used for determining 
the protein content of all lysates. The protein content of each well was used to relate 
assay results to cell densities. 15 !L of 2 mM EDTA was pipetted into a clear 96 well 
micro titer plate. 10 !L of the supernatant of the lysed cells was added. The solutions 
A and B of the BCA kit were mixed in a relation of 50:1 and 200 !L of solution AB 
was pipetted to each sample. The samples were incubated for 30 min at 37 °C, a 
purple coloring could be observed depending on the protein content. After the plates 
cooled down to room temperature, the samples were measured at $ = 562 nm in the 
microplate reader (Infinite 200, Tecan GmbH, Crailsheim, D) using the program I-
control. The protein content per well was calculated using a standard curve that was 
obtained by testing different bovine serum albumin (BSA) concentrations.  
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2.5.3.3.4  Quinone reductase assay 
With the quinone reductase (QR) assay (117) the activity of an endogenous phase II 
detoxification enzyme in the Hepa1c1c7-Lux cells was quantified. The basis of the 
assay is the reduction of menadione to menadiol by NADPH/NADH, which is 
catalyzed by the quinone reductase. 3-(4,5-dimethylthiazo2-yl)-2,5-
diphenyltetrazolium bromide (MTT) is then nonenzymetically reduced by menadiol. 
The reduction of MTT results in a blue color formation, which can be measured at $ = 
595 nm. The supernatant, 10 !L, of the lyzed cells from the luciferase assay (chapter 
2.5.3.3.2) were pipetted into a 96-well microtiter plate and mixed with 200 !L of QR 
assay solution. The samples were incubated for 25 min at room temperature before the 
absorption was determined using the microplate reader (Infinite 200, Tecan GmbH, 
Crailsheim, D) 
QR-solution: 25 mM Tris-HCl (pH 7.4) 
 30 !M NAD 
 5 !M FAD 
 50 !M menadione 
 1 mM glucose-6-phosphate 
 0.07% (w/v) BSA 
 0.03% (w/v) MTT 
 0.01% (v/v) Tween-20 
 1 u/mL glucose-6-phosphate dehydrogenase 
(Leuconostoc mesenteroides) 
 
glucose-6-phosphate 
NADPH/NADH 
glucose-6-phosphate 
dehydrogenase 
6-phospho-gluconate 
NADP/NAD 
QR 
menadione menadiol 
MTTox MTTred 
595 nm 
blue  
 
Fig. 14: Schematic overview of the reactions during the quinone reductase assay. Adapted from (117). 
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2.5.3.3.5 Analysis of the assay results 
The luminescence per well or the absorption determined during the QR assay was 
divided by the protein content of the respective well. The protein content in !g/mL 
was determined via a standard curve using BSA. Typically, three technical replicates 
were made for each mutant. The mean luminescence per protein content ( x ) of the 
technical replicates (n ) was calculated for each sample and the standard error (SE
x
) 
was determined using the following formula: 
SE
x
=
s
n
 , with s = standard deviation. 
During the screening, each 96-well plate included 3 technical replicates of a Col-0 
sample used as a standard for determining the EpRE inducing potential of a mutant 
extract. To quantify the induction potential, the mean mutant luminescence per 
protein (!g/mL) was divided by the mean Col-0 luminescence per protein (!g/mL). A 
mutant leading to a ratio above 1 was interpreted as a potential chemoprotective 
mutant. In some cases, the determined Col-0 value was unusually high in comparison 
to all other screened samples of the plate. The Col-0 plant most likely was subjected 
to unintented stress and therefore the value was seen as an outlier. Instead the mutants 
were compared to average Col-0 values of several other screenings in order consider 
mutants of the screen as putative chemoprotectants. 
2.6 Plant biotechnological methods 
2.6.1 Floral transformation 
Stable transgenic A. thaliana plants were generated via vacuum infiltration of the 
inflorescences with A. tumefaciens containing the gene of interest. The gene of 
interest was integrated into the Arabidopsis genome via T-DNA insertion. A. 
tumefaciens of the strain GV3101 pMP90 or GV3101 pMP90RK were cultivated on a 
shaker in 5 mL YEB-medium containing selective antibiotics. After ca. 16 h of 
cultivation at 28 °C and 220 rpm shaking intensity the bacteria were transferred into 
400 mL fresh YEB medium with antibiotics. The bacteria were grown until they 
reached an OD600 = 1.0. After centrifugation of the bacteria for 15 min at 3,500 x g 
(Eppendorf centrifuge 5810R), they were resuspended in 1/3 vol. infiltration medium 
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(ca. 130 mL). After transferring the bacteria into a glass dish, the inflorescences of 
Col-0 plants were dipped into the suspension. Before the transformation process, all 
siliques were removed from the flowering plants. A vacuum was applied using a 
water-jet vacuum pump. After 10 -15 min of vacuum infiltration, more bacteria were 
applied onto the inflorescences using a pipette. The plants were covered with a plastic 
lid and 12 – 16 h later more A. tumefaciens were pipetted onto the inflorescences. The 
plants were kept covered with a plastic lid for 2 days and transferred into the green 
house.  
 
Infiltration medium: 
 
2.56 mM MES/KOH (pH 5.8)  
2.2 g/l Murashige & Skoog salts (Duchefa M0221) 
 146 mM Saccharose 
 10 !L 6-benzymaminopurin (1 mg/mL in 1 N NaOH) 
 0.1% Tween 20 
 
2.6.2 Arabidopsis root cell culture 
The Arabidopsis root cells were cultured in liquid AT medium at 22 °C and 120 rpm 
(shaker: Multitron, Infors HT, Einsbach, D). The cells were diluted 1:3 - 1:5 every 7 
days depending on the growth rate of the cells. 
Arabidopsis thaliana medium (AT): 
 
4.4 g/L Murashige & Skoog salts (Duchefa 
M0221) 
 3% sucrose 
 4 mL/L B5 vitamin mixture (1 g/L nicotinic 
acid, 1 g/L pyridoxin-HCl, 10 g/L thiamin 
HCl, 100 g/L myo-inositol) 
 0.5 mL 2,4 D (2 mg/mL) (pH 5.8) 
 
2.6.3 Transient protein expression in Arabidopsis root cell culture 
modified from (163) 
Supervirulent (SV) agrobacteria containing the construct of interest were grown for 
24 h at 28 °C and 220 rpm in 5 mL liquid YEB medium in 15 mL reaction tubes 
(shaker: Multitron, Infors HT, Einsbach, D). In addition, the antisilencing strain P19 
was cultivated in a separate reaction tube. The Arabidopsis Col-0 root suspension 
culture was diluted 1:4 or 1:5, depending on the density of the pre-culture, in fresh A. 
thaliana (AT)-medium (room temperature) prior to transfection. The SV and P19 
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agrobacteria were centrifuged at 4,000 x g for 7 min (Eppendorf centrifuge 5810R). 
The bacterial pellet was resuspended in 500 - 1000 !L of AT-medium. 3 mL of 
diluted Arabidopsis cell culture were pipetted into each well of a sterile 6 well plate 
(Corning Inc. NY, USA). 25 !L of SV and P19 agrobacteria were added to each well. 
The plates were wrapped in aluminum foil to keep the cells dark and to prevent the 
evaporation of AT-medium. The plant cell culture was cultivated at 22 °C and 120 
rpm for 4 - 6 days before the GFP or ß-glucuronidases (GUS) activity was analyzed.  
2.6.4 Transient expression of protein in N. benthamiana and A. thaliana 
leaves 
Two months old N. benthamiana plants or 6 - 8 weeks old A. thaliana plants, grown 
under short day conditions, were used for transient expression of proteins. The SV 
agrobacteria were grown for 2 days on YEB-plates with the respective antibiotics. 
The bacteria were the cultivated for 24 h at 28 °C (220 rpm) in 50 mL liquid YEB-
medium. The bacteria were centrifuged for 7 min at 4000 x g and resuspended in 1x 
agromixsolution. The OD600 was adjusted to 0.7- 0.8 with the agromixsolution. The 
agrobacteria with the gene of interest were mixed in equal amounts with the 
antisilencing strain P19 (154). The agrobacteria were incubated for 2 to 6 h at room 
temperature and then infiltrated into the abaxial side of the leaves. Prior to infiltration, 
the plants were watered and kept in the dark for 2 to 6 h. The infiltrated plants were 
covered with a lid and 24 h later transferred into the green house. If the expressed 
protein was fused to a fluorescent marker for subcellular localization studies, the 
plants were analyzed 5 to 6 days after agroinfiltration. 
Agromixsolution: 10 mM MgCl2+H20 
 100 mM MES (pH 5.6) 
 0.15 mM acetosyringone  
 
2.7 Analytical methods  
2.7.1 Real time PCR 
After RNA preparation and reverse transcription, the expression of a gene in a 
specific plant tissue can by quantified by real time PCR. The real time PCR was 
performed using the fluorescence dye SYBR green, which binds mainly to double 
stranded DNA, absorbing blue light at a wavelength of $ = 497 nm and emitting green 
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light at a wavelength of $ = 520 nm. The emission is used to quantify the amount of 
double stranded DNA in a sample. After each PCR cycle the fluorescence is 
measured. In this way the cycle threshold (Ct) value can be determined, which is the 
cycle during which the fluorescence is significantly stronger than the background 
signal (exponential phase of the PCR). The cDNA was then diluted 1:4 – 1:8 with 
H2Oultrapure. During the real time PCR the amount of cDNA in each well was 
quantified via amplification of the housekeeping gene actin2, which was used as an 
internal reference gene. The gene specific real time PCR primers were designed using 
the software primer express (Applied biosystems), with a Tm of 60 °C and an 
amplicon length of 70 – 150 bp. Duplicate reactions were set up for each cDNA 
sample. The real time PCR reaction was performed using 7300 System Software 
Instrument (Applied Biosystems, Darmstadt, D). The SYBR green PCR mix contains 
a heat activated DNA polymerase, ultra pure dNTPs, 6 mM MgCl2, the internal 
reference ROX and SYBR green dye (Applied Biosystems, Darmstadt, D).  
PCR reaction mix: Program: 
2 !L diluted cDNA template 1) 50 °C & 2 min 
1.25 !L primer forward (10 mM) 2) 95 °C & 10 min 
1.25 !L primer reverse (10 mM) 3) 95 °C & 15 min 
10 !L 2 x SYBR green PCR mix  4) 60 °C & 1 min 
5.5 !L H2Oultapure 5) 95 °C & 15 s 
% 20 !L 6) 60 °C & 1 min & 39 x to step 2 
 7) 95 °C & 15 s 
 8) 60 °C & 15 s 
 
A dissociation stage was added at the end of the PCR program to check for primer 
dimers and contaminations in the minus template control. The amount of DNA was 
calculated via the relative quantification method: 
dCt-value = Ct(target gene) – Ct(internal reference gene) 
ddCt-value = dCt – dCt (control sample) 
relative quantification (RQ) = 2-ddCt 
Alternatively to the SYBR" green ready mix, Brilliant SYBR" Green QPCR Core 
Reagent kit (Agilent Technologies, Inc) was applied. In this case dream taq 
polymerase (MBI Fermentas, St-Leon-Rot, D) was used as DNA polymerase. 
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PCR reaction mix: 
2 !L diluted cDNA 
2 !L 10 x buffer for dream Taq 
1 !L SYBR (1:3000) 
3.2 !L glycerol (50%) 
0.6 !L DMSO (100%) 
0.2 !L dream Taq 
0.4 !L ROX 
0.4 !L Primer 1 (10 mM) 
0.4 !L Primer 2 (10 mM) 
0.4 !L dNTPs (10 mM) 
9.4 !L H2Oultrapure 
% 20 !L 
 
2.7.2 Microscopy 
The GFP fluorescence was observed using a fluorescence microscope (Leixa DMRB, 
Leica DMRA2) or a confocal microscope (LSM700, Zeiss). Leaf material was cut 
into small sections of ca. 5 -10 mm x 5 -10 mm using a scalpel. The sections were 
placed on a microscope slide with the abaxial side of the leaf facing up. Water was 
dropped onto the section and the sample was covered with a cover glass making sure 
to exclude any air bubbles. Alternatively 100 – 300 !L of A. thaliana cultured cells 
were pipetted onto the microscope slide. The GFP fluorescence is excited at $ = 488 
nm and detected at $ = 510 – 520 nm.  
Table 8: Filters used for microscopy 
Filter Excitation filter Emission filter Manufacturer 
DAPI  BP340-380 LP435 Leica 512804 
EGFP_LP BP470/40 LP500 AHF 
ET-EGFP 
(no chlorophyll) 
ET470/40 ET525/50 AHF 46-002 
2.7.2.1 Brefeldin A treatment of A. thaliana cultured cells 
To confirm a subcellular localization of a protein fused to GFP to the endomembrane 
system or Golgi, the A. thaliana cultured cells were treated for 2 h with 100 !g/mL 
Brefeldin A (BFA) at 22 °C. The treated cells were then observed using the 
fluorescence microscope. 
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2.7.3 Metabolic profiling 
The profiling of plant secondary metabolites was carried out by our collaborating 
partners from IPB-Halle (Stephan Schmidt, Christoph Böttcher, Dierk Scheel) using 
the method published by von Roepenack-Lahaye (2004) (164), De Vos et al. (2007) 
(124), Böttcher et al. (2008) (129). 
2.7.4 Extraction of glucosinolates 
70 - 100 mg of plant material was harvested and frozen in 2 mL tubes, in liquid 
nitrogen. The plant material was lyophilized for 16 – 20 h. For the equilibration of the 
ion-exchange-columns, 0.1 g of Sephadex A per sample (DEAE A25120, Sigma-
Aldrich, Seelze, D) was incubated in 2 mL of 0.5 M acetic acid buffer (pH 5.0) for 12 
– 16 h at room temperature. After lyophilization the dry weight of the plant material 
was determined and the dried leaves were homogenized using the tissuelyzer (1min, 
25 rpm). 1 mL of 80% MeOH was added to each sample. Finally 20 !L of 4 mM 
benzyl glucosinolate standard were added. The samples were homogenized for 
another minute and centrifuged for 10 min at 20,000 x g. The supernatant was 
transferred into a fresh 2 mL tube. To the pellet 1 mL 80% MeOH was added and the 
plant material was homogenized a second time. After centrifugation (10 min, 20,000 x 
g), the supernatant was added to the 2 mL tube. The columns were prepared by 
placing a small amount of cotton into each glas pipette, then 2 mL of the Sephadex A 
solution were added. The collected supernatant was transferred into the columns. The 
columns were washed 5x with 2 mL of HPLC grade water and twice with 0.02 M 
acetic acid NaOH buffer (pH 5.0). 50 !L of sulfatase  (Helix pomatia, Sigma, EC 
3.1.6.1) were mixed with 450 !L of 0.02 M acetic acid NaOH buffer (pH 5.0) for 
each sample. Each column was loaded with 500 !L of the prepared sulfatase solution. 
After the sulfatase had entered the column matrix, they were sealed with white pipette 
tips (sealed tips) and parafilm. In addition the top of the columns was sealed with 
parafilm. The samples were incubated for 12 – 16 h at room temperature. The 
glucosinolates were then eluted from the columns with 6 mL of HPLC grade water. 
The eluted glucosinolates were dried using the vacuum dryer. This step took about 24 
h. The dried pellets were solved in 300 mL HPLC grade water. This solvent was 
centrifuged for 5 min at 20,000 x g, before the supernatant was transferred into the 
suitable glas tubes, necessary for measurements using the Acquity UPLC-System 
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(Waters, Eschborn). During the measurements, the metabolites were separated with a 
linear gradient of acetonitrile and a flow rate of 0.225 mL/min. 
 
time (min) 0 1 5.5 9.5 9.6 9.7 9.9 10 
A =10% 
acetonitrile 
100% 100% 75% 53% 5% 5% 100% 100% 
B =90% 
acetonitrile 
0% 0% 25% 47% 95% 95% 0% 0% 
 
The desulfoglucosinolates eluted from the column BEH-C18 (1,7 µm; 2,1 Å~ 150 
mm; Waters, Eschborn, D) and detected with UV light, at a wavelength of $ = 229 
nm. The amount of glucosinolates was calculated per g of leaf dry weight (see 
Formula 1) 
 
Formula 1: Calculation of glucosinolate (GLS) content 
GLS in !mol/g dry weight =  
area GLS * response factor GLS * IS (!Mol) 
area IS * response factor IS * dry weight (g) 
 
2.7.5 GUS-Assay 
As preparation for the GUS assay, the premix solution II and the X-Glu-solution were 
mixed in a ratio of 19:1 (for 10 mL working solution: 9.5 mL premix II + 0.5 mL of 
X-glu). One to 2 mL of the prepared GUS solution were used for each leaf sample. 
The solution was vacuum infiltrated into the tissue. The samples were incubated over 
night at 37 °C. To remove the chlorophyll from the tissue, the samples were incubated 
in 80% EtOH at 60 °C. Samples were stored at 4 °C. 
1 M NaPO4  working 
solution:  
0.1 M NaPO4 
0.25 M EDTA  10 mM EDTA 
5 mM K-Ferricyanid  0.5 mM K-Ferricyanid 
5 mM K-Ferrocyanid  0.5 mM K-Ferrocyanid 
20 mM X-Glu (100 mg in 10 mL 
dimethylformamide) 
 1 mM X-Glu 
 
10% Triton X-100 (v/v)  0.1% Triton X-100 (v/v) 
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3 Results 
The first part of this section describes the screening process used in this work. The 
results of the mapping, as well as the expression analyses are presented. In the second 
section selected mutants were analyzed in relation to their function and the production 
of chemoprotective compounds. 
3.1 The screening of mutants of the TAMARA population  
The extracts of approximately 5,000 plants of the TAMARA population were tested 
for chemoprotective activity in previous screening assays using the HepG2-GFP 
reporter system (2.5.3.2) (112). After two rounds of screening, approximately 470 
mutants showing a high inducing effect were selected for further analysis using 
Hepa1c1c7-Lux cells (2.5.3.3). The screening strategy is summarized in Fig. 15. 
In the following chapters the results of the screening using the Hepa1c1c7-Lux cells 
are described. Furthermore, the genes detected after the mapping are categorized, in 
order to gain more knowledge about the functions and characteristics of genes 
involved in the production of chemoprotective compounds. In the last chapter mutants 
exhibiting phenotype under green house conditions are described. 
 
32 
 
1st screen HepG2-GFP 
2nd screen HepG2-GFP 
Hepa1c1c7-Lux 
Plant cultivation and  
production of  
methanol extracts  
Mapping of mutants  
and real time analysis 
Metabolic profiling  
(UPLC-ESI-QTOF-MS) 
Functional 
characterization 
in Methanol In DMSO 
 
Fig. 15: Summary of the screening procedure. The plants were cultivated and methanol extracts were 
prepared from leaf material. The metabolites were concentrated, resuspended in DMSO and applied to 
HepG2-GFP cells. After the selection of candidates, these were confirmed using Hepa1c1c7-Lux cells. 
The confirmed mutants were mapped and the relative expression levels of genes flanking the insertion 
site were determined. Selected genes were further analyzed in parallel to metabolic profiling by UPLC-
ESI-QTOF-MS.  
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3.1.1 Application of the luciferase assay system using plant extracts 
Boerboom et al. (2006) described the development and application of the stable 
Hepa1c1c7-Lux reporter cell lines (EpRE(mGST-Ya)-LUX). These cells contain an 
EpRE-Lux construct, which enables the screening for compounds with EpRE 
inducing activity, by simply measuring the luminescence of the induced cells (113). 
The reporter system was applied for the analysis of different flavonoids with planar or 
non-planar structure.   
Here, the Hepa1c1c7-Lux reporter cell lines were used to test mutant plant extracts for 
chemoprotective activity. Since the cells were so far only applied to test isolated 
compounds, the efficiency of the reporter system was assessed with different amounts 
of Col-0 plant extracts. The extraction was performed with 80% methanol because in 
previous work, by a former bachelor student involved in this project, it was shown 
that this method was more efficient in comparison to aequous extraction and led to a 
stronger induction of HepG2-GFP cells (165). The induction potential of 1, 2 and 4 
!L of Col-0 wild-type plant extracts redissolved in DMSO and the DMSO dilutions of 
these in 1:2, 1:4, 1:8 and 1:12 were analyzed. In this experiment, concentrated 
extracts derived from 240 mg of leaf or inflorescence material were redissolved in 
500 !L DMSO each. This corresponds to 480 !g of the original biomass of plant 
material per 1 !L DMSO. The applied amounts of plant extract (in !g) are 
summarized in Table 9.  
 
Table 9: Summary of the applied amounts of Col-0 plant extract.  
Applied amount of extract Dilution 
1:1 
 
1:2 
 
1:4 
 
1:8 
 
1:12 
1 !L 480 !g 240 !g 120 !g 60 !g 40 !g 
2 !L 960 !g 480 !g 240 !g 120 !g 80 !g 
4 !L 1920 !g 960 !g 480 !g 240 !g 160 !g 
 
In Fig. 16 the results of the induction with leaf extracts are shown. At 1 !L 
application volume (Fig. 16A) the differences of the luminescence signal between 40, 
60 and 120 !g were only slight, with intensities comparable to the untreated cells, 
while with 240 and 480 !g a noticeable induction of the luminescence signal could be 
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observed. This demonstrates an almost linear relationship between the amount of 
extract applied and the luminescence signal. When 2 !L of extract were applied to the 
system (Fig. 16B), the luminescence was induced upon treatment with 240, 480 and 
960 !g of extract in comparison to those cells treated with DMSO, 80 and 120 !g of 
extract. The average luminescence signal was almost equal in cells treated with 480 
and 960 !g of extract. When 4 !L of leaf extract were administered to the reporter 
cells (Fig. 16C), the application of 1920 !g extract resulted in luminescence intensity 
comparable to untreated cells. 960 !g extract led to a strong increase of the signal, in 
comparison to 1920 and 480 !g extract. In addition it could be shown that elevated 
amounts of DMSO had a negative effect on the induction of the cells. The results of 
the same process performed with extracts from Col-0 inflorescences showed a similar 
pattern.  
A previously described activation tagged mutant, HIGH INDOLIC 
GLUCOSINOLATE1-1DOMINANT (HIG1-1D), was used to induce the Hepa1c1c7-
Lux cells. HIG-1D accumulates a four to six fold higher amount of I3M (151). One 
potent inducer of phase II enzymes is I3C, which is derived from I3M (166). In the 
Hepa1c1c7-Lux cell assay system a three fold elevated luminescence signal in 
comparison to the signal induced by wild-type plant extracts was observed. In 
contrast, the hig1-1 loss of function mutant did not show an altered inducing effect 
when compared to Col-0 (Fig. 18).  
The data demonstrates that the EpRE based reporter system in Hepa1c1c7-Lux cells 
can be applied to screen plant extracts for chemoprotective activity based on the 
induction of phase II and detoxification enzymes that are regulated by EpRE promotor 
elements. In general, increased amounts of plant extract led to a higher luminescence 
signal. Nevertheless, a very high concentration of extract led to an inhibition of 
luminescence, this was most likely due to a toxic effect of compounds found in the 
extract. Since the aim is to screen for mutants showing higher activity than Col-0 
extracts, the applied amount of extract during the screening should enable a higher 
luminescence signal than induced by Col-0. If the applied concentration is too high, 
then extracts from mutants containing more phytochemicals may be toxic and 
therefore decrease the signal. Due to this reason the screenings were performed with 
120 !g of plant extract.  
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Fig. 16: Luciferase assay with different dilutions of leaf extract. Luminescence signal is given per 
!g/mL total cellular protein. (A) 1 !L of leaf extract/ DMSO in different dilutions with 40 !g, 60 !g, 
120 !g and 240 !g of extract (B) 2 !L of leaf extract/ DMSO in different dilutions with 80 !g, 120 !g, 
240 !g, 480 !g and 960 !g of extract (C) 4 !L of leaf extract/ DMSO in different dilutions with 160 
!g, 240 !g, 480 !g, 960 !g and 1920 !g of extract. No extract was added to untreated cells; with 
DMSO treated cells were induced with 1, 2 or 4 !L DMSO. Bars represent the standard error of three 
technical replicates.  
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Fig. 17: Luciferase assay with different dilutions of inflorescence extract. Luminescence signal is given 
per !g/mL total cellular protein. (A) 1 !L of inflorescence extract/ DMSO in different dilutions with 40 
!g, 60 !g, 120 !g and 240 !g of extract (B) 2 !L of inflorescence extract/ DMSO in different dilutions 
with 80 !g, 120 !g, 240 !g, 480 !g and 960 !g of extract (C) 4 !L of inflorescence extract/ DMSO in 
different dilutions with 160 !g, 240 !g, 480 !g, 960 !g and 1920 !g of extract. No extract was added 
to untreated cells; with DMSO treated cells were induced with 1, 2 or 4 !L DMSO. Bars represent the 
standard error of three technical replicates. 
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Fig. 18: Induction of Hepa1c1c7-Lux cells with extracts of mutants HIG1-1D and hig1-1. The bars 
represent the average of five technical replicates with standard error. The data were provided by T. 
Gigolashvili. 
 
3.1.2 Screening results using Hepa1c1c7-Lux cells and mapping of 
mutants with a high induction potential 
After a pre-selection of mutants in the HepG2-GFP system, approximately 470 
mutants were screened using the Hepa1c1c7-Lux cells. In addition, mutants of the 
pools numbered with 96-98 were screened directly in the Hepa1c1c7-Lux cells 
without pre-screening. The mapping was done in parallel to the screening. A few 
mutants that were selected for mapping had a high induction potential in the HepG2-
GFP system but this could later not be confirmed in the Hepa1c1c7-Lux cells. The 
screening results were evaluated by calculation of the ratio between the luminescence-
signal induced by extracts of the mutant and of Col-0. These ratios are listed together 
with the mapping results in Table 10. When the chemoprotective effect of a mutant 
could be confirmed in the Hepa1c1c7-Lux cells, then this is noted with “yes” in the 
farthest right column of the table. Not confirmed mutants are marked with “no”, 
“uncertain” means that the screening results from the HepG2-GFP cells could only 
partly be confirmed using Hepa1c1c7-Lux cells. This is the case when two or more 
biological replicates gave contradicting results. A ratio above “1”, means that the 
mutant extract led to a higher induction than the extract of Col-0. Is the ratio below 
“1”, the extract of the mutant did not induce the luminescence as strongly as Col-0, or 
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the extract may have had a toxic effect on the cells. Several ratios are listed for most 
of the mutants. These represent the results of different biological replicates, while one 
ratio is based on the average of three technical replicates. Since the luminescence 
signal of a screen is dependent on the quality of the substrate (age), the age of the 
cells (passage), the fitness and the age of the plants, the values of the screens cannot 
directly be compared with each other. Each screen was performed with a Col-0 
control. Therefore, the calculation of the ratios between mutant and Col-0 induced 
signals leads to a comparable value. Some of the earlier mapped mutants could not be 
confirmed in the Hepa1c1c7-Lux cells. Since they were selected for mapping due to 
the induction of GFP in the HepG2-GFP cells, they were still considered for further 
analyses. The differing results may be due to the different backgrounds of the 
systems, human and mouse cells, and to the expression levels of the genes in the 
different TAMARA generations. In addition, putative toxic effects of high amounts of 
a compound may also lead to a false interpretation of screening results. All luciferase 
assay-screening results of the mapped mutants are listed in the supplementary. In 
addition the plant phenotype is shortly described. The results of the quinone reductase 
assay are also listed in the supplementary. 
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Table 10: Summary of the mapped mutants. 
 
Nr. 
 
Mutant 
 
Insertion site/ flanking genes 
 
Description of genes 
 
Relative gene 
expression 
 
Ratio 
Luc 
 
Confirmed 
with Luc 
1 39.45 At1g80760 boron transporter  18x 1.6/ 0.71  uncertain 
    At1g80770 pigment defective 318 (ferrous iron transport) 2x 
 
 
2 39.46 At2g39000 GCN5-related N-acetyltransferase (GNAT) family protein  0.75x  1.25/ 0.65 uncertain 
    At2g39010 (3. intron) 
plasma membrane intrinsic protein; water channel activity 
(chloroplast) PIP2;6 
0.26x 
 
 
    At2g39020 
GCN5-related N-acetyltransferase (GNAT) family protein 
(chloroplast) 
0.65x 
  
 
3 
                                                   
41.08 
At5g14830 transposable element 
 1.0 
no 
  41.77 At5g14840 (1. exon) pseudogene (unknown function) ko n.d.  
    At5g14850 mannosyltransferase 1x    
4 51.14 At3g09240 protein kinase-related 17 x 0.48 no 
  42.25 At3g09250 (3. exon) DNA-binding/nuclease 0.32 x  1.80/ 0.65 uncertain 
  66.71* At3g09260 beta-glucosidase (PYK10) 730 x  1.05/ 1.16 yes 
5 41.16 At4g27250 putative NAD-dependent epimerase/dehydratase  0.74 x n.d. n.d. 
  41.66 At4g27260 IAA amydo synthase (AtGH3.5) 152 x 
1.12/ 0.94/ 
2.34  
yes 
  41.58°       
1.55/ 1.20/ 
2.13  
yes 
  40.36       
1.64/ 0.58/ 
1.97/ 2.09  
yes 
  40.76       
1.12/ 0.80/ 
0.64/ 1.06  
uncertain 
6 42.63 At1g25220 putative beta subunit of anthranilate synthase (AtASB1) 1x 1.44/ 1.36  yes 
    At1g25230 (1. exon) putative calcineurin-like phosphoesterase 45x    
    At1g25240 putative AP180-like endocytotic accessory protein 9x    
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Nr. 
 
Mutant 
 
Insertion site/ flanking genes 
 
Description of genes 
 
Relative gene 
expression 
 
Ratio 
Luc 
 
Confirmed 
with Luc 
7 43.40 At2g16340 unknown protein 130x 1.20/ 1.52  yes 
  43.09  At2g16365 6. (intron) F-box family protein 80x 1.91/ 1.67  yes 
  49.07 At2g16360 S25-type protein of small ribosomal subunit (AtRPS25A) 
 
n.d. n.d. 
  65.20       0.60 no 
8 43.62 At4g39640 gamma-glutamyl transpeptidase (AtGGT1) 1.4x 1.62/ 0.43  uncertain 
  At4g39650 (1. intron) gamma-glutamyl transpeptidase (AtGGT2) 1.22x   
  At4g39660 alanine:glyoxylate aminotransferase (AtAGT2) 0.84x   
9 47.15 At5g15490 UDP-glucose 6-dehydrogenase, putative (AtUDG3)   2.09/ 0.32 uncertain 
    At5g15500 (1. exon) 
ankyrin repeat family protein/putative membrane protein of unknown 
function 
4.6x  
 
    At5g15510 
protein of unknown function, TPX2 (targeting protein for Xklp2 
(mitotic spindle assembly)) 
124x  
 
10 47.25° At5g66570  membrane-extrinsic subunit of photosystem II complex (AtPsbO1) 7x 0.95 no 
    At5g66580 unknown protein 3.5x     
11 47.64 At4g37290 unknown protein 22x 1.73/ 0.69  uncertain 
    At4g37295 unknown protein 120x     
12 49.34 At2g45660 (5'UTR) MADS-box-type transcription factor (AtSOC1/AtAGL20) 1.74x 0.82 no 
  67.31 At2g45670 lysophosphatidylethanolamine acyltransferase (AtLPEAT2)  2.36x 1.23/ 1.29  yes 
13 49.44  At4g38990 putative glycosyl hydrolase (AtGH9B16) 48.6x 1.26/ 1.89  yes  
  49.41 At4g39000 (2. exon) putative endo-1,4-beta glucanase 7.3x n.d.  
    At4g39010 putative endo-1,4-beta glucanase 0.53x     
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Nr. Mutant Insertion site/ flanking genes 
Description of genes 
Relative gene 
expression 
Ratio  
Luc 
Confirmed 
with Luc 
 
14 
49.62 2 Insertions:     
1.58/ 0.71  uncertain 
  49.53 At5g13330 putative ERF-type transcription factor 9.5x  1.17 yes  
  49.72° At5g13340 unknown protein 12.3x n.d. n.d. 
  49.69°       n.d. n.d. 
  49.64 At5g52200 putative protein phosphatase inhibitor 2 (IPP-2) 9x n.d. n.d. 
  49.59 At1g52190 (3.exon) putative nitrate transporter ko 0.71 no 
  51.34 At1g52185 micro RNA 2x 0.47 no 
 51.23 At1g52180 putative MIP-type aquaporin or small neutral solute transporter 36x n.d. n.d. 
15 50.02° At2g38280 membrane-associated AMP deaminase, embryonic factor (AtFAC1 12x 0.60  no 
    At2g38290  ammonium transporter (AtAMT2.1) 14x     
    At2g38300 putative GARP-G2-type transcription factor 0.75x     
16 50.36 At1g04360  putative ubiquitin ligase, ATL subfamily (AtATL1) 50x n.d. n.d. 
    
At1g04370 
At1g04380 
ethylene-responsive element binding factor (AtERF14) 
putative 2OG-Fe(II) oxygenase 
13000x 
50x     
17 50.32 At2g34830 (1.exon) putative WRKY-type transcription factor (AtWRKY35) 740x  1.10/ 0.45 no  
  50.54 At2g34825 RALF-type endogenous peptide (AtRALFL20) 100x 0.41 no 
  49.59 At2g34820 putative bHLH-type transcription factor  50x 0.71 no 
  50.52       0.41 no 
18 50.46 At2g43610  putative chitinase 120x 1.00 no 
  50.56 At2g43620 putative chitinase 100x 0.72 no 
19 51.70 At1g01460 putative phosphatidylinositol phosphate 5-kinase (AtPIP5K10) 70x 0.55 no 
    At1g01470 putative LEA protein (LEA14) 1.4x    
20 52.18 At3g54840 putative RAB-F-class small GTPase (AtRAB-F1/AtARA6)  1x 0.94 no 
  46.24 At3g54830 putative Amino acid transporter 80x 2.90/ 0.81  uncertain 
  46.23        0.64 no 
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Luc 
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with Luc R 
21 52.38 At1g14410 Whirly-type transcription factor (AtWHY1)  5x n.d. n.d. 
    At1g14420 putative pectate lyase 7x    
    At1g14430 putative glyoxal oxidase 13x    
22 53.11 At5g43180 putative membrane protein of unknown function 35x 0.63 no 
    At5g43185 (1. exon) unknown protein 0.01x    
    At5g43190 F-box family protein (FBX6); ubiquitin-protein ligase activity 2x    
             
    At3g63050 unknown protein 31x    
    At3g63040 unknown protein  220000x    
    At3g63030 
protein containing methyl-CpG-binding domain. Has sequence 
similarity to human MBD proteins 
3x 
   
23 55.16 At1g31880 
BRX-type transcription factor, controls extent of cell proliferation and 
elongation (AtBRX) 
12x 
0.63 no 
    At1g31885 (3. exon) NOD26-like intrinsic protein (AtNIP3.1/AtNLM9) 87x    
    At1g31910 putative phosphomevalonate kinase 3x     
24 55.53 At3g57680 putative protein C-terminal processing serine protease  1x 0.76 no 
  55.26 At3g57670 (2. exon) 
putative subclass A1d C2H2-zinc-finger-type nucleic acid binding 
protein (AtA1d-03/AtWIP2) 
91x  
n.d. n.d. 
  55.38 At3g57660 putative 1st subunit of DNA-directed RNA polymerase 1x 0.83 no 
  48.69        1.91/ 1.21 yes  
25 59.67 At1g05240/At1g05250  putative class-III peroxidase (AtPer1)/(AtPer2) 180x n.d. n.d. 
    are 100% homolog (2. intron)         
    At1g05260 
putative class-III peroxidase (AtPer3), RCI3, cold-inducible cationic 
peroxidase 
25000x 
    
26 61.64 At3g07850  putative galacturonase/polygalacturonase 50x n.d.  n.d. 
  61.52* At3g07860 unknown protein 0.65x  0.55/ 1.66 uncertain 
  61.63* At3g07870 (1.exon) protein of unknown function, contains F-box domain 0.03x 0.43/ 1.04 uncertain 
  75.65*        0.89/ 0.33 uncertain 
  75.67*        6.76 yes 
  76.65*       5.59 yes 
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Insertion site/ flanking genes Description of genes 
Relative gene 
expression 
Ratio  
Luc 
Confirmed 
with Luc R 
27 61.36 At3g11130 putative heavy chain of clathrin complex (AtCHC1) 1.4x n.d. n.d. 
    At3g11150  unknown protein 86x     
    At3g11160 unknown protein 135x     
28 62.40 At3g60640 
ubiquitin-like protein, involved in protein degradation (AtATG8g), 
AUTOPHAGY 8G  
2.6x 
n.d. n.d. 
    At3g60647 unknown protein 286000x     
    At3g60650 (1. exon) unknown protein 3500x     
    At3g60660 unknown protein 12x     
29 63.16 At1g08670 
epsin N-terminal homology (ENTH) domain-containing protein / 
clathrin assembly protein-related  
1596x 
2.62/ 1.55  yes 
    At1g08680 
ADP ribosylation factor GTPase-activating protein 
(AtAGD14/AtZIGA4)  
1.5x 
    
30 63.17 At2g19620  putative Ndr-type hydrolase 0.8x 2.83/ 2.46  yes 
    At2g19610 (2. exon) C3HC4-type RING finger family protein  38x     
    At2g19600 putative potassium cation effluc antiporter (AtKEA4) 2x     
31 63.67 At5g65683 zinc finger (C3HC4-type RING finger) family protein 1.6x 1.70/ 0.90  uncertain 
     At5g65690 (1.intron) phosphoenolpyruvate carboxykinase 7300x     
    At5g65687 carbohydrate transmembrane transporter activity 2x     
32 64.15 At5g11530 
embryonic flower 1 (putative transcription factor, involved in 
regulating vegetative and reproductive growth) 
0.28x 
2.02/ 1.52  yes 
    At5g11520 aspartate aminotransferase (AtASP3) 0.036x    
33 64.02 At1g07190 unknown protein  1.28/ 2.07  yes 
    At1g07180 (1. intron) 
putative alternative NADPH/NADH-dependent dehydrogenase 
(AtNDA1) 
0.0579x 
    
    At1g07175 
putative signaling tyrosine-sulfated glycopeptide (18 aa) precursor 
protein 
20x 
    
34 64.22 At2g19893  defensin-like (DEFL) family protein  150000x 1.00/ 2.67  uncertain 
    At2g19890 protein of unknown function 31916x     
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Nr. Mutant Insertion site/ flanking genes 
Description of genes 
Relative gene 
expression 
Ratio  
Luc 
Confirmed  
with Luc 
35 64.47 At1g20490 
putative acyl-CoA synthetase (AtACS2,) AMP-dependent synthetase, 
ligase 
2x 
 2.68/ 1.79 yes 
    At1g20500 (1. exon) 
putative acyl-CoA synthetase (AtACS3), AMP-dependent synthetase, 
ligase 
37 000x 
    
    At1g20510 putative acyl-CoA synthetase (AtACS4/AtOPCL1)  8.6x     
       
36 
64.77 
 
At3g60966 
 
putative C3HC4-type zinc finger ubiquitin E3 ligase 
 
0.05x 
 
1.73/ 0.77/ 
0.90  no 
    At3g60970 putative subfamily C ABC-type transporter (AtABCC15/AtMRP15) 0.18x     
37 64.48 At1g70970 protein of unknown function, contains F-box domain 2670x 3.05/ 1.91  yes 
    At1g70980 putative asparaginyl-tRNA synthetase (AtSYNC3) 34x     
38 64.59 At2g38300 putative GARP-G2-type transcription factor 3.6x 2.79/ 2.03  yes 
  65.28 At2g38290 ammonium transporter (AtAMT2.1)  7.7x  1.29/ 0.84 uncertain 
  72.68        1.29/ 1.78 yes 
39 65.32 At1g63810 putative Nrap-like nucleolar RNA-associated protein 0.79x 1.27/ 1.95  yes 
  68.71* At1g63820 protein of unknown function, contains CCT domain 46.7x  0.70/ 3.56 uncertain 
  67.18        1.02/ 1.07 uncertain 
40 67.51 At1g47813  protein of unknown function 0.21x 1.32/ 0.77  uncertain 
    At1g47810 protein of unknown function, contains F-box domain 154x     
41 67.74 At3g04560 unknown protein 0.63x 1.77/ 1.29  yes 
    At3g04570 (1. exon) 
protein of unknown function, contains AT-hook-type DNA binding 
motif 
5.7x 
    
    At3g04580 putative ethylene-responsive sensor histidine protein kinase (AtEIN4)  1.2x     
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42 68.15* At2g37440 inositol polyphosphate 5-phosphatase 0.05x 2.92  yes 
    At2g37450  unknown function (Plant Drug/Metabolite Exporter) 1.15x     
    At2g38290 Ammonium transporter 1.06x     
    At2g38300 putative GARP-G2-type transcription factor 0.88x     
              
  81.77* At2g37440 inositol polyphosphate 5-phosphatase 1790x   
     At2g37450 unknown protein (Plant Drug/Metabolite Exporter)  2x     
43 68.24* At1g71002 miRNA (targets MYB family members) 
342(N)x/1320(C)
x 1.04/ 2.00  yes 
    At1g71000 Hsp40/DnaJ-type molecular chaperone 4.5x     
44 68.41* At5g41730 protein kinase family  2.54  yes 
    At5g41740 (3. exon) TIR-NBS-LRR class disease resistance protein      
    At5g41750 TIR-NBS-LRR class disease resistance protein      
45 70.14 At5g22510 putative beta fructofuranosidase/invertase/saccharase 1.7x 1.17/ 1.00  uncertain 
  50.66  At5g22500 (1.intron) fatty acid reductase 1  4x  1.34/ 1.54  yes 
  88.36* At5g22490 condensation domain containing protein 34.7x  4.02 yes 
46 
70.24 
 
At5g59340 
homeobox-type transcription factor WUSCHEL RELATED 
HOMEOBOX 2 (WOX2) 
100x 
1.12/ 0.89 
 
uncertain  
 
  71.71 At5g59330 lipid binding (involved lipid transport, in endomembrane system) 550x  1.58/ 0.91 uncertain 
  57.31       0.68 no 
  73.30*       0.53/ 1.01 no 
  70.06        2.44/ 1.06 yes  
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47 70.70 At5g49120 protein of unknown function 32x 1.15/ 1.63  yes 
    At5g49130 (1.exon) putative MATE-related effluc carrier (AtDTX55)  100x     
    At5g49140 disease resistance protein (TIR-NBS-LRR class), putative 1300x     
48 71.12 At2g30200 putative malonyl-CoA:ACP transacylase 1.6x 1.97/ 2.24  yes 
    At2g30210 (4. exon) putative laccase (AtLAC3)  547x     
    At2g30220 putative GDSL-type lipase 57.1x     
49 71.34 At3g03470 cytochrome P450 monooxygenase (AtCYP89A9)  1.52x  1.28/ 2.30 yes 
    At3g03480 (1.exon) putative BAHD-type acyltransferase 1.74x     
    At3g03490 putative peroxisomal biogenesis factor (AtPEX19-1)  2.11x     
50 71.36 At3g04100 MADS-box-type transcription factor (AtAGL57)  42x 2.58/ 1.55  yes 
    At3g04110 putative GLR-type calcium cation-permeable channel (AtGLR1.1)  0.17x     
51 71.72 At5g67411 putative GRAS-type transcription factor 1.3x 2.68/ 0.83  uncertain 
  
63.01 
 
At5g67420 
putative ASL/LBD-type transcription factor (AtASL39/AtLBD37)  
1x 
2.07/ 2.32  
 
yes 
 
52 72.14 At1g02950 putative class phi glutathione S-transferase (AtGSTF4) 1.82x 1.13/ 1.84  yes 
  72.08 At1g02940 (1. intron) putative class phi glutathione S-transferase (AtGSTF5) 130x  1.31/ 1.70 yes 
    At1g02930 putative class phi glutathione S-transferase (AtGSTF6) 56x     
53 72.29 At3g59580 putative Nin-like-type transcription factor 1.19x  1.28/ 2.44 yes 
    At3g59590 (3. exon) putative jacalin-type lectin 0.04     
    At3g59600 putative 8th subunit of DNA-directed RNA polymerase  1.6x     
              
    At5g59845 putative GASA/GAST/Snakin-type gibberellin-regulated protein       
    At5g59840 (4. exon) putative RAB-E-class small GTPase (AtRAB-E1b)       
    At5g595830 unknown protein       
              
    At2g23130 putative lysine-rich arabinogalactan protein (AtAGP17K)       
    At2g23140 (3. intron) putative U-box-type E3 ubiquitin ligase (AtPUB4)       
    At2g23142 putative S1 self-incompatibility protein       
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54 72.67 At4g37580 
GNAT-type N-acetyltransferase. involved in apical hook development 
(AtHLS1) 
2x 
1.15/ 2.81  yes 
    At4g37570 (1. intron) intron of transposable element gene 1.5x     
    At4g37560 formamidase, putative / formamide amidohydrolase 1.6x     
55 73.63* At1g05650 putative galacturonase/polygalacturonase 126200x    
    At1g05660 (4. exon) putative galacturonase/polygalacturonase 314800x 0.65/ 1.05  no  
    At1g05670 UDP-dependent glycosyl transferase (AtUGT74E1) 878x     
56 75.66* At3g13890 putative Myb-type transcription factor (AtMYB26) 26.9x 5.53  yes 
    At3g13900 (10. exon) aminophospholipid translocase ( P4-type ATPase (AtALA7) ) 0.81x     
    At3g13910 unknown 0.75x     
57 79.23* At3g27500 protein of unknown function, contains C1-type domain 15.2x  1.01/ 2.31 uncertain 
    At3g27503 putative small, secreted, cysteine rich protein (AtSCRL19) 28x     
    At3g27510 (1. exon) protein of unknown function, contains C1-type domain 0x     
    At3g27520 unknown protein 1.8x     
58 81.21* At5g46530 AWPM-19-like membrane protein of unknown function  1.67x 0.90/ 0.72 no 
    At5g46540 (8. exon) putative subfamily B ABC-type transporter (AtABCB7/AtMDR7)  8213x     
    At5g46550 unknown protein (contains bromodomain) 1.22x     
59 82.20* At3g01070 ENOD-like protein (AtENODL16)  3.6x 1.19/ 0.72  uncertain 
    At3g01080 WRKY-type transcription factor, WRKY58 1.7x     
60 84.20* At5g65630 unknown protein (contains bromodomain) 1x  1.05/ 1.62 yes 
  84.27* At5g65640 bHLH-type transcription factor bHLH093 7x  2.76/ 7.97 yes 
61 84.63* At1g61260 unknown protein  1.85/ 1.64  yes 
    At1g61270 (3. exon) lysine/histidine transporter (AtLHT3) (Amino Acid/Auxin Permease )       
    At1g61275 snRNA .     
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62 
84.64* At5g59730 exo70-type subunit of Exocyst complex (AtExo70H7) 5.12x 
0.45/ 0.99 no 
    At5g59740 
UDP-galactose/UDP-glucose transporter (UDP-Galactose:UMP 
Antiporter)   
4.58x 
    
63 84.75* At4g30350 ATP-dependent Clp-type protease 2.8x 0.38/ 4.09  uncertain 
    At4g30360 cyclic nucleotide and calmodulin-regulated ion channel (AtCNGC17)  0.7x     
64 86.25* At5g46980 invertase/pectin methylesterase inhibitor 57x 8.47/ 1.97  yes 
    AT5g46990 invertase/pectin methylesterase inhibitor 9x     
    At3g63530 E3 ubiquitin ligase (BIG BROTHER) 0.4x     
    At3g63540 (1. exon) unknown protein 1.4x     
65 86.56* At3g02000 putative glutaredoxin (AtROXY1)    3.04 yes 
    At3g02010 protein of unknown function, contains pentatricopeptide (PPR) repeat      
66 86.71* At5g11320 flavin-containing monooxygenase (AtYUC4)   1.82  yes 
    At5g11330 putative monooxygenase 1x     
67 86.76* At5g28370  unknown protein  (contains pentatricopeptide (PPR) repeat) 1.23x 2.98/ 2.75  yes 
    At5g28380 unknown protein  (contains pentatricopeptide (PPR) repeat) 0.25x     
  68 
87.09* 
 
At1g62886 
putative (yeast TFB5)-like subunit of TFIIH basal transcription factor 
complex 
3.46 
 2.13 
 
yes 
 
    At1g62880 putative membrane protein of unknown function/cornichon protein 3.38     
69 87.17* At1g30840 (1. exon) purine permease (AtPUP10) 0.9x 1.48  yes 
    At1g30845 putative membrane protein of unknown function 2.06x     
              
    At1g28300  putative LAV family B3-type transcription factor (AtLEC2) 35.6x     
    At1g28307 unknown protein 10.3x     
    At1g28310 putative Dof-type zinc finger transcription factor 1.14x     
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70 87.42* At1g15757 (2. exon) putative defensin-like protein 4.53x 3.75  yes 
    At1g15760 unknown protein 179.4x     
71 87.58* At5g10180 (5' UTR) low-affinity sulfate transporter (AtSultr2.1) (Sulfate Permease)  1.013x 2.98  yes 
    At5g10190 small solute transporter 1690x     
72 87.59* At2g41850 polygalacturonase (AtADPG2/AtPGAZAT) 71x 2.24  yes 
    At2g41860 (2. exon) calcium-dependent protein kinase (AtCPK14) 100570x     
    At2g41870 putative remorin (AtREM4.2) 3.27x     
 73 88.05* At5g35760 Beta-galactosidase related protein 26.6x 1.43  yes 
    At5g35770 (2.exon) Sterile Apetala protein (AtSAP) (TF activity) 674x     
74 88.06* At5g55880 unknown protein 100088x 2.24 yes 
  89.29* At5g55890 unknown protein    3.23 yes 
  89.37*        1.56 yes 
  90.32*        3.05 yes 
  90.40*        4.43 yes 
  90.43*        3.56 yes 
  90.53*        2.12 yes 
75 88.75* At1g52210  transposable element gene   3.25 yes 
    At1g52220  subunit PsaP of photosystem I complex      
76 89.68* At1g79110 protein of unknown function, contains RING-type zinc finger domain 1.84x 2.79  yes 
    At1g79120 putative ubiquitin carboxyl-terminal hydrolase 1.77x     
              
    At3g12900 putative 2OG-Fe(II) oxygenase 2.6x     
    At3g12910 (3. exon) putative NAC/NAM-type transcription factor 1.84x     
    At3g12915 putative type 2 translation elongation factor 0.56x     
77 90.63* At1g77180 putative TF response to abscisic acid, salt and osmotic stress 1.36x  3.09 yes 
   At1g77200 (1. exon) putative ERF-type transcription factor       0.42x     
    At1g77210 STP subfamily monosaccharide:proton symporter (AtSTP14)  0.93x     
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78 90.36* At3g10113 putative MYB_related-type transcription factor 1.85x  2.66 yes 
  90.37* At3g10114  
pseudogene of glycosyl hydrolase family 81 protein (unknown 
function) 
8.41x 
 2.67 
 
yes 
 
    At3g10116  putative GPI-anchored COBRA-type protein of unknown function 5.08x     
              
    At1g01600  Cyp86A4 subfamily of cytochrome p450 genes 321x     
    At1g01610 (3. intron) protein with glycerol-3-phosphate acyltransferasse activity 11.5x     
    At1g01620 plasma membrane intrinsic protein  0.17x     
79 90.46* At5g09520 putative proline-rich glycoprotein (AtPRP9) 67.7x 2.17 yes 
    At5g09530 (1. exon) putative proline-rich glycoprotein (AtPRP10) 16.7x     
    At5g09540 putative DnaJ-type molecular chaperone 88.7x     
80 90.54* At3g15500  NAC-type transcription factor (AtANAC055/AtNAC3) 2.33x 3.18  yes 
    At3g15510 NAC-type transcription factor (AtNAC2) 4.7x     
81 90.64* 
At2g45040 
 
putative matrixin-type metalloprotease (AtMMP4) 
 
75.7x 
 
 4.11/ 4.27/ 
2.54 yes 
    At2g45050 (3' UTR) putative GATA-type transcription factor (AtGATA-2)  153.8x     
    At2g45060 unknown protein 1.89x     
82 94.31*  At4g40000  NOL1/NOP2/sun-type protein 41.7x 0.64 no 
  94.32 At4g40010 (6. intron) 
SNF1-related protein kinase, SnRK2 family 
(AtSnRK2.7/AtSRK2F/AtOSKL5) 
114.5x 
 1.21 yes 
  94.10 At4g40011 unknown protein 4.01x n.d. n.d. 
83 
94.12* 
  
At3g63540 (1. exon) unknown protein 0.023x 
0.58/ 0.86/ 
0.45 no 
  94.52* At3g63530 E3 ubiquitin ligase (BIG BROTHER) 3.6x 0.76 no 
  94.67*       0.75 no 
  94.49*        0.48 no 
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Note: Part of the mapping was performed by Eigen, C. (167), and Krizowski, S (165). The data from these screenings are marked with an asterisk (*) for Eigen, C. 
and a circle (°) for Krizowski, S. The relative gene expression is given for those mutants written in bold. n.d.= not determined, ko = knockout. yes = mutant 
confirmed, uncertain = contradicting results, no = mutant not confirmed. The ratio is calculated by dividing the luminescence value of the mutant by the 
luminescence value of Col-0. 
 
       
Nr. Mutant Insertion site/ flanking genes Description of genes 
Relative gene 
expression 
Ratio  
Luc 
Confirmed 
with Luc 
84 94.48* At1g75440  putative ubiquitin-conjugating E2 enzyme (AtUBC16) 129x 0.45 no 
    At1g75450 cytokinin oxidase (AtCKX5)  167x     
85 95.16 At4g11910 senescence-associated protein (regulates chlorophyll degradation) 1.9x 1.98  yes 
  
95.18 
 
At4g11911 
putative senescence-associated protein, probably involved in 
regulation of chlorophyll degradation 
69x 
1.52  
 
yes 
 
  
95.22 
 
At4g11920 
putative Cdc20-like mitotic specificity factor for anaphase-promoting 
complex 
30x 
 2.07 
 
yes 
 
  95.31        1.89 yes 
86 95.19 At3g01860 unknown protein 10.72x 1.73  yes 
    At3g01870 unknown protein 52x     
    At3g01880 unknown protein 1.15x     
87 95.36 At1g11915 unknown protein 0.56x 3.55  yes 
    At1g11920 pectate lyase family protein 2.38x     
    At1g11925 Stig1 family protein 0.39x     
!
!"#$%&#'
!
! !
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3.1.3 Mapping and expression analysis of the chemoprotective mutants  
After the mutants had been screened, they were further analyzed by mapping the 
insertion site of the T-DNA (2.4.4). The expression levels of the flanking genes were 
determined via real time PCR analysis (2.7.1). From the approximately 5,000 mutants 
originally screened, 149 mutants were mapped (3%) (see Fig. 19).  
!"#
$%"#
Mapped mutants (Induction 
in HepG2-GFP/ Hepa1c1c7-
Lux cells) 
No induction in HepG2-GFP/ 
Hepa1c1c7-Lux cells  
 
 
Fig. 19: Pie diagram of the percent of mutants chosen for mapping from the total number of screened 
mutants. 
 
The mapping uncovered that some mutants have the same insertion site, suggesting 
that they are derived from the same parent plant. Therefore, after comparison of all 
insertion sites, 87 mutant lines with different insertion sites were counted. 29% of the 
detected insertion sites were identified in at least two different independent mappings 
of selected mutants (see Fig. 20). 
!"#$
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Abundant mutants: the 
same insertion site was 
identified in at least two 
individual mutant lines 
Unique mutants: the 
insertion site was found 
in one mutant line 
 
 
Fig. 20: Pie diagram of the percent of insertion sites found in at least two different mutant lines. 
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Table 10 summarizes the mutants that were mapped. The table includes the gene At-
number, a short description of the putative or known gene function as annotated in the 
online databases ARAMEMNON (159) or TAIR (158) and the relative expression 
levels of the genes flanking the insertion site for one of the mutants listed (marked in 
bold letters). The expression levels listed are designed to give an orientation of how 
strongly a gene is influenced. Expression analyses of TAMARA lines have shown 
that the expression level is not stable in all lines (data not shown). 
Those genes that show an altered expression in comparison to wild-type or that 
contain the T-DNA insertion and are therefore most likely affected in their 
functionality can be divided into different groups or clusters based on their putative 
or known gene function and annotation. In summary, 158 genes were categorized. 
32% of these genes encode for (putative) enzymes, 13% (putative) transcription 
factors, 11% of the genes encode for (putative) transporters or are involved in 
transport, 26% of the genes encode for (putative) proteins of unknown function and 
18% belong to other categories. Among this category are many proteins with 
functions in housekeeping/maintenance of life and cell structure. The latter group is 
not categorized because some of the representatives in this group can also be sorted 
to other categories and vice versa. Examples are a number of enzymes such as an 
asparaginyl-tRNA synthetase, an ubiquitin-conjugating E2 enzyme, a protein kinase-
related enzyme, a nuclease, and an ATP-dependent Clp-type protease. Genes 
involved in plant defense and/or stress response can be detected in several categories. 
Examples are putative chitinases in the enzyme category, ethylene responsive 
transcription factors or defensin like family protein in the mixed gene group. The 
latter group also contains inhibitors, pseudogenes, subunits of protein complexes, 
glycoproteins and proteins involved in the cell cycle such as the putative Cdc20-like 
mitotic specificity factor for anaphase-promoting complex or the protein TPX2 
involved in mitotic spindle assembly.  
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Fig. 21: Pie diagram of the functional gene categorization. All genes that showed an altered expression 
in the chemoprotective mutants are included. 
 
More precise analyses can be performed using the online bioinformatics tool DAVID 
(168). With this tool, the genes can, among others, be classified into functionally 
related gene groups (Gene Functional Classification) or on the basis of functional 
annotation (Functional Annotation Clustering). Gene functional classification 
summarizes the major roles of the discovered gene groups by generating a gene-to-
gene similarity matrix. This is based on the functional annotation from different 
sources. Functional Annotation Clustering is based on the theory that similar 
annotations have similar gene members, so that genes are grouped depending on the 
amount of shared gene annotations. The gene functional classification (medium 
classification stringency, default setup) of the 158 genes resulted in six clusters, 
however a high number of genes are excluded from the clustering due to unknown 
functions or categories with only one gene member (data not shown). 
Functional annotation clustering analysis results in 25 clusters (default settings, 
medium classification stringency). The results of the functional annotation clustering 
are shown in Table 11. The members of each of the 25 clusters are listed as well as 
the features of the members of a cluster. Not all gene members of a cluster have all of 
the described features; therefore the detailed data are shown in the supplementary 
material. Many of the genes are categorized into more than one group making some 
of the clusters similar to each other and consisting of almost the same genes. Twelve 
genes form the cluster I. In this cluster members exhibit glycosidase activities and are 
involved in cell wall organization. Some of the genes encode for proteins closely 
related to pectin lyase, which act on forms of pectin found in the cell wall. Cluster II 
!
!"#$%&#'
!
! !
 
 78 
consists of 14 members. Ten members of this group are involved in transport. Among 
this group are several aquaporins. The main characteristic of cluster III is hydrolase 
activity, followed by glycosidase activity, involvement in cell wall organization, 
polysaccharide and carbohydrate metabolism. Part of this group, are also three 
members of the glycoside hydrolase family 9. Most members of cluster IV contain a 
signal peptide and/or are found in the extracellular region and are glycosylated. All 
eight genes of cluster V are involved in reproductive structure development. The 
members of cluster IX are identical with those of cluster V but for two further genes 
found in cluster IX. The additional gene terms describing cluster IX include the 
involvement in the reproductive developmental process and postembryonic 
development. Furthermore, the members of this cluster can be divided into a group of 
genes involved in flower development and a group with functions in seed and fruit 
development. Cluster VI consists of genes encoding for proteins that bind to calcium 
ions and/or have an active site as a proton acceptor. Most members of cluster VII 
bind to DNA and/or have transcription factor activity, and/or are involved in 
transcription regulation. All genes of cluster VIII are integral/intrinsic to membranes. 
Some are transmembrane proteins and involved in transport. The genes of cluster X 
are involved in metabolic processes. Five out of six genes have functions in 
secondary metabolism, four in cellular amino acid derivative metabolic processes and 
three of the genes encode for proteins of the phenylpropanoid pathway. All 26 
members of cluster XI bind to metal ions. Nearly half of the genes encode for 
proteins that bind to zinc ions. The members of clusters XII, XV and XX are 
identical. The three clusters have in common, that they respond to abiotic stimuli. 
Cluster XII highlights the members that respond to water deprivation, cluster XV 
those genes that respond to osmotic and salt stress and cluster XX the genes that 
respond to radiation/light. Most genes of cluster XIII are involved in intracellular 
signaling cascades; this can include responding to a hormone stimulus, to endogenous 
stimuli and organic substances. Three of the ten members respond to ethylene. The 
three genes forming cluster XIV all exhibit ATPase activity and are involved in the 
transmembrane transport of substances. Cluster XVI contains members that have zinc 
finger domains. All ten proteins bind to zinc ions. Seven of nine members of cluster 
XVII play a role in oxidation and reduction processes. Some of the proteins bind to 
iron ions. Cluster XVIII consists of four genes that all contain a F-box associated 
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domain type I. Three of the members are annotated to contain an F-box domain. The 
genes of cluster XIX encode for proteins with roles in macromolecule catabolism 
and/or proteolysis. Three of the proteins are hypothesized to be involved in 
ubiquitination pathways. The 17 members of cluster XXI all bind to purine 
nucleotides. Most of the proteins also bind to purine ribonucleotides and to ATP. 
Cluster XXII consists of genes that encode for proteins with disulfide bonds. Three 
out of five respond to fungi. The three members of cluster XXIII are localized in an 
organelle and the members of cluster XXIV, of which two are identical with cluster 
XXIV all have a transit peptide and are targeted to chloroplasts. Cluster XXV 
consists of three protein kinases.  
In summary, considering that many clusters have common members, the functional 
annotation clustering divided the genes into the following major functional groups: 
Enzymes involved in macromolecule catabolic processes, such as polygalacturonases 
and glycosidases, playing a role in cell wall organization. Many of the enzymes are 
secreted. Some of the genes respond to abiotic or biotic factors, such as water, light 
and fungi. The second category of genes encode for proteins involved in transport. 
These proteins have transmembrane domains. Both passive and active transporters 
were found. The third group consists of genes involved in reproductive organ 
development such as the floral organs and the seeds. This group also contains 
proteins with transcription factor activity. Cluster X does not overlap with any other 
cluster. Its members are involved in secondary metabolic processes, such as the 
phenylpropanoid metabolism. The fifth group consists of genes that respond to 
abiotic stresses. Another group of genes that also contains transcription factors 
responds to hormones such as ethylene. There is also a group of proteins that bind to 
ions, such as proteins with a zinc finger domain, and finally a group of F-box 
proteins.  
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Table 11: Summary of the 25 clusters formed of the detected genes on the basis of functional 
annotation analysis. 
Cluster Characteristics Genes 
I polygalacturonase; glycosidase; Parallel beta-helix repeat; At1g14420; At1g11920; At2g43620; 
  polygalacturonase activity; Pectin lyase fold;  At3g09260; At2g43610; At4g39000; 
  cell wall organization At4g39010; At4g38990; At3g07850; 
  
 
At1g05660; At2g41850; At1g05650 
II aquaporin; transport; topological domain: Extracellular; At2g39010; At1g01620; At1g80760; 
  topological domain: Cytoplasmic; plasma membrane; At1g52180; At3g04110; At1g31880; 
  short sequence motif:NPA 1; Major intrinsic protein; At1g31885; At2g38290; At3g13900; 
  water channel activity; substrate specific channel activity; At3g60970; At5g59740; At5g46540; 
  water transporter activity; At2g43610; At4g11920 
  passive transmembrane transporter activity 
 III hydrolase; glycosidase; cell wall organization; At4g39000; At4g39010; At4g38990; 
  macromolecule catabolic process; carbohydrate metabolism; At2g43610; At2g43620; At3g07850; 
  polysaccharide metabolic process; cellulose degradation; At1g05660; At1g05650; At2g41850; 
  cellulose catabolic process; glucan catabolic process At3g09260; At2g45040; At3g60970; 
  
 
At3g13900; At2g38280; At2g30220; 
  
 
At1g25230; At1g04360; At4g11920; 
  
 
At1g75440 
IV Secreted; glycoprotein; extracellular region; signal peptide At2g34825; At4g39650; At5g66570; 
  
 
At2g43620; At2g45040; At5g46540; 
  
 
At1g11920; At1g14420; At3g04110; 
  
 
At3g09260; At2g41850; At2g19893; 
   At3g27503; At1g05240; At1g75450; 
  
 
At4g38990; At1g05260; At2g30220; 
   At4g39000; At1g25230; At2g30210; 
    At4g39010; At3g07850 
V multicellular organism reproduction; At5g59340; At2g38280; At2g34830; 
  reproductive process in a multicellular organism; At3g63530; At5g35770; At1g28300; 
  reproductive structure development At2g41850; At3g13890 
VI active site: Proton acceptor; calcium ion binding At4g40010; At5g66570; At1g11920; 
  
 
At2g45670; At1g14420; At1g05260; 
  
 
At2g41860; At1g05240 
VII sequence-specific DNA binding;  At3g59600; At1g31880; At5g11530; 
  regulation of transcription, DNA-dependent; At1g62886; At3g09250; At3g04570; 
  regulation of RNA metabolic process; Transcription; At5g22500; At3g15510; At3g57670; 
  transcription regulation; nucleus; transcription factor activity At3g12910; At5g67411; At1g14410; 
  
 
At2g38300; At3g13890; At5g35770; 
  
 
At5g65640; At2g34820; At1g77200; 
  
 
At5g13330; At1g04370; At1g28300; 
   At5g59340; At2g45050; At2g34830: 
    At3g04100 
VIII transport; transmembrane region; integral to membrane At5g66570; At1g25240; At1g07180; 
  
 
At5g49140; At3g01070; At2g45040; 
  
 
At2g41860; At1g52180; At3g54830; 
   At5g59740; At1g04360; At3g13900; 
    At2g38280; At1g52190; At1g30840; 
    At1g01610; At1g01620; At2g38290; 
    At3g60970; At1g80760; At2g39010; 
    At1g31885; At3g04110; At5g46540 
IX floral organ development; post-embryonic organ development; At3g57670; At1g31880; At5g35770; 
  flower development; At3g63530; At2g41850; At3g13890; 
  embryonic development ending in seed dormancy; At5g59340; At2g38280; At2g34830; 
  seed development; fruit development; At1g28300 
  reproductive structure development; 
   reproductive developmental process; 
   post-embryonic development 
 X phenylpropanoid metabolic process At4g39650; At1g02940; At1g02930; 
  cellular amino acid derivative metabolic process At1g20510; At2g30210; At1g20500 
  secondary metabolic process 
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XI zinc ion binding; metal-binding; At2g41860; At2g45670; At1g11920; 
  transition metal ion binding; metal ion binding;  At3g13900; At1g14420; At3g01070; 
  cation binding; ion binding At1g04380; At1g02930; At5g66570; 
  
 
At3g09260; At3g57670; At3g27510; 
  
 
At1g01600; At1g05240; At1g05260; 
  
 
At2g30210; At2g45040; At1g04360; 
  
 
At2g38280; At3g60966; At2g45050; 
   At2g19610; At3g27500; At5g22500; 
    At3g63530; At1g25230 
XII response to water; response to water deprivation; At5g66570; At5g22500; At3g04110; 
  response to abiotic stimulus At3g09260; At4g40010; At1g05260; 
  
 
At1g01620; At1g02930 
XIII response to hormone stimulus;  At1g04370; At1g77200; At5g13330; 
  
response to endogenous stimulus ; 
response to organic substance; At1g31880; At3g13890; At4g27260; 
  intracellular signaling cascade; At3g27500; At5g22500; At1g62880; 
  hormone-mediated signaling; activator; At2g45050 
  
Ethylene signaling pathway; DNA-binding region:AP2/ERF; 
two-component signal transduction system (phosphorelay) 
 XIV ATPase activity, movement of substances; At3g60970; At3g13900; At5g46540 
  hydrolase activity, acting on acid anhydrides; 
 
  
P-P-bond-hydrolysis-driven transmembrane transporter 
activity; 
   primary active transmembrane transporter activity   
XV response to salt stress; response to osmotic stress; At5g66570; At5g22500; At1g01620; 
  response to abiotic stimulus At3g04110; At1g05260; At4g40010; 
  
 
At1g02930; At3g09260 
XVI Zinc finger, C3HC4 RING-type, zinc At1g25230; At2g45040; At2g38280; 
    At3g27500; At5g22500; At2g45050; 
    At2g19610; At3g63530; At1g04360; 
    At3g60966 
XVII heme binding; tetrapyrrole binding; electron carrier activity; At3g01070; At1g25230; At2g30210; 
  iron ion binding; oxidation reduction At5g22500; At1g75450; At1g04380; 
  
 
At1g05260; At1g05240; At1g01600 
XVIII Cyclin-like F-box; F-box associated type 1 At3g59590; At1g47810; At3g07870; 
  
 
At1g70970 
XIX macromolecule catabolic process; proteolysis; At2g45040; At2g43620; At4g39000; 
  ubl conjugation pathway; At2g43610; At4g39010; At4g38990; 
  modification-dependent protein catabolic process; At4g11920; At1g04360; At1g75440 
  proteolysis involved in cellular protein catabolic process; 
   cellular macromolecule catabolic process 
 XX response to light stimulus; response to radiation; At1g05260; At4g40010; At1g01620; 
  response to abiotic stimulus At3g09260; At1g02930; At5g66570; 
  
 
At5g22500; At3g04110 
XXI binding site:ATP; nucleotide phosphate-binding region:ATP; At3g12915; At1g07180; At1g75450; 
  nucleotide-binding; purine ribonucleotide binding; At5g65690; At3g09240; At5g49140; 
  ribonucleotide binding; adenyl nucleotide binding; At1g70980; At3g13900; At3g60970; 
  purine nucleoside binding; nucleoside binding At1g01460; At5g46540; At1g75440; 
  
 
At2g38280; At1g20500; At2g41860; 
  
 
At1g20510; At4g40010 
XXII response to fungus; disulfide bond; disulfide bond At3g09260; At2g19893; At3g27503 
  
 
At1g05240; At1g05260 
XXIII organelle lumen; membrane-enclosed lumen; At3g59600; At3g63540; At5g66570 
  intracellular organelle lumen 
 XXIV chloroplast; transit peptide: Chloroplast At5g66570; At3g63540; At5g11520 
XXV Protein kinase, core; protein amino acid phosphorylation At3g09240; At2g41860; At4g40010 
  phosphate metabolic process 
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3.1.4 Phenotypically outstanding mutants 
The majority of the screened mutants phenotypically resembled wild-type plants when 
grown under green house conditions. Nevertheless, a few mutants exhibited an 
abnormal phenotype. Some mutants had mild phenotypes such as a slightly smaller 
size or darker leaves; these phenotypes were not always consistent and are therefore 
not described here. A strong phenotype on the other hand was observed for the mutant 
lines 57.31, 41.66, 72.29 and 94.12. These mutants will be described in this chapter.  
3.1.4.1 Mutant line 57.31 exhibited an altered leaf phenotype 
The mutant 57.31 had rounder shaped leaves than wild-type plants and a higher 
number of trichomes. In addition the plant was slightly darker than the wild-type plant 
(Fig. 22) 
A B 
 
Fig. 22: Phenotype of mutant line 57.31 with increased number of trichomes. The plants were grown 
under green house conditions. (A) Col-0  (B) mutant line 57.31. 
 
The T-DNA insertion site of mutant line 57.31 was mapped on chromosome 5 at 
position 23932995. The insertion is between the genes At5g59330, which encodes for 
a putative lipid binding protein, and At5g59340, the transcription factor WUSCHEL-
related homeobox 2 (WOX2) (Fig. 23). The mapping process identified further 
mutants with the same insertion site as mutant 57.31, these mutants are lines 70.24, 
71.71, 73.30 and 70.06.  
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Fig. 23: Insertion site of mutant lines 70.24, 71.71, 57.31, 73.30 and 70.06. 
 
Expression analyses of the genes flanking the insertion site revealed that the genes 
ultimately upstream and downstream of the insertion were up-regulated. The gene 
At5g59330 was up-regulated up to 9000 fold, while the gene At5g59330 was up-
regulated up to 740 fold, in the tested cDNA samples. The phenotype could not be 
observed in all mutant lines. One explanation could be the varying expression of the 
influenced genes, generally observed within this population of activation tagged 
mutants. The results of subcellular localization studies with GFP of the protein 
encoded by gene At5g59330 are shown in the supplementary section. 
3.1.4.2 Mutant line 41.66 
Plants of the mutant line 41.66 were dwarfish and had curled leaves. This phenotype 
was also observed with the mutant lines 41.16, 41.58, 30.36 and 40.76. These lines 
have the same insertion site as mutant 41.66, although the phenotype was not as 
severe as in line 41.66. The mutant 41.66 will be described in detail in chapter 3.2.6.  
3.1.4.3 Mutant line 72.29 
The mutant 72.29 phenotypically differed from wild-type plants because the flowers 
of the mutant were missing the petals, while the sepals, stamen and carpel were 
developed (Fig. 24). 
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A B C 
 
 
Fig. 24: Phenotype of the mutant line 72.29. The inflorescences of Col-0 plants (A) and the mutant line 
72.29 (B, C) are shown. 
 
The line 72.29 was mapped because it led to an induction of the reporter systems. The 
mapping resulted in the identification of three insertion sites.  The first insertion was 
localized in the third exon of gene At3g59590, a putative jacalin-type lectin. 
Expression analysis confirmed a down-regulation of this gene to 0.069 fold. The 
flanking genes At3g59580 and At3g59600 remained unaltered in their expression 
levels. This insertion site was confirmed via PCR analysis with primers flanking the 
insertion site. A segregation of the phenotype could be observed but this could not be 
ascribed to the genotype of the plants, when checking for homozygous and 
heterozygous individuals (data not shown). The mapping of line 72.29 was repeated 
and in addition to confirming the insertion site 1, two further insertion sites were 
identified. An insertion in the fourth exon of gene At5g59840, a Ras-related GTP-
binding family protein, and in the third intron of gene At2g23140, an ubiquitin protein 
ligase, were found. Since several insertion sites were identified in this mutant line it is 
not possible to assign the lack of flower petals to one gene without further segregation 
analyses of all insertion sites. The segregation of the phenotype can either be ascribed 
to the genotype of the individual plants, if the loss of function of a gene is the cause, 
or, it can be led back to the variable expression levels of the flanking genes.  
 
3.1.4.4 Mutant line 94.12 
It was shown that mutant line 94.12 has the same insertion site as the mutant lines 
94.52, 94.67 and 94.49. The insertion was localized in the first exon of gene 
At3g63840, which encodes for a protein of unknown function. The flanking gene 
At3g63530 encodes for an E3 ubiquitin ligase (also known as BIG BROTHER). This 
gene is a negative regulator of floral organ size. Studies have shown that a small 
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change in the expression level of BIG BROTHER can already alter organ size (169). 
The expression of gene At3g63530 was up-regulated 3.6 fold in the analyzed cDNA. 
The plants were dwarfish and showed abnormal leaf shape and development (Fig. 25).  
!
A B 
 
Fig. 25: Phenotype of mutant line 94.12. (A) Line 94.12 (B) Col-0. Grown under green house 
conditions. The picture was taken from C. Eigen, 2010 (167). 
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3.2 Analysis of Selected Genes 
3.2.1 Selection and analysis of mutants 
From the numerous genes discovered during the screening, candidates with putative 
roles in the production of chemoprotective metabolites were selected for further 
studies. This selection was based on the putative or known gene functions, the 
publicly available microarray data and the gene expression levels in the mutants. The 
putative function of the gene can give some insight into whether the gene is involved 
in plant secondary metabolism. Microarray data and coexpression networks of genes 
can be an indicator of a role in a certain metabolic pathway. Mutants that contain the 
T-DNA insertion in the coding region a of gene, leading to loss of function, and 
overexpression of upstream and downstream genes are more complicated to analyze 
in further studies than those with the T-DNA in the intergenic region resulting in the 
overexpression of only one or two genes. In order to assign the chemoprotective 
compound to a certain gene, both the knocked out gene and the overexpressed genes 
need to be subject of further analyses.  
Subcellular localization studies were performed via fusion with GFP using the vector 
pGWB5 (C-terminal GFP fusion) or pGWB6 (N-terminal GFP fusion) and selected 
genes were cloned into pAMPAT for the generation of over expression lines 
(recapitulation lines) using the CaMV35S-promotor. The expression of GFP fusion 
proteins, on the one hand, can give some insight into the putative functions of still 
unknown proteins on the other hand it confirms the functionality of the clone. Fig. 26 
summarizes the selection procedure of candidate mutants. 
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•! gene function 
•! functionality of the clone 
 
 
Fig. 26: Schematic diagram of the general procedure for selecting candidate mutants/genes and further 
analysis. 
 
18 mutant lines were selected for further analyses, with the affected genes all having 
different predicted functions. The genes that were chosen for cloning, including the 
generated constructs and the respective mutants are listed in the following Table 12. 
The mutants 51.14, 52.18, 65.32, 41.66, 88.06 and 68.24 are dealt with in the 
following chapters. Additionally, GFP data is available for further genes not included 
in the results chapter, which can be found in the supplementary section. These are 
genes At4g37290, At4g37295, At1g01470, At5g59330, At5g49120 and At1g08670 
(see chapter 5). The following table lists all constructs developed in course of the 
analysis of chemoprotective TAMARA mutants. The constructs marked with “*” 
were created and analyzed by L. Marbaise. These data are published in her Master’s 
Thesis (2010) (170).  
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Table 12: List of constructs 
Mutant Gene Entry vector Expression vector 
52.18 At3g54830 clone 5 (pDONR207) 
clone 6 (pDONR207) 
clone 2.9 (pDONR207) 
V55: clone2.9 (in frame) (pDONR207)  
 
 
 
V15: promshortAt3g54830 (pDONR207) 
V16: clone5 (pGWB6) 
V21: clone5 (pAMPAT) 
V17: clone6 (pGWB6) 
V22: clone6 (pAMPAT) 
V18: clone2.9 (pGWB6) 
V23: clone2.9 (pAMPAT) 
V58: clone2.9 (pGWB5) 
V20: promshortAt3g54830 
(pGWB3i) 
65.32 At1g63820 V11: At1g63820 (pDONR207) V13: At1g63820 (pGWB5) 
V25: At1g63820 (pAMPAT) 
47.64 At4g37290 
At4g37295 
V40: At4g37290 (pENTR1A) 
V41: At4g37295 (pENTR1A) 
V49: At4g37290 (pGWB6) 
V62: At4g37290 (pAMPAT) 
V50: At4g37295 (pGWB5) 
V63: At4g37295 (pAMPAT) 
88.6 At5g55880 V33: At5g55880 (pENTR1A) 
7 *: N-terminal At5g55880 (pDONR207) 
V44: At5g55880 (pGWB5) 
V59: At5g55880 (pAMPAT) 
7 *: N-term.At5g55880 (pGWB5) 
51.14 At3g09260 V34: At3g09260 (pENTR1A) V45: At3g09260 (pGWB5) 
V60: At3g09260 (pAMPAT) 
V79: At3g09260 (pGWB8) 
63.16 At1g08670 V43: At1g08670 (pENTR1A) V51: At1g08670 (pGWB5) 
V53: At1g08670 (pDEST24) 
V54: At1g08670 (pDEST42) 
V61: At1g08670 (pAMPAT) 
51.70 At1g01470 V35: At1g01470 (pENTR1A) V46: At1g01470 (pGWB5) 
V64: At1g01470 (pAMPAT) 
70.06 At5g59330 V36: At5g59330 (pENTR4) V47: At5g59330 (pGWB5) 
V65: At5g59330 (pAMPAT) 
70.70 At5g49120 V37: At5g49120 (pENTR4) V52: At5g49120 (pGWB5) 
V66: At5g49120 (pAMPAT) 
68.24 At1g71002 43*: At1g71002 (pDONR207) 
V72: promshortAt1g71002 (pENTR1A) 
V76: prommidAt1g71002 (pENTR1A) 
V78: promshortAt1g71002 
(pGWB3i) 
V80: prommidAt1g71002 
(pGWB3i) 
43*: At1g71002 (pGWB2) 
43 (V): At1g71002 (pAMPAT) 
90.46 At5g09520 
At5g09540 
25a*: At5g09520 (pDONR207) 
25b*: At5g09540 (pDONR207) 
25a*: At5g09520 (pGWB5) 
25a (V): At5g09520 (pAMPAT) 
25b*: At5g09540 (pGWB5) 
25b*: At5g09549 (pAMPAT) 
87.58 At5g10190 32*: At5g10190 (pDONR207)  32*: At5g10190 (pGWB5) 
32*: At5g10190 (pAMPAT) 
81.77 At2g37440 52*: At2g37440 (pDONR207)  
64.22 At2g19893 63*: At2g19893 (pDONR207) 63*: At2g19893 (pGWB5) 
63*: At2g19893 (pAMPAT) 
64.48 At1g70970 65*: At1g70970 (pDONR207) 65*: At1g70970 (pGWB5) 
65*: At1g70970 (pAMPAT) 
72.14 At1g02930 67*: At1g02930 (pDONR207) 67*: At1g02930 (pGWB5) 
67*: At1g02930 (pAMPAT) 
59.67 At1g05260 69*: At1g05260 (pDONR207) 69*: At1g05260 (pGWB5) 
69 (V): At1g05260 (pAMPAT) 
50.46 At2g43610 72a*: At2g43610 (pDONR207) 72a *: At2g43610 (pGWB5) 
72a (V): At2g43610 (pAMPAT) 
Clones marked with “*” were constructed by Lillian Marbaise and published in her Master’s Thesis in 
2010 (170). 
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3.2.2 Mutant lines 51.14, 42.25 and 66.71 
3.2.2.1 The insertion site of mutant lines 51.14, 42.25 and 66.71 was mapped on 
chromosome 3 
In three individual mutant lines (51.14, 42.25 and 66.71) the insertion was localized 
on chromosome 3 in the third exon of a gene encoding for a DNA-binding 
protein/nuclease. The neighboring genes encode for the !- glucosidase PYK10 
(At3g09260), and a putative protein kinase (At3g09240) (Fig. 27). The mutant was 
named PYK10-1D-cp (PYK10-dominant-chemoprotective). In expression analyses of 
RNA, derived from leaf material of line 51.14, the gene encoding for PYK10 was up-
regulated up to 5,500 fold. The gene encoding for the protein kinase was up-regulated 
17 fold.  
chromosome 3 
At3g09260 At3g09240 At3g09270 
  
3! 5! 
1kb 
position: 2839879 
ATTATGTGGAGGCAGCTAAAATCCGTGATAAACTAAA 
At3g09250 
 
 
Fig. 27: Insertion site of mutant lines 51.14, 42.25 and 66.71. 
 
PYK10 encodes for a root and hypocotyl specific !-glucosidase and belongs to the 
family of glycosyl hydrolases 1 (171,172). It was demonstrated that PYK10 exhibits 
!-D-glucosidase and !-D-fucosidase activity (173). So far it was shown that PYK10 
hydrolyzes the hydroxycoumarin scopolin and esculin in vitro (174). The 
coexpression network from the Atted-II database of PYK10 is shown in Fig. 28 (175, 
176). The monooxygenase CYP81F4 is coexpressed with PYK10 (Fig. 28). This 
enzyme has been shown to synthesize 1MO-I3M (177). PYK10 is coexpressed with 
the transcription factor MYB34, which regulates the production of 1MO-I3M in roots 
(178).  
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Fig. 28: Coexpression network of gene At3g09260 (Atted-II database). Jacalin lectin= homologs of 
nitrile specifier proteins, ATR1=MYB34, TSA1LIKE= NAI2. 
3.2.2.2 Cloning and subcellular localization of PYK10 
The PYK10 gene was cloned into the entry vector pENTR1A and the gateway 
cassette containing the gene was recombined into the expression vector pGWB5, for 
the production of C-terminal GFP fusion protein, and PAMPAT, for the over 
expression of PYK10 in planta. PYK10 protein is known to be the main component 
of constitutive endoplasmatic reticulum (ER) bodies, which are spindle shaped and 
surrounded by ribosomes (173,179). This could be confirmed via expression of the 
construct 35S:PYK10-GFP in A. thaliana cultured cells (Fig. 29). The ER bodies 
were visible as spindle shaped structures throughout the cell lumen. The expression 
and correct localization of the GFP-tagged PYK10 protein was used as a control to 
confirm the functionality of the PYK10 clone.  
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25 !m 
25 !m  
 
Fig. 29: Wide-field fluorescence microscopy of A. thaliana cultured cells transformed with 
35S:PYK10-GFP. 
3.2.2.3 Isolation of homozygous PYK10 insertion lines 
The T-DNA insertion line WiscDsLox461-464F2 was obtained from NASC. This line 
contains the T-DNA insertion in the first intron of At3g09260 (Fig. 30). Nagano et al. 
(2008) have previously shown by immunoblot analysis that the line WiscDSLOX461-
464F2 (pyk10-1) has no PYK10 protein (180). Homozygous plants of line 
WiscDsLox461-464F2 were isolated (Fig. 31).  
 
 
Fig. 30: Insertion site of T-DNA insertion line WiscDsLox461-464F2. The figure was taken from the 
publication Nagano et al. (2008) (180). 
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1    2    3   4    5    1     2              3      4      5    C1     C2 
WiscDsLox-464F2 
NASC 
b c 
 
 
Fig. 31: Agarose gelelectrophoresis of a PCR reaction using genomic DNA of PYK10 knockout lines 
as template DNA and primers flanking the T-DNA insertion site. Homozygous knockout lines of 
PYK10 (WiscDsLox461-464F2) were identified. The plants were obtained from NASC. The T-DNA 
insertion site is located in the first intron at position: 2843529. The expected PCR-fragment has a size 
of 1080 nt. C1, C2= control plants (Col-0).  
3.2.2.4 Production of 35S:PYK10 lines  
The 35S:PYK10 construct in pAMPAT vector was used for stable transformation of 
Col-0 plants. 26 lines were analyzed for their expression in the T1 generation. Among 
these 26 lines, 14 overexpressing lines could be identified. The lines that showed the 
highest expression were chosen for further analysis, namely lines 59, 43 and 19. 
40  31  9  59  35  47 17  62  25 12  24  77  32 43 39 76       55   2   53 54  42 60  19   6   57  46 C1 C2 
40  31  9  59  35  47 17  62  25 12  24  77  32 43  39 76 55  2   53  54  42  60  19   6  57  46  C1  C2 
actin 
PYK10 
lines V60 (35S:PYK10) 
 
 
Fig. 32: Agarose gelelectrophoresis of the results of a semi quantitative PCR analysis of PYK10 
expression in T1 plants transformed with 35S:PYK10. Upper panel shows the actin control PCR. The 
lower panel the expression of PYK10 using gene specific primers. The actin PCR was performed with 
25 cycles, the PYK10 PCR with 40 cycles. The full-length coding region was amplified, which has a 
length of 1575 nt. 
3.2.2.5 Confirmation of chemoprotective activity in PYK10 overexpressing lines 
using Hepa1c1c7-Lux reporter cells 
The three PYK10 overexpressing lines 59, 43 and 19 were chosen for confirmation of 
the gene-to-trait relationship. Two samples were taken for each line. Each sample 
consisting of leaf material pooled from two plants. Methanol extracts were made from 
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these pools. The DMSO samples were diluted 1:5 in cell culture medium. Two !L of 
diluted plant extracts were used to induce the cell culture. The two sample pools taken 
for each line were tested in two individual screens (screen 1 and screen 2). The third 
screen was performed with the samples from screen 1, which were diluted once more 
to 1:50, in order to exclude any inhibiting effect of a high amount of active 
compounds in one sample (see 3.1.1). During each screening assay three Col-0 wt 
samples were used as control. The median of all triplicates of control measurements 
was determined and used as a standard. The activation tagged line 51.14 and pyk10-1 
were tested in parallel. In a first screen the lines 51.14, V60.59 and pyk10-1 led to an 
increased luminescence signal in comparison to Col-0 extracts. These results were 
confirmed in screen 3. Screen 2 confirmed the inducing effect of the extracts from 
51.14, V60.59 and pyk10-1, here also the extracts from lines V60.19 and V60.43 led 
to a higher luminescence signal in comparison to wild-type plants. All in all the 
extracts from plants overexpressing PYK10 had an inducing effect on the reporter 
cells. The results suggest that the enhanced expression of PYK10 in the activation 
tagged lines leads to the production of EPRE inducing metabolic compounds. In 
addition, the loss of function of PYK10 led to an induction of EPRE. Mutant pyk10-1 
probably accumulates compounds that are normally converted by PYK10.  
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Fig. 33: Analysis of the induction potential of PYK10 mutants in Hepa1c1c7-Lux cells. Under analysis 
were the recapitulation lines (V60), line 51.14 and pyk10-1. The luminescence signal is shown as the 
median luminescence per total cellular protein (!g/mL) of three technical replicates per biological 
replicate (screen 1 and 2). Screen 3 consists of 1:50 diluted samples of screen 1. The bars represent the 
standard error of 3 technical replicates for the mutants. The Col-0 median was determined from three to 
four samples per screening assay with three technical replicates each.  
 
3.2.2.6 Metabolite analysis of root extracts of PYK10 mutants 
The secondary metabolites of the PYK10 mutants PYK10-1D-cp, 35S:PYK10 and 
pyk10-1 were analyzed by Dr. Christoph Böttcher (Leibniz Institute of Plant 
Biochemistry, Halle). The samples were taken from ca. 4-week-old seedlings, which 
were grown vertically on " MS-plates with gelrite, under long day conditions in the 
growth cabinet. Since PYK10 is mainly expressed in roots, extracts of roots were 
analyzed. Each sample consisted of three pooled seedlings from one plate. The root 
extracts were analyzed for 1MO-I3M and 4MO-I3M and their respective nitrile (1-
methoxyindol-3-acetonitrile (1MO-IAN), 4-methoxyindol-3-acetonitrile (4MO-IAN)) 
and ascorbigen breakdown products (1-methoxyindol-3-ascorbigen (1MO-
ascorbigen), 4-methoxyindol-3-ascorbigen (4MO-ascorbigen)). PYK10 is 
hypothesized to have myrosinase activity. Since it was demonstrated in vitro that 
PYK10 hydrolyzes scopolin and esculin, the content of scopolin was also determined. 
Esculin could not be detected in the given samples. The 1MO-I3M content was 30 to 
50% reduced in the analyzed PYK10-1D-cp and the 35S:PYK10 lines in comparison 
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to Col-0. In the pyk10-1 line the 1MO-I3M content was comparable to the content in 
Col-0 (Fig. 34 A). The 1MO-ascorbigen content was reduced in the PYK10-1D-cp and 
the pyk10-1 lines and unaltered and in the 35S:PYK10 lines in comparison to Col-0 
(Fig. 34 B). The 1MO-IAN content was strongly decreased in the pyk10-1 line to 
around 30% of the content in Col-0. In the PYK10-1D-cp and the 35S:PYK10 lines it 
was comparable to the 1MO-IAN content in Col-0 (Fig. 34 C). 
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Fig. 34: UPLC-ESI-QTOF-MS analysis of 1MO-I3M and its derived compounds in PYK10 mutants.  
(A) 1-methoxyindol-3-ylmethylglucosinolate (1MO-I3M) and the breakdown products (B) 1-
methoxyindol-3-ascorbigen (1MO-ascorbigen) and (C) 1-methoxyindol-3-acetonitrile (1MO-IAN) in 
roots of four-week-old A. thaliana mutant seedlings. Under analysis were the mutants pyk10-1, pyk10-
1D-cp, and the 35S:PYK10-lines V60.19 and V60.59. The median of 10 technical replicates of each 
mutant (6 for V60.19) was determined along with the standard error (bars).  
 
The 4MO-I3M content in roots was comparable to Col-0 in all mutants. It was mildly 
decreased in the overexpressing lines 35S:PYK10 (Fig. 35 A). The 4MO-ascorbigen 
content was slightly decreased in the pyk10-1 and PYK10-1D-cp lines (Fig. 35 B). In 
the pyk10-1 mutant the 4MO-IAN content was around 16% of then content found in 
Col-0. In the PYK10-1D-cp the nitrile content was 1.2 fold increased and in the 
35S:PYK10 V60.19 line it was decreased to 74% of Col-0 (Fig. 35 C). The scopolin 
content is shown in Fig. 35 D. Here the content was mildly reduced in all analyzed 
mutants in comparison to Col-0. 
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Fig. 35: UPLC-ESI-QTOF-MS analysis of 4MO-I3M and its derived compounds in PYK10 mutants.  
(A) 4-methoxyindol-3-ylmethylglucosinolate (4MO-I3M) and the breakdown products (B) 4-
methoxyindol-3-ascorbigen (4MO-ascorbigen) and (C) 4-methoxyindol-3-acetonitrile (4MO-IAN) in 
roots of four-week-old A. thaliana mutant seedlings. Under analysis were the mutants pyk10-1, pyk10-
1D-cp, and the 35S:PYK10-lines V60.19 and V60.59. The median of 10 technical replicates of each 
mutant (6 for V60.19) was determined along with the standard error (bars).  
 
 
In summary the data suggest that PYK10 overexpression leads to mildly reduced 
amounts of 1MO-I3M in the roots. The loss of function mutant produces less 1MO-
IAN and 4MO-IAN.  
 
3.2.3 Mutant lines 52.18, 46.23 and 46.24 
3.2.3.1 The insertion site of mutant lines 52.18, 46.24 and 46.23 was mapped on 
chromosome 3 
The T-DNA insertion of mutants 52.18, 46.23 and 46.24 was mapped on 
chromosome 3 between the genes At3g54830, a putative amino acid transporter, and 
At3g54840, a RAB-like GTPase (Fig. 36). The mutant was named AAT-1D-cp 
(Amino acid transporter-dominant-chemoprotective). An up-regulation of up to 80-
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fold of the expression in comparison to wild-type plants was determined for gene 
At3g54830 in the analyzed cDNAs, whilst the expression of At3g54840 was 
unaltered. 
 
 
Fig. 36: Insertion site of mutant lines 52.18, 46.23 and 46.24. 
 
At3g54830 is annotated in TAIR as a putative amino acid transporter based on 
sequence and structure similarities (158). In silico analysis of At3g54830 using the 
tool ARAMEMNON (159) shows that this putative amino acid transporter is clustered 
together with ten other putative amino acid transporters. On the basis of sequence 
homology, At3g54830 has been grouped into the amino acid/ auxin permease family. 
Furthermore, two related amino acid transporters (At5g65990 and At5g02180) have 
been subcellularly localized to the endomembrane system (181).  The prediction tool 
THMHMM was applied in order to predict the topology of the putative transporter 
(182). The protein of 546 amino acids (AA) in length and 59.7 kDa molecular mass 
has six putative transmembrane domains.  
3.2.3.2 AAT-1D-cp accumulated isothiocyanates 
Metabolic profiling using UPLC-ESI-QTOF-MS performed and analyzed by Dr. 
Stephan Schmidt (Leibniz Institute of Plant Biochemistry, Halle) indicate that AAT-
1D-cp accumulates the glucosinolate I3M, ascorbigen, which is a breakdown product 
of glucobrassicin that is formed in the presence of ascorbic acid, the flavonoid 
kaempferol, and the ITCs 4-methylsulphinylbutyl (4-MSOB-ITC), 5-
methylsulphinylpentyl (5-MSOP-ITC), 7-methylsulphinylheptyl (7-MSOH-ITC) and 
8-methylsulphinyloctyl (8-MSOO-ITC). The chromatogram excerpt in Fig. 37 
illustrates the detected ITCs. 
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Fig. 37: Excerpt of the chromatogram of mutant AAT-1D-cp. The mutant accumulates different ITCs. 
The figure was provided by Dr. Stephan Schmidt (IPB, Halle). 
3.2.3.3 Alternative splicing of gene At3g54830 
The gene At3g54830 was amplified from cDNA, derived from both mutant and Col-0 
RNA, and cloned into the gateway vector pDONR207. Sequencing analyses indicate 
that the mRNA is spliced in alternative ways. On the basis of the sequencing results it 
can be concluded that the mRNA of At3g54830 exists in at least three different 
splicing variants. These were named after the clones 5, 6 and 2.9. Based on 
ARAMEMNON, the gene is predicted to have 12 exons (159). The first seven exons 
of the three different splicing variants correlate with the annotated sequence. The 
alternative splicing of the mRNA, if translated, would lead to three different proteins. 
From the sequencing results it can be predicted that clone 5 results in a protein with 
543 AA, clone 6 with 448 AA and clone 2.9 with 451 AA. Both for clone 5 and clone 
2.9 the new stop codon is 16 nt downstream of the original stop codon. The clone 6 
has a predicted premature stop codon. Nine cDNAs derived from Col-0 RNA of 
leaves were sequenced and from these nine clones, six correlated with clone 5, clone 
6 was detected twice and the splicing variant of clone 2.9 was detected once. A 
schematic diagram of the splicing variants is shown in Fig. 38. 
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protein 1 
(clone 2.9) 
protein 2 
(clone 5) 
protein 3 
(clone 6) 
Aramemnon annotated splicing 
40 bp of exon 8 spliced 
19 bp of intron expressed between  
exon 8 and 9 
13 bp of exon 11 spliced 
 
1st 97 bp of exon 7  spliced 
exon 8 spliced 
exon 9 spliced 
1st 7 bp of exon 10 spliced 
1st 13 bp of exon 11 spliced 
1. exon 2. exon 3. exon 4. exon 5. exon 6. exon 7. exon 
8. exon 
9. exon 
10. exon 
11. exon 
12. exon 
5‘ 3‘ 
intron between exon 8 and 9 expressed 
1st 13 bp of exon 11 spliced 
stop codon 
 
Fig. 38: Schematic diagram of the detected splicing variants of At3g54830 mRNA. 
3.2.3.4 The putative amino acid transporter was localized to the endomembrane 
system 
For the visualization of the subcellular localization of the three different cDNA 
clones, N-terminal GFP-fusion proteins were constructed using the expression vector 
pGWB6. The alternate splicing of the putative transporter C-terminal fusion with 
GFP led to a frame shift of the reporter gene. Therefore, the GFP was fused N-
terminally to the different splicing variants. The fusion proteins were transiently 
expressed in A. thaliana cultured cells. GFP fluorescence was detected in cells 
transformed with clone 5 (Fig. 40) and clone 2.9 (Fig. 39) but not with clone 6 (data 
not shown). The fluorescence signal indicated a localization of the putative 
transporter in the endomembrane system, presumably in the ER.  
25 !m  
 
Fig. 39: Wide-field fluorescence microscopy of A. thaliana cultured cells transformed with 35S:GFP-
At3g54830 (clone 2.9).  
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25 !m 
 
 
Fig. 40: Wide-field fluorescence microscopy of A. thaliana cultured cells transformed with 35S:GFP-
At3g54830 (clone 5).  
 
To confirm an ER-localization of the putative transporter, the transformed A. thaliana 
cultured cells were treated with BFA (2.7.2.1). This toxin disrupts the Golgi 
apparatus and leads to mislocalization of ER resident protein as well. After 2 h of 
treatment with the cytotoxin, the distinct fluorescence structures that could be 
observed before the treatment had disappeared. The GFP signal could be seen 
throughout the cell lumen. This observation was made for both clones (Fig. 41) 
25 !m 
25 !m 25 !m 
25 !m 
1a 1b 2a 2b 
 
Fig. 41: Wide-field fluorescence microscopy of A. thaliana cultured cells treated with BFA and 
transformed with 35S:GFP-At3g54830. A. thaliana cultured cells transiently expressing clone 2.9 (1) 
and clone 5 (2). (a) untreated cells (b) with BFA (100 !g/mL; 2 h; 22 °C) treated cells. 
3.2.3.5 Promotor analysis 
To find out more about the role of At3g54830 in the plant, 1992 nt of the intergenic 
region and the first three exons of At3g54830 were cloned via gateway cloning into 
pDONR207. The GUS gene was placed under the control of the putative promotor 
region using the expression vector pGWB3i. GUS expression was analyzed in 
seedlings and adult plants of the T2 generation of the stably transformed A. thaliana 
plants of three independent lines. The GUS signal was observed in the veins of adult 
leaves (green house conditions). GUS activity was also visible in the cotyledons, the 
leaves and in root tips of seedlings. 
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a b c d 
 
Fig. 42: GUS analysis of promAAT:GUS in A. thaliana Col-0 plants. (a) 13-day-old seedling (b) 10-
day-old seedling roots (c) 10-day-old seedling cotyledons, (d) adult leaf (T2). The plants from (a), were 
grown on " MS-plates under long day conditions, (b) and (c) under short day conditions. The adult 
plants were grown in the greenhouse (d). 
 
3.2.3.6 Production of At3g54830 overexpressing lines and analysis in Hepa1c1c7-
Lux cells 
To obtain further information on the functional splicing variant of At3g54830, the 
different clones were placed under the control of the CaMV35S-promotor in the 
pAMPAT vector. Different lines of selected T1-generation plants were tested in the 
Hepa1c1c7-Lux cells. In general an induction of the luminescence could not be 
observed (data not shown).  
 
3.2.4 Mutant lines 65.32 and 67.18   
3.2.4.1 The insertion site of mutant lines 65.32 and 67.18 was mapped on 
chromosome 1 
The T-DNA insertion site of mutants 65.32 and 67.18 was mapped on chromosome 1 
between the genes At1g63810 and At1g63820 (Fig. 43). An up-regulation of 
At1g63820 of up to 53-fold to the expression in wild-type plants was determined. 
The expression of the gene At1g63810 was not changed. The gene At1g63810 
encodes for a putative Nrap-like nucleolar RNA-associated protein. The function of 
the protein encoded by At1g63820 is unknown. In silico analysis using 
ARAMEMNON predicts that this unknown protein is soluble. It contains a CCT-
domain (CONSTANS, CONSTANS-like, TOC1), which is a short motif of 43 amino 
acids containing a putative nuclear localization signal within its second half. The 
protein is 51% homologous to one other protein (At5g41380), which is of unknown 
function as well. Maximum expression of At1g63820 is in dry and germinating seeds 
(183) (Fig. 44). The protein belongs to the ASML2 (Activator of Spomin::LUC2) 
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family proteins class I. One member of this protein family, ASML2 (At3g12890), has 
been shown to function as a transcriptional activator. ASML2 regulates a subset of 
sugar inducible genes (184). 
 
 
Fig. 43: Insertion site in mutant lines 65.32 and 67.18. 
 
 
 
Fig. 44: Expression level of At1g63820 in different Arabidopsis organs. The gene is expressed in the 
siliques and seeds, but only mild or no expression takes place in the leaves and other organs. The 
highest expression takes place in seeds (stages 7 to 10). Source: Arabidopsis eFP Browser (183). 
3.2.4.2 Subcellular localization analysis of gene At1g63820 
To determine the subcellular location of the protein it was C-terminally fused with 
GFP. Both in N. benthamiana cells and in A. thaliana cultured cells the transient 
expression led to a nuclear and cytoplasmic GFP signal (Fig. 45). These results 
confirmed the prediction for the CCT domain. 
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Fig. 45: Wide-field fluorescence microscopy of GFP fluorescence of cells transiently expressing 
35S:At1g63820-GFP. (a) N. benthamiana leaves (b) A. thaliana cultured cells. 
3.2.4.3 Production of At1g63820 overexpressing lines and analysis in Hepa1c1c7-
Lux cells 
The gene At1g63820 was stably expressed in A. thaliana plants under the control of 
the CaMV35S-promotor using the pAMPAT vector. Three overexpressing lines 
(V25.5, 7 and 9) were tested in the Hepa1c1c7-Lux reporter system.  
Fig. 46 is a summary of the screening results in Hepa1c1c7-Lux cells. The line 65.32 
was used for comparison. In both screening assays the lines 25.7 and 25.9 showed a 
high induction of the reporter system. The TAMARA line 65.32 did not induce the 
system as strongly as in past screening with an induction of 1.27 and 1.95 fold to 
wild-type plants. Since the expression levels of the genes in the activation tagged 
lines was not stable, this was observed in many TAMARA lines (data not shown), the 
accumulation of active compounds in these mutants may also vary leading to variable 
induction potential in the reporter systems.  
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Luciferase assay with At1g63820 mutants 
 
Fig. 46: Analysis of the induction potential of At1g63820 recapitulation lines (V25) using the 
Hepa1c1c7-Lux reporter system. The luminescence signal is shown as median luminescence per total 
cellular protein (!g/mL). Bars represent the standard error of three technical replicates. The median for 
Col-0 is from three to four samples per screening assay with three technical replicates each.  
 
3.2.5 Mutant lines 88.06, 89.29, 89.37, 90.32, 90.40, 90.43 and 90.53 
3.2.5.1 The insertion site of mutant lines 88.06, 89.29, 89.37, 90.32, 90.40, 90.43 
and 90.53 was mapped on chromosome 5 
The insertion site of the lines 88.6, 89.29, 89.37, 90.32, 90.40, 90.43 and 90.53 was 
mapped on chromosome 5, flanking a gene encoding a protein of unknown function. 
The gene is present in two identical copies. In addition to the gene, the intergenic 
region is also partly identical. For this reason, the insertion site was allocated to two 
possible positions. The T-DNA insertion could be either between the two identical 
genes At5g55880 and At5g55890, or it could flank only gene At5g55880 (Fig. 47). 
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Fig. 47: Insertion site of mutant lines 88.6, 89.29, 89.37, 90.32, 90.40, 90.43 and 90.53. 
 
Expression analyses revealed that the gene(s) was up-regulated up to 100,000 fold. In 
silico analysis using ARAMEMNON uncovered that the genes At5g55880 and 
At5g55890 are part of a cluster of 27 genes in A. thaliana (159). None of the members 
of this gene cluster have been characterized to date. Strikingly, several duplication 
events have taken place within the cluster. Most of the related genes are located on 
chromosome 5, ten members can be found on chromosomes 1, 2 and 4. The genes of 
this cluster have one common domain; the function of this domain is also unknown 
(Fig. 48). No microarray data is available for the genes in public expression databases.  
 
Fig. 48: Protein encoded by At5g55880/At5g55890 with the DUF295 domain (159). 
3.2.5.2 Subcellular localization via GFP fusion protein 
To learn more about the protein encoded by gene At5g55880/At5g55890, the gene 
was cloned and recombined into the vector pGWB5. Under the control of the 
CaMV35S-promotor, C-terminal GFP fusion protein was transiently expressed in A. 
thaliana cultured cells and N. benthamiana leaves. The GFP fluorescence was 
observed using a confocal microscope (2.7.2). Both in the cultured cells and in the 
tobacco leaves, the GFP was visible throughout the cell in small dots (Fig. 50, Fig. 
51). In silico analysis, using ARAMEMNON, predicts that the protein is localized to 
the mitochondrion (Fig. 49).  
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Fig. 49: Predicted subcellular localization of At5g55880 protein using ARAMEMNON (159). 
 
The overlay image, which shows the autofluorescence of the chloroplasts in tobacco, 
reveals that the protein was not localized to the plastids. Together with the in silico 
analysis it can be concluded that the protein is localized to the mitochondrion. 
 
50 !m 
 
 
Fig. 50: Confocal microscopy of A. thaliana cultured cells transformed with 35S:At5g55880-GFP. 
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Fig. 51: Confocal microscopy of GFP in N. benthamiana leaves transformed with 35S:At5g55880-
GFP. The chloroplasts exhibit red autofluorescence. GFP is visible in green.  
3.2.5.3 Metabolite profiling of mutant lines 90.32, 90.40 and 90.43 
Extracts of the mutant lines 90.32, 90.40 and 90.43 were subjected to metabolite 
profiling, performed by Dr. Stephan Schmidt (IPB, Halle). The mutants accumulated 
unknown compounds with long carbon chains with up to 34 carbons (data not shown). 
While initially it was suggested that these compounds are long-chain fatty acids, 
subsequent studies did not confirm an accumulation of fatty acids in the mutant lines 
(personal communication Prof. Dr. Ivo Feußner, University of Göttingen) and future 
analyses are needed to conclusively find the identity of the accumulated metabolites. 
 
3.2.6 Mutant lines 41.66, 41.16, 41.58, 40.36 and 40.76 
3.2.6.1 The insertion site of mutant lines 41.66, 41.16, 41.58, 40.36 and 40.76 was 
mapped on chromosome 4 
During the mapping process, five mutant lines were identified with the same insertion 
site, namely 41.66, 41.16, 41.58, 40.36 and 40.76. The mutant was named GH3.5-1D-
cp, since the insertion site was localized on chromosome 4 at position 12649372 
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between genes At4g27250 and At4g27260. Gene At4g27260 encodes for the IAA 
amido synthetase AtGH3.5 (Gretchen Hagen) and gene At4g27250 encodes for a 
putative NAD-dependent epimerase/dehydratase. In the analyzed cDNAs, the GH3.5 
gene was up-regulated up to 152 fold, while the expression level of the putative NAD-
dependent epimerase/dehydratase was slightly down regulated or remained 
unchanged. The insertion site of mutant GH3.5-1D-cp is shown in Fig. 52. 
 
 
 
Fig. 52: Insertion site of mutant lines 41.66, 41.16, 41.58, 40.36 and 40.76. 
 
As already mentioned in chapter 3.1.4.2, the mutant GH3.5-1D-cp exhibited a strong 
phenotype. Depending on the expression level of GH3.5, the plants were dwarfish and 
had curled rosette leaves (Fig. 53). The detected lines had a variable expression level 
of the GH3.5 gene. The dwarfish phenotype and the curled leaves reflect the typical 
morphology for auxin imbalance and correspond with the phenotype observed with 
other activation tagged GH3.5 mutants, namely the gh3.5-1D and wes1-D mutants 
(185,186). An activation tagged mutant (dfl1-D) of the closely related AtGH3.6 has 
also been detected with a similar phenotype (187,188). 
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Fig. 53: Phenotype of mutant line (A) 41.66 and (B) Col-0. The plants were grown under short day 
conditions in a growth chamber.  
 
3.2.6.2 Metabolite profiling of GH3.5-1D-cp 
The mutant GH3.5-1D-cp was subjected to UPLC-ESI-QTOF-MS analysis performed 
by Dr. Stephan Schmidt (Leibniz Institute of Plant Biochemistry). The mutant 
accumulated elevated amounts of oxindole-3-acetyl-glucose ester/glucoside (OxIAA-
Glc) (Fig. 54), the aliphatic glucosinolates glucosibarin (7MSOH) and glucohirsutin 
(8MSOO), as well as I3M. 
 
Fig. 54: Excerpt of the chromatogram of mutant GH3.5-1D-cp, which accumulated OxIAA-Glc. The 
chromatogram was provided by Dr. Stephan Schmidt (IPB, Halle). 
 
To confirm the data obtained via UPLC-ESI-QTOF-MS, glucosinolates were 
extracted from the leaves and analyzed via UPLC as described in chapter 2.7.4. In the 
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follow-up measurements the glucosinolate content was also altered, the specific 
pattern observed from UPLC-ESI-QTOF-MS, could not be confirmed though. Other 
metabolic derangements were suggested such an increase of 8MSOO (experiment 1) 
and modestly reduced concentrations of I3M (experiments 1 and 2). All in all, the 
overexpression of GH3.5, resulting in the production of auxin conjugates, leads to an 
auxin imbalance in the plant. As a side effect, the glucosinolate content seems to be 
affected. Factors that determined the different glucosinolate content in Halle and 
Cologne might have been varying expression levels of GH3.5 in the different 
experiments and the plant cultivation conditions. 
 
3.2.7 Mutant line 68.24 
3.2.7.1 The insertion site of mutant 68.24 was mapped on chromosome 1 
The T-DNA insertion site of mutant line 68.24 was localized on chromosome 1, at 
position 26773523 between the genes At1g71000 and At1g71002 (Fig. 55). The gene 
At1g71000 encodes for an Hsp40/DNAJ-type molecular chaperone. At1g71000 was 
up-regulated 4.5 fold in the analyzed sample. The gene At1g71002 encodes a 
microRNA (miR858a). The gene MIR858a was up-regulated up to 1320 fold in the 
analyzed cDNA samples.  
 
 
Fig. 55: Insertion site of mutant line 68.24. 
3.2.7.2 Putative targets of miR858a and the effect on the phenylpropanoid 
pathway 
On the TAIR database miR858a is annotated to target several MYB transcription 
factor family members. The mature sequence of miR858a is predicted as follows: 
UUUCGUUGUCUGUUCGACCUU (158). The WMD3 MicroRNA Designer target 
search tool, predicts 22 putative target MYBs of miR858a: MYB80, MYB12, 
MYB83, MYB4, MYB19, MYB120, MYB13, MYB71, MYB11, MYB17, MYB20, 
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MYB42, MYB111, MYB84, MYB37, MYB123, MYB74, MYB87, MYB116, 
MYB99, MYB6 and MYB85 (189). Experimentally, via degradome sequencing, 
determined targets of miR858a are MYB12, MYB111, MYB13 and MYB20 (190). 
Fahlgren et al. (2007) identified MYB12 and MYB83 as putative targets of miR858a 
via deep sequencing and computational analysis (191). The transcription factors 
MYB11, MYB12 and MYB111 have a regulatory function in the phenylpropanoid 
pathway. Arabidopsis triple loss of function mutants of MYB11, MYB12 and 
MYB111 (myb11/myb12/myb111) do not produce flavonols in seedlings, while the 
anthocyanin content is induced (149). 
Due to the known chemoprotective activity of phenylpropanoid derived compounds, a 
first experiment was performed testing the expression of MYB11, MYB12 and 
MYB111 in the available 68.24 cDNA from the screening (experiment performed by 
L. Marbaise, see (170)). The transcription factors MYB51 and MYB28 functioned as 
controls because they are not predicted targets of miR858a. The high overexpression 
of MIR858a (1320 fold) resulted in a strong downregulation of MYB11 (0.001 fold), 
MYB12 (0.019 fold) and MYB111 (0.157 fold), while the expression of MYB28 
(0.94 fold) and MYB51 (1.7 fold) remained unaffected. These results suggest that 
among others MYB11, MYB12 and MYB111 are targets of miR858a. In addition, 
genes that encode enzymes involved in the phenylpropanoid pathway were tested, 
namely At5g13930, At3g55120, At3g51240, At5g08640, At5g42800, At2g37040, 
At3g53260, At5g07990 as well as MYB13 and MYB20, which are two putative 
targets of miR858a. The results together with the full gene names are listed in Table 
13. The chalcone synthase (CHS), chalcone isomerase (CHI), flavanone-3-
hydroxylase (F3H), and flavonol synthase (FLS) are transcriptionally controlled by 
MYB11, MYB12 and MYB111. Except for CHS, which showed a 5.6 fold 
upregulation, these genes were all downregulated in the tested cDNA. In addition the 
genes PAL1 (phenylalanine ammonia-lyase) and PAL2, which catalyze the 
production of cinnamate from phenylalanine were less expressed than in wild-type 
plants. The effect on the expression of genes F3’H and DFR was only minimal. The 
putative miR858a target gene MYB13 was downregulated and MYB20 was slightly 
up-regulated. 
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Table 13: Relative gene expression of different enzymes involved in the phenylpropanoid pathway. 
Gene Name Relative gene expression  
(fold change) 
At5g13930 chalcone synthase (CHS) 5.6 x 
At3g55120 chalcone isomerase (CHI) 0.139 x 
At3g51240 flavanone-3-hydroxylase (F3H) 0.042 x 
At5g08640 flavonol synthase (FLS) 0.57 x 
At5g42800 dihydroflavonol 4-reductase (DFR) 1.3 x 
At2g37040 phenylalanine ammonia-lyase (PAL1) 0.092 x 
At3g53260 phenylalanine ammonia-lyase (PAL2) 0.335 x 
At5g07990 cytochrome P450 monooxygenase 
(F3’H) 
0.783 x 
At1g06180 MYB13 0.256 x 
At1g66230 MYB20 1.851 x 
Downregulated genes are marked in grey. 
 
To confirm the obtained results, further 68.24 cDNAs were tested. Due to silencing of 
MIR858a in individual plants of line 68.24, those plants showing an overexpression of 
MIR858a were selected and the expression of MYB11, MYB12 and MYB111 was 
determined in each cDNA. An upregulation of the target genes was observed in some 
of the mutants that were overexpressing MIR858a. It was hypothesized that 
breakdown products of the target mRNA were amplified. The predicted miRNA target 
site lies at the 5’-end of the genes and this region is similar in all three genes. In order 
to distinguish between the genes the applied primers annealed to the 3’-end of the 
mRNA (cDNA), and did not span the miRNA target site.  
To check that the amplified sequences were not cleavage products a semi quantitative 
PCR was performed using primers that flank the putative cleavage site. This was 
performed for MYB11 and MYB111, since the expression of MYB12 is mainly in the 
roots. MYB11 was downregulated in lines 48, 4.3, 42 and 4.1 and could not be 
detected in lines 43 and 25. MYB111 was expressed in lines 48, 4.3, 42 and 4.1 and 
was also not detected in lines 43 and 25. It seems that a relatively high expression of 
the gene MiR858a is necessary in order to reduce the target MYB mRNA.  
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Fig. 56: Agarosegelelectrophoresis of a semiquantitative PCR of genes MYB11 and MYB111 in 
cDNA of different 68.24 plants. The fragments have sizes of 882 and 912 bp, respectively. The PCR 
was performed with 39 cycles and 55 °C annealing temperature. C1 and C2 are controls of wild-type 
plants. The actin ct values were determined via real time PCR: 48 (Ctactin=17.7), 4.3 (Ctactin=19.02), 42 
(Ctactin=17.6), 4.1 (Ctactin=17.6), 43 (Ctactin=21.6), 25 (Ctactin= 21.2), C1 (Ctactin= 17.4) and C2 (Ctactin= 
17.5).  
 
Taken together, the data suggest that miR858a targets the transcription factors 
MYB11, MYB12 and MYB111. This influences the expression of genes involved in 
the phenylpropanoid pathway. In addition further targets of miR858a might exist, 
such as MYB13. At a relatively high expression of MIR858a (178 fold), MYB11 and 
MYB111 were downregulated. An overexpression of MIR858a at a lower level (ca. 
15 fold for MYB11 and less than 100 fold for MYB111) most likely also led to 
cleavage of target genes but low levels of target mRNAs were still present.  
3.2.7.3 The expression of MiR858a at different day times 
The analysis of the MIR858a expression pattern was performed to gain more insight 
into the role of miR858a in Arabidopsis. One hypothesis is that microRNAs are 
derived from duplication events of their target gene(s), this can also include the 
promotor region of the founder gene (192,193). In addition, evidence exists that 
microRNA expression is regulated by the target transcription factors in a negative 
feedback loop (194,195). If the target genes of miR858a are in fact MYB11, MYB12 
and MYB111, then one possibility is that these transcription factors also regulate the 
expression of MiR858a. Therefore, different attempts were made to learn more about 
the regulation of MIR858a.  
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From microarray data it is known that the expression of MYB12 changes after light-
to-dark transition (personal communication with Dr. Ralf Stracke, University of 
Bielefeld) therefore the expression pattern of MIR858a during the course of a day was 
analyzed. In a first experiment the expression levels of MIR858a in leaves of adult 
Col-0 plants and plants of line 68.24 were analyzed. Despite a high variance between 
the expression levels of MIR858a in the individual plants, it became apparent that the 
expression of MIR858a did not stay constant throughout the day (data not shown). 
This could also be confirmed for MYB11. In order to reduce the high variation 
between the samples, Col-0 seedlings grown on " MS agar plates, under short day 
conditions in the growth cabinet. The 6-day-old seedlings were harvested in pools of 
ca. 20 individuals. The RNA was extracted using the Z6-extraction protocol (see 
2.4.1.3.1.2). The samples were taken at the end of the night (8:45), after the light had 
been turned on for one hour (11:00), shortly before the light would turn off (17:30) 
and 1" h after start of the night (19:30). Expression analyses revealed that the 
expression of MIR858a was the highest at the end of the day (17:30), while it stayed 
relatively constant at the end of the night and start of the day (8:45, 11:00). After the 
night had started, the expression of MIR858a was down regulated again (Fig. 57). 
 
 
 
Fig. 57: Relative expression of MIR858a in pooled Col-0 seedlings depending on daytime. The relative 
expression was calculated in relation to the average expression at 8:45. RNA samples were taken from 
ca. 20-pooled seedlings 6 days of age. The plants were grown on " MS agarose plates under short day 
conditions. The relative expression values are an average of three pools of one biological replicate. The 
bars represent the standard error. The repetition of the experiment showed similar results. 
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In a further experiment, the expression of MIR858a in the triple loss of function 
mutants myb11/myb12/myb111 was tested throughout the day (the mutants were 
kindly provided by Dr. Ralf Stracke, University of Bielefeld). The expression of 
MIR858a in these plants varied at the different day times and did not follow the 
pattern observed in Col-0 wild-type plants. The results suggest that the expression of 
MIR858a is influenced by the putative target transcription. 
 
Fig. 58: Relative expression of MIR858a in pooled myb11/myb12/myb111 triple knockout mutant 
seedlings depending on daytime. The relative expression was calculated in relation to the average 
expression at 8:45 in Col-0 plants. RNA samples were taken from ca. 20-pooled seedlings 6 days of 
age. The plants were grown on " MS agarose plates under short day conditions. The relative 
expression values are an average of three pools. The bars represent the standard error. 
 
3.2.7.4 Analysis of MIR858a expression in different tissues 
To learn more about the expression pattern of MIR858a within the plant, the GUS 
gene was placed under the control of the putative promotor region of MIR858a, using 
the vector pGWB3i. In general the promotor region of MIR genes is predicted within 
the upstream region of 800 nt (194). A region of 2082 nt, including the MIR858a gene 
sequence, was cloned. Different organs of the T1-generation were tested for GUS 
activity. The promotor of MIR858a was active in the inflorescences, the veins of 
rosette leaves and in the stems of the siliques, but not in the siliques and seeds (Fig. 
59). 
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Fig. 59: GUS activity in inflorescences (A,B), siliques (C,E) and leaves (D) of PromMIR858a:GUS 
lines. The GUS activity was observed in different lines of the T1-generation of transformants. 
Representative pictures from different lines are shown here.  
 
The promotor activity was also analyzed in developing seedlings from two-day-old to 
eight-day-old plants of different lines. The samples were always taken at the same 
daytime on each day. From the staining it becomes apparent that MiR858a is 
expressed during seedling development. After germination, the promotor was active at 
the tip of the radicle and in the cotyledons, which were still inside the seed coat. On 
day three, the seedling had shed the seed coat and GUS staining was visible in the 
vascular of the cotyledons and in the hypocotyl and in the tip of the root (meristem). 
On days four and five the GUS distribution was similar as on day three. The eight-
day-old seedlings exhibited GUS activity in the vascular of the leaves and in the 
hypocotyl. There was also intensive GUS staining visible at the hypocotyl-root 
junction (Fig. 60).  
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Fig. 60: MiR858a promotor GUS analyses in two to eight-day-old seedlings. (A) two-day-old seedlings 
(lines V80.3, 16a, 6a) (B) three-day-old seedlings (lines V80.3, V80.6) (C) four-day-old seedlings 
(lines V80.3, V80.6a) (D) five-day-old seedling (lineV80.6a) (E) eight-day-old seedlings (lines V80.1a, 
V8016c). The seedlings were grown on " MS-medium under short day conditions. T
2 
generation plants 
were analyzed. 
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It could be shown that MYB12 and MYB111 are regulated by the bZIP transcription 
factor HY5 in response to light and UV-B radiation (196). Light regulatory elements 
were also detected in the promotor region of MIR858a (197). Here the effect of 
different light intensities was tested using the promotor-GUS lines. The seedlings 
were transferred from short day conditions to long day and high light conditions. 
After one week, the GUS activity was determined. The GUS assay was performed 
with 13-day-old seedlings of two independent lines. Under short day conditions the 
staining was limited to the shoot apex region and the base of the leaf stems. A very 
mild staining was visible in the vascular tissue of the leaves. Seedlings that were 
transferred to the long day exhibited stronger staining. The staining was visible in the 
shoot apical meristem (SAM), the leaf stems and very mildly in the roots. Under high 
light conditions the GUS activity was the highest in both lines. It was clearly visible 
in the vascular tissue of the leaves, the SAM and the roots. In summary the data 
suggest that the promotor of MIR858a is induced upon increased intensity of light 
(long day and high light).  
1 2 3 
 
Fig. 61: Treatment of promMIR858a:GUS seedlings with different light conditions. After the seedlings 
were grown on " MS-medium for 6 days under short day conditions, they were transferred to (2) long 
day, (3) high light or (1) remained at short day. After 7 days the GUS activity was determined. 
 
3.2.7.5 MIR858a mutant analysis 
To confirm the gene-to-trait relationship the MIR858a gene was cloned into the 
expression vector pGWB2 and Col-0 plants were transformed with the construct. A 
number of resistant T1-lines were isolated but subsequent expression analyses via real 
time PCR revealed that none of the lines overexpress MIR858a more than ca. 10-fold 
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of wild-type levels. Nevertheless for an initial experiment with Hepa1c1c7-Lux cells, 
extracts of line 35S:MIR858a9 were tested. In addition plants overexpressing a 
miR858 target mimic (MIM858) were cultivated (MIM858 lines were kindly provided 
by I. Rubio-Somoza, MPI for Developmental Biology, Tübingen). Since classical 
loss-of-function mutants via T-DNA insertion are not available, these plants were 
constructed to inhibit the function of a specific miRNA (150). In one experiment, 
extracts of MIM858, MIR858a and 68.24 induced the reporter cells. This was not the 
case in a second screen. Since also extracts of 68.24 failed to induce luminescence in 
this screen, the lack of induction was probably due to a problem with the reporter 
cells.  
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4 Discussion 
4.1 Screening of TAMARA mutants with the Hepa1c1c7-Lux reporter 
cells 
The anticancerogenic effect of many phytochemicals can be ascribed to their 
induction of phase II and detoxification enzymes. Some phytochemicals can 
additionally inactivate carcinogens by directly functioning as anti-oxidants (110). To 
test the chemoprotective activity of a compound, the expression of phase II and 
detoxification enzymes and the activation of Nrf2 in response to treatment with the 
respective compounds or extracts were analyzed (5,198-200). To simplify these tests, 
reporter systems have been developed in which a reporter gene is placed under the 
control of EpRE. The HepG2-GFP and Hepa1c1c7-Lux reporter cells developed by 
Zhu et al. (2000) and Boerboom et al. (2005) are such systems (112,113). EpRE 
based reporter systems have been applied to test single compounds and extracts from 
different plants (201-209). In this way the molecular characteristics of a 
chemoprotective compound could be eluciated such as the role of planarity of 
flavonoid molecules in the induction of phase II enzymes (113).  
Here, the EpRE based reporter systems were applied for testing the chemoprotective 
activity of compounds found in A. thaliana Col-0 plant extracts. In contrast to using 
isolated substances, plant extracts contain a variety of different compounds. These 
compounds may have inducing, inhibiting or even toxic effects on the cells. When 
administered in a high concentration the compounds may be toxic (210). This was 
observed with extracts from grape and A. thaliana (Col-0) (114,208). Therefore, the 
assessment of an appropriate amount of Col-0 extract was a first necessary step in this 
work. The fact that the secondary metabolism of a plant is easily affected when the 
environmental conditions change is a further challenge (211). It was therefore 
important to cultivate the plants under controlled conditions. A treatment of the 
Hepa1c1c7-Lux reporter cells with Col-0 extracts led to a basal induction of luciferase 
due to the high amount of phase II enzyme inducers found in this plant. 80% of the 
induction activity of the extracts can be ascribed to methylsulfinylalkyl 
glucosinolates, mainly glucoraphanin (114).  
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The EpRE based cell culture reporter system is a valuable tool for the discovery and 
analysis of chemoprotective compounds. To test the Hepa1c1c7-Lux cells, extract of 
the HIG1-1D mutant was used as an inducer. The overexpression of MYB51 in this 
mutant leads to the accumulation of I3M (151). The breakdown product I3C is a 
known chemoprotective compound (61,166). The mutant extracts led to an increased 
luciferase signal. Hepa1c1c7-Lux cells thus enable the screening of A. thaliana plant 
extracts.  
As with most model systems, some limitations though exist with using cell models. 
One aspect is the fact that the cells with which we are working are cancer cells. Many 
aberrations have taken place in these cells. Some phytochemicals even lead to 
apoptosis of cancer cells (212). The cancer cells have lost many characteristics such 
as contact inhibition. In addition the cells are not in their in vivo environment and in 
contact with other cell types from different tissues. Many of the compounds 
consumed by mammals will not reach the organisms’ systemic circulation in their 
original state after they have passed the digestive tract. Therefore, the reporter cells 
treated with plant extracts are exposed to compounds and compound levels, which 
they would not encounter in vivo (213). Recently, it was demonstrated that increased 
constitutive Nrf2 transcription may even promote tumorigenesis in the analyzed cells 
(214). This demonstrates that the use of EpRE based reporter systems for the search 
of new phytochemicals is only one aspect of chemoprevention and that many other 
factors play a role in cancer development and intervention. Nevertheless, the cell 
culture reporter systems offer the opportunity to discover new phytochemicals in a 
high-throughput and ethical manner. The discovered compounds can later be tested in 
animal models and clinical studies. In addition, the screening allows the further 
elucidation of secondary metabolism in plants. 
4.2 Analysis of the discovered genes 
Approximately 5,000 TAMARA mutants were screened using the HepG2-GFP cells 
with the goal of finding new chemoprotective compounds and genes involved in the 
metabolite production. After two rounds of screening, ca. 470 candidates were 
selected for further analyses using Hepa1c1c7-Lux cells. 149 mutants were mapped, 
which led to the identification of 87 different mutants. The expression of the genes 
ultimately up and downstream of the insertion site was determined. These data give an 
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indication of which genes may be responsible for the EpRE inducing effect of the 
mutant extract. In order to get a general picture, 158 discovered genes were 
categorized into different groups. In a first attempt, the groups were formed on the 
basis of the putative or known gene functions listed in TAIR and ARAMEMNON. 
32% of the genes encode for enzymes, 13% for transcription factors, 11% are 
involved in transport, 26% are of unknown function and 18% could not be categorized 
into a general group.  
The drawback of the clustering or grouping of those genes showing an altered 
expression level is the fact that in many mutants more than one gene had an altered 
expression. The chemoprotective effect may be allocated to only one of the genes. 
Since at this point it can only be speculated which of the genes is responsible for the 
chemoprotective activity of a mutant, the analysis of all altered genes can be 
misleading. On the other hand the chemoprotective effect may also be due to the 
altered expression of a combination of genes. Neighboring genes can for examples 
have similar functions due to duplication events. 
With the help of the bioinformatic tool DAVID the genes detected during the 
screening can be sorted on the basis of functional annotations. This form of clustering 
gives more detailed insight to the functions of the genes such as the pathway in which 
it may be involved. The analysis resulted in 25 clusters. Some of their members 
overlap with members of other clusters.  
The discovered groups include enzymes involved in macromolecule catabolic 
processes, mainly glycosyl hydrolases of the family 1, 9, 19 and 28. The majority of 
these glycosyl hydrolases are predicted to function as !-glucanases, chitinases and 
polygalacturonases that are associated with cell wall organization, which also reflects 
the situation in the plant, where most glycosyl hydrolases are involved in cell wall 
polysaccharide metabolism (215). Some of the detected genes in this group respond to 
abiotic or biotic factors, such as water, light and fungal pathogens. Members of the 
class of glycosyl hydrolases have been reported to play a role in the metabolism of 
cell wall polysaccharides, biosynthesis and remodulation of glycans, mobilisation of 
storage reserves, plant defense, symbiosis, secondary metabolism, glycolipid 
metabolism and signaling (215). Glycosyl hydrolases can be directly involved in the 
production of chemoprotective secondary compounds via the hydrolysis of secondary 
metabolites, which influences their biological activity, chemical stability and water 
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solubility. The activation and inactivation of phytohormones, such as auxins, 
cytokinins, gibberellins, abscisic acid and SA can also be caused via hydrolysis by 
glycosyl hydrolases. In this way glycosyl hydrolases can affect signaling in the plant 
which can result in changes of secondary metabolism (215). 
The second category of genes is involved in transport. Members of this group have 
transmembrane domains. Representatives of both passive and active transport were 
found. The detected transporters include among others several putative aquaporins 
and two ABC transporters. The altered expression of plasma membrane transporters 
can have an effect on nutrient availability in the plant and therefore can have an 
impact on plant growth and metabolism. An example is the overexpression of the 
aquaporin PIP1b, which leads to increased plant growth rate, transpiration rate, 
stomatal density, and photosynthetic efficiency under favorable growth conditions 
(216). In addition, some transporters have been reported to transport phytohormones 
such as amino acid transporters of the amino acid/ auxin permease family for auxin 
transport or purine permeases for cytokinins (217). The altered transport of 
phytohormones effects plant signaling and can impact secondary metabolism. 
Transporters of secondary metabolites have also been identified, which offer a target 
for increasing the production of secondary metabolites in addition to altering the 
expression of biosynthetic enzymes (218,219). 
The third group consists of genes involved in reproductive organ development such as 
the floral organs and the seeds and post-embryonic organ development. This group of 
ten members contains several transcription factors, namely WRKY35, MYB26, 
WOX2, Brevis Radix- type transcription factor, sterile apelata protein transcription 
factor, and the leafy cotyledon 2 family B3 type transcription factor. Transcription 
factors have key regulatory roles in plant metabolic pathways and can control multiple 
steps. Therefore, they are considered as promising factors for plant metabolic 
engineering. Many transcription factors that regulate plant secondary metabolism are 
still unknown (220). The Brevis Radix-2 is known to be involved in cell proliferation 
and elongation of the root tip (221), mediates the interaction between the 
brassinosteroid pathway and auxin signaling in roots (222) and is involved in 
cytokinin-mediated inhibition of lateral rot initiation (223).  
The screening detected several genes involved in secondary metabolic processes. The 
six members include proteins involved in glutathione metabolism, namely a gamma-
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glutamyl transpeptidase, which degrades the anti-oxidant glutathione, and two 
glutathione-S-transferases. Three proteins were predicted to be involved in the 
phenylpropanoid pathway. These are two acyl-CoA synthetases and a laccase that is 
involved in lignin catabolic processes. The acyl-CoA synthetases, At1g20500 and 
At1g20510 are closely related to 4-coumarate:CoA ligases, which catalyze the 
formation of CoA-esters from 4-coumarate and cinnamic acid derivatives, building 
blocks of the phenylpropanoid metabolism. The acyl CoA synthetases found here 
have been shown to be involved in jasmonic acid biosynthesis. At1g20500 catalyzes 
the conversion of OPC-6 to OPC-6-CoA ester and can also activate the cinnamic acid 
derivative sinapic acid. At1g20510 catalyzes the conversion of 12-oxo-phytodienoic 
acid, (3-oxo-2(2’-[Z]-pentenyl)cyclo-pentane-1-octanoic acid) OPC-8, OPC-6 and 
OPC-4 to the respective esters. These steps are necessary for the !-oxidative 
shortening of the side chain, which leads to jasmonoyl-CoA formation, a precursor of 
jasmonic acid (224). As mentioned in chapter 1.1.7, chemoprotective activity of 
jasmonic acid has been demonstrated. Glutathione-S-transferases are involved in the 
detoxification of toxins via conjugation with glutathione. Some form a complex with 
flavonoids to facilitate the transport into the vacuole, they play a role in stress 
metabolism and function in stress signaling by inducing chalcone synthase upon 
exposure to UV-light (225). Via the action of glutathione-S-transferases putative 
chemoprotective compounds could be produced. 
The fifth group consists of genes that respond to abiotic stresses. As stress response, 
plants produce a variety of secondary metabolites (211). Therefore, genes of this 
group represent putative candidates for the production of chemoprotective 
compounds. The eight members forming this group are very diverse. Some of them 
have already been discussed, such as a glutathione-S-transferase (At1g02930) or the 
plasma membrane intrinsic protein (At1g01620). Also the !-glucosidase PYK10 will 
be discussed in the following chapter. One group of genes responds to water 
deprivation, namely the class-III peroxidase (At1g05260), the plasma membrane 
intrinsic protein and the glutathione-S-transferase. The peroxidase, a protein kinase, 
the glutathione-S-transferase and PYK10 respond to salt and osmotic stress and the 
membrane-extrinsic subunit of photosystem II complex (At5g66570), a fatty acyl-
CoA reductase (At5g22500) and a calcium cation permeable channel (At3g04110) 
respond to light. Members of this group may have signaling functions in stress 
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response. For example, the protein kinase SnRK2.7 of the sucrose nonfermenting 1-
related protein kinase 2 family is activated both by hyperosmotic stress and abscisic 
acid (ABA). This protein kinase family is involved in osmotic signaling (226). ABA 
and osmotic stress leads to the production of various secondary compounds in plant 
cells, such as indole alkaloids in cell culture of C.roseus, taxol in Taxus spp. cell 
culture, hydroxycinnamic acid amides and tryptophan in barley. ABA inhibits 
flavonoid accumulation in soybean (227). 
Another group of genes respond to hormone signaling. The fact that more than half of 
the ten members of this group encode for transcription factors shows that genes were 
detected with key regulatory roles in plant signaling. Three members of this group 
respond to ethylene, namely the ethylene-responsive binding factor (AtERF14), and 
two putative ERF-type transcription factors (At1g77200, At5g13330). Ethylene is an 
important factor in growth, development and plant defense and can be induced by 
wounding, ozone, pathogens and insects. The accumulation of ethylene can have an 
effect on secondary metabolism. For example in grape cell culture, ethylene treatment 
increased flavonoid, stilbenoid and anthocyanin production (227,228). AtERF14 plays 
an important role in regulating plant defense responses (229).  
The group of proteins that bind to metal ions consists of 25 members and is the largest 
group of genes detected here. In general, metal ions can function as protein cofactors. 
Metal ion binding to proteins can for example influence the interaction of the protein 
to DNA (230). The diverse group of metal ion binding proteins detected here consists 
mainly of enzymes. The important role of enzymes in the production of secondary 
metabolites was discussed already.  
Finally, a small group with four members was detected that have F-box domains. F-
box proteins function in protein ubiquitination and degradation and nearly 700 F-box 
proteins are predicted to exist in A. thaliana (231). The function of the detected genes 
is still unknown. The genes At1g47810 and At1g70970 are part of a common cluster 
of unknown proteins (159). The gene At3g59590 is related to a myrosinase binding 
protein. The homology may point to a putative role of At3g59590 protein in 
glucosinolate hydrolysis via myrosinases. In general F-box proteins have a number of 
different functions in plants, they function in hormone signaling, such as the receptor 
TIR1 that binds to auxin, but also play a role in jasmonate, gibberellin and ethylene 
pathways. F-box proteins are involved in light signaling and the circadian clock, 
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pollen recognition and rejection, different developmental processes such as lateral 
root formation and shoot branching, have functions in cell cycle, and defense response 
(231-233).  
Examples for each category could be found that are known or predicted to play a role 
in secondary metabolism. This demonstrates the potential of the detected mutants in 
the analysis of phytochemical production in plants.  
 
4.3 Analysis of selected mutants 
4.3.1 Mutant line PYK10-1D-cp  
PYK10 is a root and hypocotyl specific enzyme that has been associated with 
glucosinolate breakdown in roots (22). In PYK10-1D-cp the transcript level of PYK10 
was strongly enhanced in the leaves. Interestingly, PYK10 expression has so far been 
believed to be limited to the root and hypocotyl of seedlings and was not thought to 
take place in rosette leaves (172). The fact that PYK10 transcript was highly abundant 
in rosette leaves of PYK10-1D-cp demonstrates that PYK10 expression must take 
place at least in low basal levels in leaves of wild-type plants. Since the breakdown 
products of glucosinolates are known inducers of phase II and detoxification enzymes, 
the detection of the PYK10-1D-cp line offers new opportunities to study the 
chemoprotective effects of compounds derived from glucosinolate breakdown.  
Until a few years ago, the hydrolysis of glucosinolates was believed to take place only 
upon tissue disruption. Bednarek et al. (2009) discovered that the atypical myrosinase 
PEN2 degrades the indole glucosinolates I3M and 4MO-I3M to raphanusamic acid 
and indol-3-ylmethylamin or 4-methoxyindol-3-ylmethylamin in intact cells in 
response to fungal infection (36). Parallels between the PEN2 and PYK10 pathways 
can help to further elucidate the role of PYK10 in roots. The homologous enzymes are 
part of a subclade of !-glucosidases and are considered to be atypical myrosinases. 
The PYK10 coexpression network reveals that the monooxygenase CYP81F4, 
necessary for the synthesis of 1MO-I3M, is coexpressed with PYK10, so that 1MO-
I3M might serve as a substrate of the enzyme (177). Moreover, PYK10 is coexpressed 
with the transcription factor MYB34, which has recently been demonstrated to 
regulate the production of 1MO-I3M in roots (178).  
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PYK10 is the main component of constitutive ER bodies (179,234-236). The transient 
expression of PYK10-GFP protein in A. thaliana cultured cells confirmed the 
functionality of the clone and the localization of PYK10 protein to the ER bodies (see 
chapter 3.2.2.2). ER bodies are grouped into the constitutive and inducible. The 
constitutive ER bodies are present in the roots, hypocotyl and cotyledons of 
Arabidopsis seedlings (234,237,238). ER bodies have been suggested to play a role in 
plant defense reactions, because they are induced upon wounding and jasmonate 
treatment (235,238). 
The mutant lines PYK10-1D-cp, pyk10-1, and 35S:PYK10 were analyzed for 1MO-
I3M, 1MO-ascorbigen, 1MO-IAN, 4MO-I3M, 4MO-ascorbigen, 4MO-IAN and 
scopolin content in comparison to Col-0. The metabolite profiling revealed that the 
nitriles 1MO-IAN and 4MO-IAN were strongly reduced in the PYK10 loss-of-
function mutant. The content of 1MO-I3M was reduced in PYK10 overexpressing 
lines. Ascorbigen substitutions, namely 1MO-ascorbigen and 4MO-ascorbigen were 
reduced in PYK10-1D-cp and pyk10-1 lines but not in the two 35S:PYK10 lines, 
therefore not giving a clear picture for interpretation. Since PYK10 was found to 
hydrolyze the compounds scopolin and esculin in vitro, the scopolin content was also 
analyzed in the mutants (173,174). No clear results could be obtained from the present 
data, since the scopolin concentration was almost the same in all mutants but reduced 
in comparison to Col-0. The obtained data on nitrile accumulation suggest that 
PYK10 is involved in the formation of nitriles in roots. In addition, the reduced 
amount of 1MO-I3M in the overexpressing lines indicates that 1MO-I3M is a 
substrate of PYK10. Since 4MO-IAN was strongly reduced in pyk10-1 it can be 
concluded that PYK10 is also involved in the formation of 4MO-I3M derived nitriles. 
The 4MO-I3M content was not affected by PYK10 overexpression, suggesting that 
this glucosinolate is not a primary substrate of PYK10. PYK10 interacts with a 
number of other proteins, such as PYK10-binding protein 1 (PBP1) (239). In intact 
cells PYK10 and PBP1 are stored in separate compartments (239). For its activation, 
the enzyme needs to polymerize, making the protein non-soluble. This activation is 
induced by the PBP1 (239). In addition, PYK10 is coexpressed with a number of 
JALs (jacalin-related lectin) and GLLs (GDSL lipase-like protein). The expression of 
PYK10, JAL22, JAL23, JAL31, JAL33, PBP1, JAL30, GLL23 and GLL25 is 
regulated by the basic helix-loop-helix type transcription factor NAI1 (173,180,239). 
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PYK10 forms large complexes with JALs and GLLs (180). It is assumed that JALs 
and GLLs regulate the size of the PYK10 complex and its substrate specificity 
(180,237). The presence of nitrile specifier proteins during hydrolysis of 
glucosinolates leads to the production of simple nitriles (27). JALs or other specifier 
proteins could regulate the outcome of glucosinolate hydrolysis via PYK10 in a 
similar fashion. The nitrile content was not higher in overexpressing lines suggesting 
that this reaction may be dependent on other proteins not up-regulated in the mutants. 
It could also be the case that nitriles are not the main hydrolysis products of indole 
glucosinolates catalyzed by PYK10. Nevertheless, presently unidentified compounds 
may be accumulating in the PYK10 overexpressing lines causing the induction of the 
reporter systems. From a chemoprotective point of view, it is still unclear, if the 
formation of nitriles at the cost of other breakdown products is an unwanted effect 
(26). It could be shown though that carcinogens are formed when IAN reacts with 
nitrite (60). In the pyk10-1 lines, less nitriles were formed and since 1MO-I3M and 
4MO-I3M concentrations did not increase, other chemoprotective breakdown 
products might be produced. Further untargeted metabolic profiling attempts will be 
necessary to search for accumulating compounds in the overexpressing PYK10 lines. 
Here it will be necessary to analyze leaf material, since this was the source for the 
plant extracts during the screening. To find out if these compounds have a function in 
plant defense it would be interesting to test the resistance of PYK10-1D-cp and 
35S:PYK10 against different pathogens. Another question to be answered in the future 
is whether PYK10 protein has a function in rosette leaves. In addition, PYK10 protein 
will need to be isolated and the substrate specificity for indole glucosinolates further 
assessed.  
 
4.3.2 Mutant line AAT-1D-cp 
In the mutant line 52.18 (AAT-1D-cp) the transcript level of the putative amino acid 
transporter At3g54830 was 80-fold higher in comparison to Col-0. The gene 
At3g54830 encodes for a putative amino acid transporter, which belongs to the amino 
acid/auxin permease family (transporter classification 2.A.18). Due to the 
identification of elevated amounts of several aliphatic ITCs via metabolite profiling, 
the mutant was chosen for further studies. The discovered ITCs included 4-MSOB-
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ITC, 5-MSOP-ITC, 7-MSOH-ITC and 8-MSOO-ITC. In addition, the indole 
glucosinolate I3M and its breakdown product ascorbigen also accumulated in higher 
concentrations. Glucobrassicin derivatives are known inducers of phase II enzymes 
(166). 7-MSOH-ITC and 8-MSOO-ITC are inducers of the phase II enzyme quinone 
reductase in Hepa1c1c7 cells (240). Sulforaphane (4-MSOB-ITC) is derived from the 
glucosinolate glucoraphanin and is known as a strong inducer of phase II enzymes 
(49,52,114,241). The flavonol kaempferol, which also accumulated in the mutant, is 
also a chemoprotective compound (88,89,242).  
Analyses of At3g54830 transcripts revealed that the gene exists in at least three 
different splicing variants. N-terminal GFP fusion constructs with all three splicing 
variants were made and a GFP signal for two of the three constructs (clone 5 and 
clone 2.9) could be detected. The protein was localized to the endomembrane system 
outside of the vacuole, similar results were found for the related amino acid 
transporters At5g02180 and At5g65990 of the same family (181).  
The promotor GUS analysis revealed promotor activity in the vascular tissue of 
rosette leaves, and in the cotyledons, young leaves and root tips of seedlings. The 
amino acid transporter At2g39130 is with 66% protein sequence identity the closest 
relative of At3g54830. The promotor of this gene was active in cotyledons and young 
leaves, as well as in the roots of developing seedlings and the lateral roots of adult 
plants. Therefore it was hypothesized that At2g39130 is involved in the supply of 
nitrogen to sink organs in seedlings and uptake of amino acids from soil. At2g39130 
was also expressed in the pollen but this was not analyzed here. Since At3g54830 
shows a similar expression pattern as At2g39130, the two transporters may have 
similar roles (181).  
In a microarray experiment performed by Schmidt (2007), the amino acid transporter 
was down regulated upon treatment with phytoprostanes (243). These compounds are 
formed non-enzymatically from "-linolenic acid and are produced during oxidative 
stress in higher plants (244,245). In a preliminary wounding experiment of Col-0 
adult plants and treatment of Col-0 seedlings with jasmonate and SA, transcript of 
At3g54830 was also reduced (data not shown). Taken together these data implicate an 
indirect involvement of At3g54830 in stress response. Upon pathogen infection plants 
induce defense responses, which can reduce the metabolism of the plant (246). 
Further data will need to be gathered here.  
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In summary, a direct link between the overexpression of At3g54830 and the 
accumulation of glucobrassicin and aliphatic ITCs cannot be made at this point. Since 
especially ITCs are strong inducers of phase II enzymes, they are probably the causal 
agent of the EpRe induction in HepG2-GFP cells. The induction of the Hepa1c1c7-
Lux cells was less convincing as during previous screens with HepG2-GFP cells. A 
preliminary experiment performed with extracts of overexpressing plants of the 
splicing variants 5 and 2.9 in Hepa1c1c7-Lux cells did not confirm the gene-to-trait 
relationship of linking the At3g54830 overexpression with chemoprotective activity. 
Therefore, it should be considered that this mutant might after all not be 
chemoprotective. Lines overexpressing different splicing variants should be analyzed 
metabolically to determine the amino acid and secondary metabolite content. The 
identification of a functional splicing variant would enable experiments for 
elucidating the substrate of the transporter.  
 
4.3.3 Mutant lines 65.32 and 67.18 
The mutant lines 65.32 and 67.18 overexpressed the gene At1g63820. On the basis of 
in silico analysis the unknown protein is predicted to be soluble and it contains a 
CCT-domain, which possesses a putative nuclear localization signal. The nuclear 
localization could be experimentally confirmed via a GFP fusion construct in cell 
culture and tobacco.  
The CCT-domain is found in 45 A. thaliana proteins. Among them are proteins 
involved in flowering (247), circadian rhythm regulation (248-250), light signaling 
(251,252) and response to sugars (184). It could be shown that the CCT domain of 
the proteins TIMING OF CAB EXPRESSION 1 and CONSTANS interacts with the 
transcription factor ABSCISIC ACID INSENSITIVE3 and the CCT domain of 
CONSTANS interacts with the proteins AtHAP2 and HAP3 to form a complex that is 
involved in flowering control (253,254). The gene At1g63820 has been categorized 
to the ASML2 family. This family of eight members differs from other CCT-domain 
protein families due to several unique characteristic residues and lack of the B-box 
zinc-finger domains, the pseudo receiver domain and the GATA-type zinc finger 
domain found in members of other CCT-domain families. The only experimentally 
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analyzed member of this family is the protein ASML2, which regulates a subset of 
sugar inducible genes (184).  
Extracts of the At1g63820 recapitulation lines led to a strong induction of the 
luminescence signal in Hepa1c1c7-Lux cells. The induction was higher than that 
caused by extracts of line 65.32. One explanation could be differences in At1g63820 
expression levels. In past screens, the extracts of 65.32 led to a stronger induction of 
the EpRE promotor.  
A metabolite profile would allow a better understanding of the role of At1g63820 in 
plant secondary metabolism. Even though little information is available at this point 
the recapitulation of At1g63820 could confirm the chemoprotective effect of the 
mutant extracts. From what is known about other CCT-domain proteins, this protein 
may also interact with other proteins and have gene regulatory functions. It would be 
interesting to determine interaction partners of the protein for example via a yeast-
two-hybrid screen using an A. thaliana transcription factor library.  
4.3.4 Mutant lines 88.06, 89.29, 89.37, 90.32, 90.40, 90.43 and 90.53 
The seven mutant lines 88.06, 89.29, 89.37, 90.32, 90.40, 90.43 and 90.53 
overexpressed the gene At5g55880/At5g55890. Since the two genes are identical, also 
including parts of the intergenic regions, the insertion site could not be precisely 
localized. The genes At5g55880 and At5g55890 are part of a cluster of 27 genes. 
Within this cluster several duplication events have taken place. The mutant became of 
interest because of the repeated discovery of the same mutation during the screening. 
In addition, metabolite profiling revealed that the plants accumulated unknown 
compounds with long carbon chains, which were initially identified as long chain 
fatty acids. Further analyses did not confirm an accumulation of fatty acids. To date 
the unknown compounds could not be identified. Further metabolite profiling 
attempts will be necessary. It will be interesting to experimentally analyze the gene 
functions in the future, since none of the gene functions of this cluster are known. The 
isolation of loss-of-function mutants will be challenging, due to numerous duplication 
events that have take place within this cluster.  
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4.3.5 Mutant line GH3.5-1D-cp 
The mutant line GH3.5-1D-cp overexpressed the early auxin responsive gene 
AtGH3.5. The rosette leaves of the mutants were curled, showing the typical 
morphology during auxin deficiency, which corresponds with the phenotypes of the 
AtGH3.5 activation tagged mutants observed by Zhang et al. (2008) and Park et al. 
(2007) in the gh3.5-1D and wes1-D mutants, respectively (185,186). An activation 
tagged mutant (dfl1-D) of the closely related AtGH3.6 with a similar phenotype has 
also been identified (187,188).  
Metabolite profiling of 41.66 revealed elevated amounts of the auxin degradation 
product OxIAA-Glc (255), the aliphatic glucosinolates 7MSOH and 8MSOO, as well 
as the indole glucosinolate I3M. AtGH3.5 adenylates IAA and SA in vitro (256). 
Staswick et al. (2005) could demonstrate that GH3.5 conjugates the amino acids Ala, 
Asp, Phe, and Trp to IAA (188). Park et al. (2007) detected reduced amounts of free 
IAA and elevated concentrations of IAA-amino acid conjugates in wes1-D (186). In 
our detection system IAA amino acid conjugates were not measurable. In the gh3.5-
1D mutant on the other hand the free IAA level as well as the IAA-amino acid 
conjugate levels did not differ from wild-type plants (257). The different IAA-amino 
acid conjugates influence the fate of auxin. IAA-Asp conjugates are precursors of a 
degradation pathway. The auxin conjugates with Ala and Phe are hydrolyzed back to 
free auxin, while IAA-Trp was shown to inhibit several IAA-induced growth 
responses (255). An accumulation of OxIAA-Glc was observed here. A conversion of 
IAA into OxIAA-Glc has been reported to be the main metabolic process of IAA in 
Arabidopsis (258). A role of AtGH3.5 in plant defense has been proposed 
(185,186,257). This is supported by the fact that in both the wes1-D and the gh3.5-1D 
mutants the SA content is elevated and transcript levels of PR-1 gene are enhanced 
(186,257). The activation tagged mutants of GH3.5 are more stress tolerant to both 
biotic and abiotic factors.  
The observed altered accumulation of glucosinolates could be a product of defense 
signaling. Further analyses of the glucosinolate content will need to be performed in 
order to confirm the obtained results. The link between IAA and SA conjugation and 
glucosinolate accumulation needs to be clarified in future studies.  From the given 
data it can be concluded that the enhanced amount of glucosinolates in the samples 
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most likely induced the EpRE reporter cells. The well-known chemoprotective effects 
of glucosinolates have been described already in this thesis. It has not been reported 
that auxin conjugates induce phase II detoxification enzymes. It cannot be ruled out 
that OxIAA-Glc or its further degradation products have an inducing effect on the 
EpRE reporter systems. To answer this question it is necessary to test the individual 
compounds for inducing effects in the reporter systems in the future. 
 
4.3.6 Mutant line 68.24 
The mutant line 68.24 overexpressed the gene MIR858a, which encodes the miR858a, 
the only member of the miR858 family. Targets of miR858a have been predicted via 
in silico analyses and partly confirmed experimentally. Addo-Quaye et al. (2011) 
published in vitro confirmed targets of plant microRNAs based on degradome 
sequencing (190). The authors sorted the targets into three categories, with category I 
being the most abundant tags matching the transcript. Using the degradome 
sequencing method, four targets of miR858a could be identified: MYB12 (category I), 
MYB111 (category II), MYB13 and MYB20 (category III). Fahlgren et al. (2007) 
identified putative targets of microRNAs using a deep sequencing and computational 
approach (191). The identified targets of miR858a are MYB12 and MYB83. MYB20 
and MYB83 have been suggested to play a role in the secondary cell wall biosynthesis 
(259). The expression of MYB13 is regulated by dehydration, exogenous ABA and 
wounding. A role as a linker between shoot morphogenesis and environmental 
signaling has been suggested for MYB13 because it was detected at the shoot apex 
and base of developing flowers (260-262).  
The regulatory role of the transcription factors MYB11, MYB12 and MYB111 in the 
phenylpropanoid pathway has been analyzed in detail. In developing seedlings of 
Arabidopsis it could be demonstrated that MYB12 controls the flavonol biosynthesis 
in the roots and MYB111 has a regulatory function mainly in the cotyledons. MYB11 
has only a minor regulatory function in the flavonol biosynthesis in seedlings 
(149,263). The transcription factors activate the expression of the enzymes CHS, CHI, 
F3H and FLS1, which are necessary for the production of flavonols via the processing 
of p-coumaroyl-CoA to form the basic flavonol aglycone (Fig. 62). 
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Anthocyanins are also produced via the phenylpropanoid pathway. Their production 
is regulated among others by the transcription factors MYB75, MYB90, MYB113, 
MYB114 and MYB123 (260). The beneficial effect of flavonols, such as quercetin 
and kaempferol, has been described already in the introduction (1.1.5). These 
compounds are known inducers of phase II enzymes (113,200,207). The line 68.24 
can be used to gain new insights into the regulation of the production of 
chemoprotective compounds in Arabidopsis.  
Several plants of line 68.24 were analyzed for MYB11, MYB12 and MYB111 
expression. The plant with the highest overexpression exhibited a strong 
downregulation of MYB11, MYB12 and MYB111, with the expression of MYB11 
being the lowest, followed by MYB12 and MYB111. It could also be shown that the 
genes CHI, F3H, FLS, PAL1, and PAL2 were downregulated. CHI, F3H, and FLS are 
transcriptionally controlled by MYB11, MYB12 and MYB111 (149,263). Further 
analyses of MIR858a overexpressing lines revealed that MYB11 and MYB111 were 
downregulated only upon a relatively high expression of MIR858a. Taken together 
the data suggest that MIR858a influences the phenylpropanoid pathway by targeting 
the transcription factors MYB11, MYB12 and MYB111. 
The expression pattern of MIR858a was analyzed using promotor:GUS lines. In 
developing seedlings, the expression could be detected in the vascular tissue of the 
cotyledons, the hypocotyl and the root meristem under short days conditions. No 
expression could be observed in the roots. Under high light conditions, the promotor 
was also active in the roots. Stracke et al. (2007) analyzed the promotor activity of 
MYB11, MYB12 and MYB111 in seedlings. The authors could find MYB11 
expression in the apical meristem, the primary leaves, the apex of cotyledons, at the 
hypocotyl-root transition, the origin of lateral roots, root tips and vascular tissue of 
lateral roots. MYB12 is expressed in the root, in the vascular tissue of the hypocotyl-
root transition and mildly at the region of apical meristem and cotyledon apex. 
MYB111 expression was found in the cotyledons and primary leaves (149). The 
parallel analysis of promMIR858a:GUS lines and MYB11, MYB12 and MYB111 
promotor:GUS lines under different light conditions would help to elucidate if the 
genes are expressed in the same organs under given light conditions. From the given 
data it can be speculated that under short day conditions miR858a is expressed in the 
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same tissue as MYB11 and MYB111, while under more intensive light conditions 
MIR858a is expressed in roots and targets MYB12.  
The flavonoid gene expression in Arabidopsis seedlings is controlled by a precise 
developmental timing mechanism. It was proposed that the link between seedling 
development and flavonoid synthesis helps the germinating plant to survive in the 
environment because the flavonoids can protect against pathogens and UV-light, 
especially, when the chloroplasts are not yet fully developed (264). The miR858a 
might also play a regulatory role in flavonoid compound biosynthesis during seedling 
development. 
The promotor of MIR858a was also active in the flowers, the veins of rosette leaves 
and in the stems of the siliques. It could be shown that MYB11, MYB12 and 
MYB111 are needed for flavonol biosynthesis in the flowers but not in pollen grains. 
MYB111 is necessary for the production of flavonols in leaves. MYB12 and 
MYB111 are needed for production of flavonols in siliques (265). In addition, another 
putative target of miR858a, MYB13, is also expressed in the basis of developing 
flowers (261).  
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Fig. 62: A simplified schematic summary of the flavonol and anthocyanidin biosynthesis in A. thaliana 
and the role of MYB11, MYB12 and MYB111 (adapted from (149,260)).  
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The basic leucine zipper (bZIP) transcription factor ELONGATED HYPOCOTYL 5 
(HY5) is involved in the regulation of light responsive genes (266-269). Among 
others, HY5 has been shown to regulate flavonoid accumulation in response to UV-B 
and visible light (270,271). The transcription factor is necessary for the activation of 
MYB12 and MYB111 under UV-B and visible light (196). Recently, it was shown by 
Zhang et al. (2011) that the promotor region of MIR858a contains light regulatory 
elements that are targeted by HY5 (197,272). A nothernblot analyses revealed 
reduced expression of MIR858 in a HY5 loss-of-function mutant (hy5) and during 
light-to-dark transition. These results are consistent with the observation that 
MIR858a was expressed differentially depending on light intensity and time of day.  
The metabolite profiling of plants of line 68.24 did not yield analyzable results due to 
high variation between individual plants. Since the expression of MIR858a in later 
generations of 68.24 was low and varied between individual plants, these factors can 
influence the secondary metabolite accumulation in the plants.  
In future analyses the miR858a accumulation itself needs to be analyzed, since the 
expression pattern using promotor:GUS-lines and the analysis of gene expression may 
not reflect actual accumulation of the mature microRNA. MicroRNAs have been 
shown to be able to travel from cell-to-cell and long-distance within the phloem (273). 
In addition, the tissue specific expression of miR858a should be analyzed further. As 
performed in another study with miR395 and its target gene (274), one way of 
analysis would be by expressing MYB11, MYB12 and MYB111 fused with GFP 
under the control of the native promotor and inducing MIR858a. In addition, the 
MIM858 lines should be subject of further analyses such as the impact of high light 
on the mutants. One way of analyzing the tissue specific accumulation of different 
flavonols in seedlings is by staining them with diphenylboric acid 2-aminoethylester. 
Stracke et al. (2007) could make a link between flavonol accumulation and the 
function of MYB11, MYB12 and MYB111 by using different loss-of-function 
mutants in their experiment (149). These experiments are currrently in progress with 
the different MIR858a mutant lines. 
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4.4 Conclusion and Prospects 
The screening for chemoprotective activity in the TAMARA population has led to the 
discovery of a broad spectrum of candidate genes. 26% of the detected genes have not 
been assigned to a function. Many of the other detected genes could be allocated to a 
putative gene function only on the basis of sequence similarities but have not been 
characterized experimentally. Together with further metabolite profiles the detected 
mutants offer much potential for further discovery of genes involved in plant 
secondary metabolism.  
In this thesis, six genes were analyzed in more detail, with emphasis on finding a link 
to the production of chemoprotective compounds. The !-glucosidase PYK10 is a 
promising enzyme for further studies both from the point of view of elucidating plant 
secondary metabolism and defense responses and in finding new chemoprotective 
compounds. The mutant PYK10-1D-cp enables further analyses in these directions.  
A direct link between the overexpression of the putative amino acid transporter in 
mutant AAT-1D-cp and the accumulation of ITCs could not be found with the given 
data. The metabolite profile uncovered an accumulation of ITCs, which are strong 
inducers of phase II enzymes. The chemoprotective activity could not be confirmed in 
all screens. The overexpressing lines and the different splicing variants will be 
interesting for further studies.  
The mutant 65.32, which overexpresses a protein of unknown function, seems to be a 
potent candidate for further experiments. Little is known about this CCT-domain 
protein family ASML2. On the basis of information known about other CCT-domain 
proteins and their regulatory functions, the gene At1g63820 might be an important 
regulator of a secondary metabolite pathway. It would be interesting to find out if the 
protein has transcription factor activity and to find its target genes. One way to find 
putative targets would be via a pull down assay. As already mentioned above the 
protein might also interact with other proteins.  
The second gene, for which little data could be obtained, is At5g55880/At5g55890. 
The repeated detection of this mutant during the screening and the relatively high 
induction of luminescence suggest an involvement of the protein in the production or 
regulation of EpRE inducing compounds. Further research in this area will be 
worthwhile.  
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The well-characterized gene AtGH3.5 has been detected in two further activation 
tagged mutants by other groups. The enzyme conjugates amino acids to auxin and SA 
and plays a role in plant-pathogen interaction. The discovered glucosinolates are most 
likely the EpRE inducing compounds of this mutant. Nevertheless, for future analyses 
it will be interesting to study the fate of the OxIAA-Glc conjugates and if they exhibit 
chemoprotective activity. In addition, it should be considered that other compounds 
are affected in this mutant, such as SA, which is also conjugated by GH3.5.  
The MIR858a is a candidate with a lot of potential for further studies. It is likely that 
phenylpropanoid derived compounds induced the EpRE reporter system. The 
characterization of miR858a will give further insight into the regulation of 
phenylpropanoid production. In addition, other MYB transcription factors should be 
considered as targets of miR858a. 
In general, compounds with putative chemoprotective activity need to be isolated and 
tested individually, using the reporter cells, in order to confirm their chemoprotective 
activity.  
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5 Supplementary material 
5.1 Results of the luciferase and quinone reductase assays 
Table S1: Luciferase screening results of the mapped mutant lines 
  
 
luminescence  /protein         
line mutant stnd.er. Col-0 stnd.er. ratio phenotype  
39.45 74.50 ±3.39 46.46 ±2.55 1.60 like wt 
  117.46 ±10.27 166.08 ±38.46 0.71   
39.46 58.00 ±2.65 46.46 ±2.55 1.25 smaller, slimmer leaves 
  97.38 ±11.49 149.05 ±9.24 0.65   
40.36 91.72 ±5.27 55.80 ±1.13 1.64 like wt 
  
16.02 
73.71 
127.37 
±0.47 
±3.00 
±8.82 
27.69 
37.41 
60.85 
±3.03 
±6.78 
±3.58 
0.58 
1.97 
2.09   
40.76 51.95 ±5.076 46.46 ±2.55 1.12 rolled leaves 
  
22.29 
23.94 
64.34 
±2.44 
±1.17 
±10.28 
27.69 
37.41 
60.85 
±3.03 
±6.78 
±3.58 
0.80 
0.64 
1.06   
41.08 44.63 ±2.47 44.85 ±2.29 1.00 slightly smaller plants 
41.58 
 
 
86.77 
44.72 
129.51 
±4.35 
±1.1 
±6.66 
55.81 
37.41 
60.85 
±1.13 
±6.78 
±3.58 
1.55 
1.20 
2.13 
curly leaves, smaller 
 
 
41.66 
 
 
50.09 
35.25 
142.55 
±3.91 
± 0.54 
±4.59 
44.85 
37.41 
60.85 
±2.29 
±6.78 
±3.58 
1.12 
0.94 
2.34 
curly leaves, smaller 
 
 
42.25 80.84 ±2.59 44.85 ±2.29 1.80 like wt 
  96.93 ±14.22 149.05 ±9.24 0.65   
42.63 73.33 ±5.07 50.88 ±2.91 1.44 like wt 
  202.08 ±9.27 149.05 ±9.24 1.36   
43.09 54.95 ±3.2 28.71 ±2.66 1.91 like wt 
  248.77 ±20.38 149.05 ±9.24 1.67   
43.40 62.05 ±1.76 51.60 ±1.76 1.20 like wt 
  42.17 ±3.59 27.69 ±3.03 1.52   
43.62 46.60 ±4.03 28.71 ±2.66 1.62 like wt 
  71.78 ±2.39 166.08 ±38.46 0.43   
46.23 80.81 ±0.76 125.37 ±9.26 0.64 like wt 
46.24 142.16 ±10.63 48.98 ±2.17 2.90 like wt 
  120.98 ±6.39 149.05 ±9.24 0.81   
47.15 102.30 ±3.85 48.98 ±2.17 2.09 like wt 
  53.65 ±1.59 166.07 ±38.46 0.32   
47.25 99.67 ±3.3 104.40 ±6.69 0.95 like wt 
47.64 180.89 ±25.34 104.40 ±6.69 1.73 like wt 
  103.35 ±13.04 149.05 ±9.24 0.69   
48.69 106.75 ±3.04 55.80 ±1.13 1.91 like wt 
  180.24 ±58.46 149.05 ±9.24 1.21   
49.34 38.09 ±1.78 46.46 ±2.55 0.82 smaller 
49.44 70.45 ±5.07 55.80 ±1.13 1.26 smaller  
  313.62 ±28.74 166.07 ±38.46 1.89   
49.53 87.48 ±2.83 75.05 ±3.16 1.17 darker, earlier flowering 
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luminescence  /protein         
line mutant stnd.er. Col-0 stnd.er. ratio phenotype  
49.59 52.99 ±3.58 75.05 ±3.16 0.71 smaller 
49.62 51.59 ±4.34 32.62 ±2.75 1.58 like wt 
  105.20 ±6.59 149.05 ±9.24 0.71   
50.02 62.76 ±4.71 104.40 ±6.69 0.60 like wt 
50.32 114.89 ±9.49 104.40 ±6.69 1.10 like wt 
  67.15 ±3.58 149.05 ±9.24 0.45   
50.46 125.76 ±4.99 125.37 ±9.26 1.00 like wt 
50.52 30.63 ±0.75 75.05 ±3.16 0.41 smaller 
50.54 30.50 ±2.73 75.05 ±3.16 0.41 like wt 
50.56 75.06 ±12.16 104.39 ±6.69 0.72 like wt 
50.66 140.17 ±5.977 104.40 ±6.69 1.34 smaller 
  42.51 ±1.19 27.69 ±3.03 1.54   
51.14 36.15 ±1.81 75.05 ±3.16 0.48 smaller 
51.34 35.04 ±3.08 75.05 ±3.16 0.47 smaller  
51.70 41.44 ±0.81 75.05 ±3.16 0.55 like wt 
52.18 98.11 ±4.74 104.40 ±6.69 0.94 like wt 
53.11 47.57 ±4.72 75.05 ±3.16 0.63 like wt 
55.16 47.58 ±0.75 75.05 ±3.16 0.63 slightly larger 
55.38 62.21 ±6.37 75.04 ±3.16 0.83 like wt 
55.53 57.36 ±2.79 75.05 ±3.16 0.76 larger, darker leaves 
57.31 51.20 ±5.88 75.05 ±3.16 0.68 more trichomes 
61.23 101.23 ±15.97 103.65 ±6.36 0.98   
  49.63 ±2.85 92.43 ±6.18 0.54   
61.52* 50.66 ±1.73 92.43 ±6.18 0.55   
  77.57 ±0.47 46.82 ±1.18 1.66   
61.63* 39.72 ±2.33 92.43 ±6.18 0.43 smaller 
  134.37 ±12.42 129.71 ±7.03 1.04   
63.01 124.63 ±10.99 60.23 ±2.84 2.07 like wt 
  71.78 ±3.36 30.89 ±2.69 2.32   
63.16 157.71 ±14.73 60.23 ±2.84 2.62 like wt 
  47.77 ±1.19 30.89 ±2.69 1.55   
63.17 170.46 ±21.61 60.23 ±2.84 2.83 smaller 
  82.36 ±4.78 33.44 ±2.49 2.46   
63.67 48.73 ±1.33 28.71 ±2.66 1.70 like wt 
  134.02 ±4.58 149.05 ±9.24 0.90   
64.15 121.78 ±12.83 60.23 ±2.84 2.02 smaller 
  50.71 ±0.79 33.44 ±2.49 1.52   
64.02 48.12 ±1.95 37.58 ±1.8 1.28 like wt 
  144.69 ±2.93 69.83 ±2.99 2.07   
64.22 103.24 ±13.42 103.65 ±6.36 1.00 like wt 
  160.68 ±27.58 60.23 ±2.84 2.67   
64.33 174.72 ±18.12 125.37 ±9.26 1.39 like wt 
  80.55 ±4.41 149.05 ±9.24 0.54   
64.47 161.34 ±0.39 60.23 ±2.84 2.68 like wt 
  55.36 ±0.27 30.89 ±2.69 1.79   
64.48 183.70 ±34.19 60.23 ±2.84 3.05 like wt 
  58.92 ±5.82 30.89 ±2.69 1.91   
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luminescence  /protein         
line mutant stnd.er. Col-0 stnd.er. ratio phenotype  
       
64.59 168.15 ±25.24 60.23 ±2.84 2.79 smaller 
  57.27 ±0.28 28.17 ±1.72 2.03   
64.77 96.80 ±6.44 55.80 ±1.13 1.73 like wt 
  114.86 ±1.95 149.05 ±9.24 0.77   
  24.88 ±3.9 27.69 ±3.03 0.90   
65.20 33.74 ±0.1 55.80 ±1.13 0.60   
65.28 72.04 ±3.53 55.80 ±1.13 1.29 like wt 
  23.32 ±1.53 27.69 ±3.03 0.84   
65.32 70.99 ±2.91 55.80 ±1.13 1.27 like wt 
  324.26 ±24.03 166.08 ±38.46 1.95   
66.71* 96.86 ±4.58 92.43 ±6.18 1.05   
  54.24 ±2.76 46.82 ±1.18 1.16   
67.18 127.64 ±16.12 125.37 ±9.26 1.02 like wt 
  29.66 ±1.52 27.69 ±3.03 1.07   
67.31 127.60 ±8.95 103.65 ±6.36 1.23 like wt 
  192.92 ±13.67 149.05 ±9.24 1.29   
67.51 73.64 ±1.86 55.80 ±1.13 1.32 smaller 
  21.24 ±1.14 27.69 ±3.03 0.77   
67.74 183.64 ±17.46 103.65 ±6.36 1.77 like wt 
  192.44 ±10.58 149.05 ±9.24 1.29   
68.15* 92.48 ±1.7 31.62 ±2.13 2.92 like wt 
68.24* 32.93 ±2.68 31.62 ±2.13 1.04 like wt 
  93.42 ±0.79 46.82 ±1.18 2.00   
68.41 118.97 ±6.86 46.82 ±1.18 2.54   
68.71* 22.14 ±2.08 31.62 ±2.13 0.70   
  78.79 ±14.96 22.11 ±1.50 3.56   
70.06 136.00 ±12.45 55.80 ±1.13 2.44 like wt 
  158.20 ±5.83 149.05 ±9.24 1.06   
70.14 122.04 ±11.37 104.40 ±6.69 1.17 smaller 
  27.59 ±2.50 27.69 ±3.03 1.00   
70.24 62.51 ±4.27 55.80 ±1.13 1.12 smaller 
  24.68 ±2.72 27.69 ±3.03 0.89   
70.70 221.93 ±9.79 192.75 ±13.45 1.15 like wt 
  50.29 ±0.59 30.89 ±2.69 1.63   
71.12 239.41 ±7.75 121.71 ±7.44 1.97 like wt 
  69.34 ±7.57 30.89 ±2.69 2.24   
71.34 159.70 ±15.98 125.06 ±15.46 1.28 like wt 
  71.08 ±1.02 30.89 ±2.69 2.30   
71.36 314.22 ±22.11 121.71 ±7.44 2.58 like wt 
  47.87 ±3.06 30.89 ±2.69 1.55   
71.71 63.72 ±2.03 40.30 ±2.47 1.58 smaller 
  25.08 ±1.17 27.69 ±3.03 0.91   
71.72 108.04 ±5.17 40.30 ±2.47 2.68 smaller 
  23.04 ±0.93 27.69 ±3.03 0.83   
72.08 171.01 ±18.09 130.33 ±23.54 1.31 like wt 
  52.65 ±4.46 30.89 ±2.69 1.70   
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luminescence  /protein         
line mutant stnd.er. Col-0 stnd.er. ratio phenotype  
72.14 184.79 ±12.07 163.90 ±13.93 1.13 smaller 
  56.90 ±1.3 30.89 ±2.69 1.84   
72.29 51.54 ±0.83 40.30 ±2.47 1.28 smaller, no flower petals 
  75.25 ±4.09 30.89 ±2.69 2.44   
72.67 187.69 ±11.36 163.90 ±13.93 1.15 like wt 
  86.65 ±3.52 30.89 ±2.69 2.81   
72.68 156.82 ±5.75 121.71 ±7.44 1.29 like wt 
  50.02 ±1.46 28.17 ±1.72 1.78   
73.30* 16.87 ±0.45 31.62 ±2.13 0.53   
  61.13 ±3.55 60.45 ±5.19 1.01   
73.63* 20.45 ±1.42 31.62 ±2.13 0.65   
  63.73 ±13.03 60.45 ±5.19 1.05   
75.65* 28.06 ±1.64 31.62 ±2.13 0.89 smaller 
  20.15 ±1.00 60.45 ±5.19 0.33   
75.66* 122.22 ±2.77 22.11 ±1.50 5.53 like wt 
75.67* 149.54 ±19.82 22.11 ±1.50 6.76   
76.65* 123.59 ±3.98 22.11 ±1.50 5.59   
79.23* 32.02 ±2.76 31.62 ±2.13 1.01 like wt 
  53.32 ±5.95 23.12 ±0.55 2.31   
81.21* 26.12 ±5.13 28.95 ±6.15 0.90 smaller 
  16.74 ±1.41 23.12 ±0.55 0.72   
81.77* 40.29 ±3.03 28.95 ±6.15 1.39 like wt 
  108.70 ±6.71 23.12 ±0.55 4.70   
82.20* 27.40 ±1.98 23.12 ±0.55 1.19 like wt 
  20.70 ±4.01 28.95 ±6.15 0.72   
84.20* 29.19 ±1.45 27.83 ±2.73 1.05   
  30.91 ±3.21 19.11 ±1.74 1.62   
84.27* 76.90 ±8.37 27.83 ±2.73 2.76 like wt 
  152.31 ±8.12 19.11 ±1.74 7.97   
84.63* 51.41 ±3.76 27.83 ±2.73 1.85 like wt 
  64.35 ±3.33 39.29 ±0.98 1.64   
84.64* 15.28 ±0.65 34.04 ±1.89 0.45 like wt 
  38.93 ±5.43 39.29 ±0.98 0.99   
84.75* 13.16 ±0.20 34.67 ±0.89 0.38 smaller 
  87.52 ±6.20 21.41 ±0.6 4.09   
86.25* 285.16 ±13.62 33.68 ±2.87 8.47 like wt 
  77.56 ±4.22 39.29 ±0.98 1.97 like wt 
86.56* 119.48 ±14.12 39.29 ±0.98 3.04   
86.71* 71.53 ±5.11 39.29 ±0.98 1.82 larger, pointy leaves 
86.76* 120.68 ±1.58 40.48 ±1.49 2.98 like wt 
  108.05 ±7.50 39.29 ±0.98 2.75   
87.09* 83.84 ±6.51 39.29 ±0.98 2.13 like wt 
87.17* 61.54 ±3.13 41.48 ±1.8 1.48 smaller 
87.42* 155.68 ±11.84 41.48 ±1.8 3.75 smaller 
87.58* 123.50 ±6.73 41.48 ±1.8 2.98 like wt 
87.59* 88.31 ±5.69 39.37 ±0.83 2.24 like wt 
88.05* 56.18 ±8.63 39.37 ±0.83 1.43 smaller 
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luminescence  /protein         
line mutant stnd.er. Col-0 stnd.er. ratio phenotype  
88.06* 88.02 ±8.67 39.37 ±0.83 2.24 smaller 
88.36* 158.29 ±26.15 39.37 ±0.83 4.02 like wt 
88.75* 128.08 ±7.11 39.37 ±0.83 3.25 smaller 
89.01* 113.81 ±6.19 39.68 ±2.71 2.87 smaller 
89.29* 128.22 ±24.46 39.68 ±2.71 3.23 like wt 
89.37* 61.71 ±15.29 39.68 ±2.71 1.56 smaller 
89.68* 110.54 ±15.64 39.68 ±2.71 2.79 smaller 
90.15* 68.57 ±3.92 39.68 ±2.71 1.73   
90.32* 145.86 ±1.46 47.85 ±5.23 3.05 smaller 
90.36* 127.22 ±15.64 47.85 ±5.23 2.66 smaller 
90.37* 127.63 ±20.35 47.85 ±5.23 2.67 smaller 
90.40* 211.98 ±23.98 47.85 ±5.23 4.43 like wt 
90.43* 170.40 ±18.58 47.85 ±5.23 3.56 like wt 
90.46* 103.73 ±27.18 47.85 ±5.23 2.17 like wt 
90.53* 96.16 ±15.01 45.47 ±4.79 2.12 smaller 
90.54* 144.55 ±11.8 45.47 ±4.79 3.18 like wt 
90.63* 140.34 ±21.83 45.47 ±4.79 3.09 like wt 
90.64* 186.71 ±39.88 45.47 ±4.79 4.11 like wt 
  194.12 ±30.44 45.47 ±4.79 4.27   
  115.37 ±10.03 45.47 ±4.79 2.54   
94.12 * 74.68 ±7.20 129.71 ±7.03 0.58 dwarfish 
  111.27 ±8.45 129.71 ±7.03 0.86   
  57.84 ±5.10 129.71 ±7.03 0.45   
94.31 * 82.49 ±2.68 129.71 ±7.03 0.64 very small 
94.32 61.07 ±6.81 50.36 ±3.71 1.21   
94.48* 58.38 ±8.00 129.71 ±7.03 0.45 very small 
94.49 * 62.57 ±1.03 129.71 ±7.03 0.48   
94.52 * 58.87 ±6.97 77.83 ±3.60 0.76 dwarfish 
94.67 * 58.25 ±12.54 77.83 ±3.6 0.75   
95.16 85.38 ±7.90 43.08 ±1.95 1.98   
95.18 65.38 ±8.44 43.08 ±1.95 1.52   
95.19 74.62 ±3.99 43.08 ±1.95 1.73   
95.22 89.23 ±4.33 43.08 ±1.95 2.07   
95.31 81.54 ±6.22 43.08 ±1.95 1.89   
95.36 57.89 ±6.10 16.32 ±0.61 3.55   
Note: Part of the screening was performed by Eigen, C. and published in his diploma thesis (2009). The 
data from these screenings are marked with an asterisk (*).   
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Table S2: Results of the QR-assay 
 QR mutant stnd.er. Col-0 stnd.er. ratio 
39.45 0.35 ±0.005 0.27 ±0.009 1.31 
39.46 0.37 ±0.009 0.27 ±0.009 1.37 
40.36 0.52 ±0.009 0.39 ±0.016 1.32 
40.76 0.33 ±0.008 0.27 ±0.009 1.23 
42.25 0.40 ±0.008 0.27 ±0.009 1.50 
42.63 0.37 ±0.003 0.27 ±0.009 1.40 
43.09 0.39 ±0.009 0.40 ±0.001 0.96 
43.40 0.32 ±0.006 0.26 ±0.004 1.25 
43.62 0.41 ±0.012 0.40 ±0.001 1.02 
46.23 0.31 ±0.003 0.31 ±0.018 1.00 
46.24 0.20 ±0.030 0.27 ±0.009 0.74 
47.15 0.39 ±0.004 0.27 ±0.009 1.47 
47.64 0.20 ±0.003 0.22 ±0.012 0.94 
48.69 0.68 ±0.039 0.39 ±0.016 1.73 
49.44 0.38 ±0.006 0.27 ±0.009 1.41 
49.53 0.36 ±0.005 0.33 ±0.007 1.10 
49.62 0.34 ±0.045 0.36 ±0.007 0.94 
50.02 0.26 ±0.008 0.22 ±0.012 1.21 
50.32 0.25 ±0.008 0.22 ±0.012 1.15 
50.46 0.31 ±0.013 0.31 ±0.018 1.01 
50.52 0.26 ±0.006 0.33 ±0.007 0.79 
50.56 0.23 ±0.012 0.22 ±0.012 1.05 
50.66 0.17 ±0.008 0.22 ±0.012 0.76 
51.34 0.28 ±0.007 0.33 ±0.007 0.84 
55.38 0.34 ±0.006 0.33 ±0.007 1.02 
61.23 0.21 ±0.008 0.29 ±0.025 0.71 
63.01 0.30 ±0.003 0.31 ±0.005 0.95 
63.67 0.44 ±0.022 0.40 ±0.001 1.09 
64.22 0.21 ±0.014 0.29 ±0.024 0.71 
64.33 0.24 ±0.011 0.31 ±0.018 0.77 
64.77 0.29 ±0.012 0.31 ±0.005 0.92 
65.20 0.25 ±0.005 0.30 ±0.003 0.86 
65.28 0.28 ±0.003 0.31 ±0.005 0.90 
65.32 0.29 ±0.006 0.30 ±0.003 0.97 
67.18 0.23 ±0.013 0.31 ±0.018 0.76 
67.31 0.29 ±0.009 0.29 ±0.025 1.00 
67.51 0.32 ±0.004 0.31 ±0.005 1.02 
67.74 0.26 ±0.009 0.29 ±0.024 0.88 
70.06 0.32 ±0.005 0.30 ±0.003 1.10 
70.14 0.21 ±0.004 0.29 ±0.012 0.73 
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 QR mutant stnd.er. Col-0 stnd.er. ratio 
70.24 0.30 ±0.004 0.30 ±0.003 1.01 
70.70 0.41 ±0.016 0.44 ±0.014 0.93 
71.71 0.27 ±0.022 0.36 ±0.005 0.75 
71.72 0.32 ±0.009 0.36 ±0.005 0.90 
72.08 0.45 ±0.038 0.44 ±0.035 1.02 
72.14 0.39 ±0.015 0.41 ±0.016 0.96 
72.29 0.29 ±0.009 0.36 ±0.005 0.81 
72.67 0.42 ±0.014 0.41 ±0.016 1.02 
 
5.2 Results of the functional annotation clustering 
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Fig. S1: Diagrams of the 25 gene clusters formed after Functional annotation clustering using DAVID. 
If a gene was positively reported with the specific term, the box is marked in dark grey. Light grey 
boxes show that the respective gene was not annotated with this term. 
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5.3 Subcellular localization studies of further genes 
Mutant 47.64 
T-DNA insertion: chromosome 4 at position 17551869  
Genes cloned: At4g37290 and At4g37295 
Subcellular localization: vacuole 
20 !m 25 !m 
A B C 
 
Fig. S2: Confocal microscopy of A. thaliana cultured cells transformed with (A) 35S: At4g37290-GFP 
and (B, C) 35S: At4g37295-GFP. 
Mutant 57.31 
T-DNA insertion: chromosome 5 at position 23932995 
Gene cloned: At5g59330 
Subcellular localization: cytoplasm, around the nucleus, aggregates 
25 !m 
25 !m 
A B 
 
Fig. S3: Wide-field fluorescence microscopy of 35S:At5g59330-GFP transiently expressed in (A) A. 
thaliana cultured cells and (B) N. benthamiana leaves. 
Mutant 70.70 
T-DNA insertion: chromosome 5 at position 19916110, first exon of At5g49130 
Gene cloned: At5g49120 
Subcellular localization: nucleus 
10 !m 10 !m 
 
 
Fig. S4: Wide-field fluorescence microscopy of A. thaliana cultured cells transiently transformed with 
35S: At5g49120-GFP 
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Mutant 63.16 
T-DNA insertion: chromosome 1 between the genes At1g08670 and At1g08680 
Gene cloned: At1g08670 
Subcellular localization: nucleus, endomembrane system 
25 !m 
25 !m 100 !m 
A 
B C 
 
Fig. S5: Wide-field fluorescence microscopy of A. thaliana cultured cells and N. benthamiana 
transiently transformed with 35S: At1g08670-GFP 
Mutant 51.70 
T-DNA insertion: chromosome 1 between genes At1g01470 and At1g01460 
Gene cloned: At1g01470 
Subcellular localization: around the nucleus and in cytosol 
25 !m 25 !m 
 
 
Fig. S6: Wide-field fluorescence microscopy of (A) N. benthamiana and (B) A. thaliana cultured cells 
transiently transformed with 35S: At1g01470-GFP.  
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Table S3: List of oligonucleotides used for Cloning 
Name Sequence (5’-3’) 
At5g55880EcoFor AAAGAATTCAATGTCTCTGCTTCTCAACCA 
A5g55880NotRev TTTGCGGCCGCTTGTTGTCTATATTTTGAG 
At3g09260EcoRIFor AAAGAATTCAATGGTTTTGCAAAAGCTTCCTCTCATTGG 
At3g09260NotIRev TTTGCGGCCGCTTAAGCTCATCCTTCTTGAGC 
At1g08670forBamHI AAAGGATCCAAATGTCTAAGCTTATGCAGAATCCGGTGTT 
At1g08670revNotI TTTGCGGCCGCTTAGTCGAAGAAGAAAGCAAGAGTTGAG 
At1g01470BamHIFor AAAGGATCCAAATGGCGAGCTTGCTAGATAAAGCC 
At1g01470NotIrev TTTGCGGCCGCTTGAAGAAATCTTTAAAAGTAGGAAG 
At5g59330NcoIfor AAACCATGGCTTTGGCTCTCAGG 
At5g59330NotIrev TTTGCGGCCGCTTGGAAGACCAGAGGCTAGACTTGG 
At5g49120NcoIfor AAACCATGGTGGGACTAAGTATTGTTTTG 
At5g49120NotIrev TTTGCGGCCGCTTGTAAGCGAAACCGCCTGCTTGG 
At3g54830 attB1 GGGACAAGTTTGTACAAAAAAGCAGGCTTCATGAATCACTCCACTTCT
GACC 
At3g54830 attB2 GGGACCACTTTGTACAAGAAAGCTGGGTCATGATCTTTGCAAGGGCTG
AAT 
PromshAt3g54830attB2 GGGACCACTTTGTACAAGAAAGCTGGGTCGTCGAGGCAGTACCGCAGA
A 
PromshAt3g54830attB1 GGGACAAGTTTGTACAAAAAAGCAGGCTTCTGAACGAAGCAACAGTCG
ACAC 
At4g37290ecorIfor AAAGAATTCATGATGATGAACAAAA 
At4g37290ecorIrev TTTGAATTCTTGTGGCCCGGTCCG 
At4g37295ecorIfor AAAGAATTCATGAGACCGGTTGGCT 
At4g37295ecorIrev TTTGAATTCTTGTGACCAGCACCTC 
At1g63820forattB1 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGGATTCTGATCTTTAT
ATCT 
At1g63820revattB2 GGGGACCACTTTGTACAAGAAAGCTGGGTCCCAGTAGGAATTTGTCAT
GT 
Promshort At1g71002 
BamHIfor 
AAGGATCCAATCATTGTACTATCAGTAACGGCACAAC 
Promshort At1g71002 
NotIrev 
TTTGCGGCCGCCTCAGAAATCAAAAGTTTCGATCGTCTA 
Prommid At1g71002 
BamHIfor 
AAAGGATCCTAATTCTTTGCTCTATCGAATGACCTAA 
Attb1_At1g71002fw GGGGACAAGTTTGTACAAAAAGCAGGCTTCCTCATCTTTGTTTCGTTGT
CTGT 
Attb2_At1g71002 rv GGGGACCACTTTGTACAAGAAAGCTGGGTCCTCAGAAATCAAAAGTTT
CGATCGT 
 
Table S4: List of oligonucleotides used for mapping 
name sequence (5’-3’) 
LR32 ACTCGATTCTCAACCCGAAAGTATAGATCCCA 
LR26 ACTCGATTCTCAAACCGAAAGTATAG 
APL16 P-TATGGGATCACATTAA-amino (NH2) 
APL17 P-CGTGGGATCACATTAA-amino (NH2) 
En230as AGAAGCACGACGGCTGTAGAATAGGA 
En82as ACCCACACTTTTACTTCGATTAAGAGTGT 
En8130s GAGCGTCGGTCCCCACACTTCTATAC 
En8153s TACGAATAAGAGCGTCCATTTTAGAGTG 
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Table S5: List of oligonucleotides used for confirmation of the T-DNA insertion site 
mutant primer sequence 
41.66 41.66/Hin6 Fw AAGAGCTTTTGCCCTATTGTAGTGG 
41.66 41.66/Hin6 Rv TCAATAAATAACACACATGGGAGGC 
47.64 6433F TGAGTCGGATCTCATGTGTTT 
47.64 6433R TACGGTCGTGGATCATCGACT 
50.46 g_At2g43620 FW TTTCTGATTGGTGTCTCTTAGGAAT 
50.46 g_At2g43620 RV TCCGATTTGAGTTAAAGTATTGCG 
51.14 51.14/Csp Fw CAAGCTGCAAAACAAAGAACCGT 
51.14 51.14/Csp Rv CCAATCGCCAACCTCAGAAATA 
52.18 52.18_Hin6/53.56_Csp Fw TCTCATTACGCCAAACCTTCTCC 
52.18 52.18_Hin6/53.56_Csp Rv GCAAAAACAAACACCGATCACTAAA 
59.67 g_At1g05240 FW ATTGTTCGTGGTGTCACAGTACAAT 
59.67 g_At1g05240 RV GACGAGAGCGCAACTAGAGATTC 
63.16 6316F TGGATGAGTGATCGCTGCCC 
63.16 6316R TTATCTAGGTTTTCAATCAATCGTTTCATT 
64.22 6422F CAAGAAATGCAGCACAAGGCT 
64.22 6422R ATGAGACTTGTGCTTGTAGCGG 
64.22 g_At2g19893 FW ATCGTTCATCTGGCAACTAATATCT 
64.22 g_At2g19893 RV GATCGAGGAATCCTTATCAAACA 
64.48 g_At1g70970 FW GCATGGAAGCAAATATTAGCCAG 
64.48 g_At1g70970 RV TGTAATTGTATGGGCTTATTCATGG 
65.32 6532F AATCGAACAGGGTATAGTTTAAGCTGT 
65.32 6532R ATTCACCGAAAACAAGGATAATCCAC 
66.71 g_At3g09250 FW AGAAAGAATCCGGCAAGTATTACAA 
66.71 g_At3g09250 RV CGATGCAATCACTATGGTCAAAAT 
68.24 g_At1g71002 FW TCAAGTTTTGTCGTAAGCCTTCT 
68.24 g_At1g71002 RV ATTTGCTCGAACATGAAGACTAAA 
70.06 706F TATTCGCATACGGAGAGCAAAA 
70.06 706R TCCGGTGGATTGTTCTAGCG 
70.70 7070F ACACTAACAATGGTGGTCGAAGAA 
70.70 7070R TGTAGCAAAGGAGAAGCGACAA 
72.14 7214F CGAGCCATGTACCGGAAACTT 
72.14 7214R CAGTCAACTTAAGACCCCCGTC 
72.29 7229F TCCAGACGACGAAGTACGTGAC 
72.29 7229R AACCCAATAAAAAACACGGCC 
81.77 g_At2g37450 FW ACACTGAAACACCAGCCATGAGT 
81.77 g_At2g37450 RV CCTCGTTTTTTCACATATACAAGCT 
87.58 g_At5g10180 FW GGGATTACTGCTTTGCTGGAACT 
87.58 g_At5g10180 RV GTCCTTCCACTAATTTGATTCACC 
89.29 g_At5g55880 FW TATTATTAGTGGAGGGTTTGACCG 
89.29 g_At5g55880 RV ACGAGAGGAGTAGAAACAAGGGTT 
90.46 g_At5g09530 FW CCGTCCAAAAGATGACAAA 
90.46 g_At5g09530 RV ATGGAGACTGAAAAGCCTG 
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Table S6: List of oligonucleotides used for mutant screening with real time PCR 
mutant name sequence (5’-3’) 
39.45 At1g80760F TTCTTGGAGCGTTAATCGGA 
39.45 At1g80760R TTTGGGTGCTTCATCTTCCTCT 
39.45 At1g80770F ACAGAACAAGGTCTCAATGAGCTAAA 
39.45 At1g80770R TGGATCTTCTCCATCTCACTACTCAG 
39.46 At2g39020F TCACCTCTCGTCCTTTCCAATCA 
39.46 At2g39020R GGTTGCTGGAAATGGAGAACG 
39.46 At2g39010F ATCAGTGGATCTTCTGGGTCGG 
39.46 At2g39010R CAACACAAACTGATGGTAAAATGCT 
39.46 At2g39000F GGCTGATTACCTTCCAAGAAAAGGA 
39.46 At2g39000R GCCACATTTGATACATAAGCGATC 
41.08 At5g14850 R.T.Fw  AGAGGTAAGGAGGTTTTTCCACG 
41.08 At5g14850 R.T.Rv  ACATAGACGACCACTGAGGATTGA 
41.66 At4g27250 r.t. Fw TCCCATCAAGCGTTCAAGTTCT 
41.66 At4g27250 r.t Rv CCCATTCTTTTGTTCACAGCTGA 
41.66 At4g27260 r.t. Fw GTGGTCTTGAGCATAGATTCCGA 
41.66 At4g27260 r.t Rv GACAAGGTGTGTCACTGCGTTCT 
42.63 At1g25220F ATCCTGTCTTCTTCAACCCAAGTC 
42.63 At1g25220R GGAAACTCTTGTGGGATTCGTAAG 
42.63 At1g25230F TGAGTGTCGTTTTTTATGATGTCTCC 
42.63 At1g25230R CGAGTCTAACATTTTCGATGTGTCC 
42.63 At1g25240F GATCAGCATAGAAAGTTTAACATGGAT 
42.63 At1g25240R GAAGTAAACTGGCTCGTCGATAACTA 
43.62 At4g39640 GGTGGGAAAGAAATTGCTTATGATT 
43.62 At4g39640 CCTCCATACATATTCTCAGTGGCTCT 
43.62 At4g39650 TGAAAGATTTGCAGAATTACAACGT 
43.62 At4g39650 TAATCGGTATCCAAGAATCTCCGTA 
43.62 At4g39660 ACAAAGGCAACTCCTGAAGAGAGC 
43.62 At4g39660 CAGTACGGAGGAGAGAGATCGC 
47.15 At5g15500F TGATGATACGTTTGTTGAGTTTAGGA 
47.15 At5g15500R GACCATAGGAACGAACAGAGGG 
47.15 At5g15510F CCAAGGCAGCTGAGATAGATTGTA 
47.15 At5g15510R TGCAACACAAACACACTTCATGTT 
47.25 At5g66570 r.t Fw ATTGACCTATGATGAGATTCAGAGCA 
47.25 At5g66570 r.t. Rv TCAATAGTAGGGCACTGGTTAGCC 
47.25 At5g66580 r.t Fw ACTTACCAAAAGAAAAACATTGCCG 
47.25 At5g66580 r.t. Rv TCTTCCCTTTACCGCAACCTC 
47.64 At4g37290F GGTCTAACAAAGACCGAGGAGAAGT 
47.64 At4g37290R TGAGTCTTTGATCGAACCAAGTGA 
47.64 At4g37295F GGAGGAAATCGATCAATCTAAAATTC 
47.64 At4g37295R CCATGTATCACGACCCCTAATAAGT 
49.07 At2g16340 R.T Fw GAGGGCAGTGGTTCCAATGAA 
49.07 At2g16340 R.T Rv AGTTTCGCTATCGGCGGA 
49.07 At2g16365 R.T Fw  TGGGCGGCGTTATGATGAATATA 
49.07 At2g16365 R.T Rv AACTTGAACCCACTTTCTCTTTCCT 
49.07 At2g16370 R.T Fw  AAGATAAACCCGGAGAAGAAACAAA 
49.07 At2g16370 R.T Rv GGATCATAGCCTGTGAGGTCAAAG 
49.34 AT2G45650 R.T. Fw  TACTACGTGCAAGGTGAAGGGTCTT 
49.34 AT2G45650 R.T. Rv CCTTGGACGAAATTAGTCTCACCTG 
49.34 AT2G45660 R.T. Fw GAATAGAGAATGCAACAAGCAGACAA 
49.34 AT2G45660 R.T. Rv CTTCAACAAACCATTCCTTCTTTTG 
49.34 AT2G45670 R.T. Fw  GAACTCGGAGAAGCTCTCAAAAAC 
49.34 AT2G45670 R.T. Rv GTACATTCCTCGAATCTCGTCCTT 
49.41 AT4G38980 R.T. Fw  GGACAATGATGAGGAAGATGGGTT 
49.41 AT4G38980 R.T. Rv GGACAGTGGAAGACTCATCGAGG 
49.41 AT4G39000 R.T. Fw GTCTATACCGTCTGTTACCGTTCATC 
49.41 AT4G39000 R.T. Rv GAGAAAATATTCCATCCTGCTATGC 
49.41 AT4G39010 R.T. Fw  GAGAGGACGATATGTACGATGATGAT 
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Table S6 continued: List of oligonucleotides used for mutant screening with real time PCR 
 
49.41 AT4G39010 R.T. Rv  TGATGTAAGTAGTGGGCTCGGACT 
49.44 At4g39000F GTGCATAGCAGGATGGAATATTTTC 
49.44 At4g39000R CAATCACCGCACCTATAAGAATGTT 
49.44 At4g39010F GAGGACGATATGTACGATGATGATC 
49.44 At4g39010R GGAGCATTGATGTAAGTAGTGGGC 
49.44 At4g38990F ATGCTCAGAAGGATGGAACAGTTTC 
49.44 At4g38990R CGATCACTGCACCTACTAAAACGTT 
49.53 At1g52180 r.t. Fw AGGTGTTGCTTCTCTTACTGTTTCAGT 
49.53 At1g52180 r.t. Rv GAATCGCGTTGGAAGTTGGAA 
49.53 At1g52185 r.t Fw AGTTATCACGATTTAGCACATATCAATCTA 
49.53 At1g52185 r.t Rv GTTTCTTTCGGATTCTGGATTACAA 
49.53 At1g52190 r.t Fw AGGAATGGTAGGGTTAATGGTGTG 
49.53 At1g52190 r.t Rv TTCTCGAATCCTTTGCCAACA 
49.53 At1g52200 r.t Fw GCAGAAGTGATGGATGAAGGAGAG 
49.53 At1g52200 r.t Rv AGCCGGCATCATCAATAAGTACAT 
49.53 At5g13330 r.t Fw GTCAACCTTTTTCAACGCCTTCTT 
49.53 At5g13330 r.t Rv TCTTCTCTTCTTCTTCACGCTGCT 
49.53 At5g13340 r.t Fw AAGAGCAGATCTCCTGCACCAA 
49.53 At5g13340 r.t Rv CAATCGCAATTCTATGCTCGGA 
50.02 At2g38280 r.t. Fw CCATGGGAAAAAGAAGTCATATCTGA 
50.02 At2g38280 r.t. Rv GGATAGTGTGCAAATGGCTCTGTAT 
50.02 At2g38290 r.t. Fw AAAAGGTGGATG ATACATTAGCGG 
50.02 At2g38290 r.t. Rv CAACCCTGTCATTATTCCACCAAG 
50.02 At2g38300 r.t. Fw CGAGACTTCCACAGATCGAAATATT 
50.02 At2g38300 r.t. Rv TGGTTATGATTATAGCCTCGGAACA 
50.36 At1g04360 r.t. Fw CTCTCCTCGGGAGAATAGCCCT 
50.36 At1g04360 r.t. Rv ACGAAGTCATCATCGCCTCCTA 
50.36 At1g04370 r.t. Fw CTCATCCACTGCGGCTAATTCT 
50.36 At1g04370 r.t. Rv GAAGTTCATCCAAAACGCTATCGT 
50.36 At1g04380 r.t Fw CGCTTGACCTCACCAAAACATTTAT 
50.36 At1g04380 r.t Rv CCAGTTACCAGCAGACGAACTGTAA 
50.46 At2g43610 RL F477 CAGAGGAAGGTACTGCTCACCAAG 
50.46 At2g43610 RL R547 GACCGCGACCATAGTAGTTCTTTC 
50.46 At2g43620 RL F682 AACCTAAATGTTCGTCCAGTCTTGG 
50.46 At2g43620 RL R752 CATTCACCACCATTGATCTTCCTAG 
50.54 AT2G34830 RL_FW TCAGGAAAAGATGGAGTTCGATTAT 
50.54 AT2G34830 RL_RV TCTTGCAACAACTCCGGTCTATAG 
50.54 AT2G34825 RL_FW GAAAACAATTATGCAATCATTCGC 
50.54 AT2G34825 RL_RV GCTTCTGTTGTGCTCATGACGATAG 
50.54 AT2G34820 RL_FW GTATTTGCTTGAATCGCAAGCAA 
50.54 AT2G34820 RL_RV CACGGTACCAAACACACTTCCTCT 
51.14 AT3G09250 RL_FW TGCGATGCAATCACTATGGTC 
51.14 AT3G09250 RL_RV CCAGTTATGCCTTTGGCCC 
51.14 AT3G09240 RL_FW ATGTAGGAGTGAGCATATGGCCAA 
51.14 AT3G09240 RL_RV ACAAGCAACCTCTCGTGACCTTCT 
51.14 AT3G09260 RL_FW CTTCTTACGTCAATGCTAAATGCC 
51.14 AT3G09260 RL_RV TGTGAGTGACAAGGTAAGCCTCG 
51.14 At3g09250 RL_Fw GTTTTATCAGCCAATTCTCGGTTC 
51.14 At3g09250 RL_Rv CATAGTGATTGCATCGCAGCTAA 
51.14 At3g09260 RL_Fw ACATTAAGGACAAATACGCAAATCC 
51.14 At3g09260 RL_Rv GGCCCCTAGTTCTTCTCCATATC 
51.70 At1g01460r.t.Fw AAACAGCTCAAGCACTAACTTCGGT 
51.70 At1g01460r.t.Rv CTGATTCTCCTCTCCCAACCC 
51.70 At1g01470r.t.Fw ATTCGATTCCGATCTGTGAGATC 
51.70 At1g01470r.t.Rv GTATCTTCCCCTTTCCAATCTCC 
52.18 At3g54830 r.t. Fw TGACCAGAGCCTCTACATCGAGA 
52.18 At3g54830 r.t. Rv GTTCCATCGTCGTCTTCATCGT 
52.18 At3g54840 r.t. Fw TGTGCTTCTTCTCTTCCAGATAGGA 
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Table S6 continued: List of oligonucleotides used for mutant screening with real time PCR 
 
52.18 At3g54840 r.t. Rv CAGCTGGAACAGCATTCTCTGAAT 
52.38 At1g14410 r.t Fw .  TCGCAACTCTTATCGACTCCTCTAA 
52.38 At1g14410 r.t. Rv AGTACTGAAGACGAAGAGAGAAAGCG 
52.38 At1g14420 r.t Fw .  GTGCAGATGGTATGATCGATGCTAT 
52.38 At1g14420 r.t. Rv GTCGGTGAAATGACTGTTGGAAATA 
52.38 At1g14430 r.t Fw .  TGTTTTCGCTTATAAAGCTGACGTG 
52.38 At1g14430 r.t. Rv AACATCATATAATACCCAGGTGGTGC 
53.11 At5g43180r.t.Fw ACTTCACTTGGCATTGATTCCTCA 
53.11 At5g43180r.t.Rv GTCTTATCGTCACCCTCTTTGATGT 
53.11 At5g43185r.t.Fw TCTATTGTAGGAATTTGTCGACGTTG 
53.11 At5g43185r.t.Rv ATAGGATGAATGCTGGGAGAATTT 
53.11 At5g43190r.t.Fw CTACGAGCATGTGTACTGTCTGTGG 
53.11 At5g43190r.t.Rv AGAATCTCAGGCCAATTGTAACAAC 
53.11 At3g63030 R.T. Fw GAAACAGGGCATGTCTTGTGAAGA 
53.11 At3g63030 R.T. Rv CCAAGTCCGAGAAGAATCGTAGTC 
55.16 At1g31880 r.t. Fw GATTGAAGAGGACGAGCCTGGT 
55.16 At1g31880 r.t. Rv CGACGTAGCTCTCTAGTCCCATCT 
55.16 At1g31885 r.t. Fw GACCTTAGCGGCTGCAGTTCTA 
55.16 At1g31885 r.t. Rv TTCCCACATAAACATCGCCTTT 
55.16 At1g31910 r.t. Fw ATCACATTCAATGCTGCGGAGT 
55.16 At1g31910 r.t. Rv TGCTGCAGAAGAACCTAAGCCA 
55.53 At3g57660 r.t. Fw GGAAGTTGGAGGACGCTATAGAGAC 
55.53 At3g57660 r.t. Rv ACCTGTGACATCATTGTGTATGCC 
55.53 At3g57670 r.t. Fw CCTCCTCTCCGAGAAGCCCT 
55.53 At3g57670 r.t. Rv GGTTGTGATGGTGGTCTTGTTGTT 
55.53 At3g57680 r.t. Fw TTGACAACAGTACCATCGGAAGAAG 
55.53 At3g57680 r.t. Rv CGACAAAGAAACCGCTACTGAAAC 
57.31 At5g59340f GTTCACTCAGATTTGACAGATTTGCC 
57.31 At5g59340r GGAATTGACGTTAATGTCCTCACC 
57.31 At5g59330f TCAAAAGGTGGTGTGGTACCG 
57.31 At5g59330r ATGGTTTGAGCCACACCGT 
59.67 At1g05230 R.T.Fw  GCCACTTCTTTTTGGATCCCTGTT 
59.67 At1g05230 R.T.Rv  TCTCGTCTCTGAGGAAGTCAAAGAC 
59.67 At1g05240(50) R.T.Fw  TGAGACCAAAAACTACGTTCAGACTC 
59.67 At1g05240(50) R.T.Rv  ATTGAAAGAAGAAAACACAGGAGGG 
59.67 At1g05260 R.T.Fw  TCTGAGTTTGCCAAGTCAATGGAG 
59.67 At1g05260 R.T.Rv  CAGCTGAACCAGTCTTGACATTGAT 
61.36 At3g11130 R.T.Fw  AGAAGGATGTCATGTCACAACAGAA 
61.36 At3g11130 R.T.Rv  GCGGGTAGAGCCAGTGGTAATAAT 
61.36 At3g11150 R.T.Fw  GAGTACGCATGGAGAGTGTACCAAG  
61.36 At3g11150 R.T.Rv  TGTATCTGTCAAGTGGATCCCTGA 
61.36 At3g11160 R.T.Fw1  ATCTATGGGAGTCTATGGGAGTCAG  
61.36 At3g11160 R.T.Rv1  TCGTTAGATAATCCCACATCTTTTC 
61.36 At3g11160 R.T.Fw2   GAGGTCTGATCTATGGGAGTCTATG 
61.36 At3g11160 R.T.Rv2  TAGATAATCCCACATCTTTTCCTCC 
61.64 At3g07850 R.T.Fw1  CCATCGCAAGTGAAGTTGTCAGAC 
61.64 At3g07850 R.T.Rv1  TTGTTGCTGATGTACCCTTAATGC 
61.64 At3g07850 R.T.Fw2  GGCATTAAGGGTACATCAGCAAC 
61.64 At3g07850 R.T.Rv2  GCACTCCTTTGCTGCACATTAG 
61.64 At3g07860 R.T.Fw  GCATGTATGGTCAAACTTCTGTCTTT 
61.64 At3g07860 R.T.Rv  CAGCATTATCGTCAAGCAACTTCTC 
61.64 At3g07870 R.T.Fw  GTTGCCTAATTGGTTTCACACTGTTG 
61.64 At3g07870 R.T.Rv  GGGTGTATCAAACCAAGACAATGTTC 
61.64 At3g07880 R.T.Fw  GAAGGGAGCAAGTACAACTTGAAATT 
61.64 At3g07880 R.T.Rv  TGGTGTACCTAAGACCAGAGACAATG 
61.64 At3g07860 RL_Fw CTTGGAAGCATGTATGGTCAAACT 
61.64 At3g07860 RL_Rv AACAGCATTATCGTCAAGCAACTT 
61.64 At3g07870 RL_Fw TATAGCATTGGGACTTACTTGCCA 
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Table S6 continued: List of oligonucleotides used for mutant screening with real time PCR 
 
61.64 At3g07870 RL_Rv GTTCTTCCAAATCCACATTGGTC 
61.64 At3g07880 RL_Fw CATACAACCACGTGATGCCAGAA 
61.64 At3g07880 RL_Rv TCTTGCAGAATATGATCCTCGAGC 
62.40 At3g60047 R.T.Fw  CTTGGACACATGGAGAAGAAGCTTAG 
62.40 At3g60047 R.T.Rv  CAAGCGAAGGGCTTACCTTATTTA  
62.40 At3g60640 R.T.Fw  CGATGATGTCAACCATTTACGATG 
62.40 At3g60640 R.T.Rv  TGTGTTTTCCCCACTGTAGGTAACATA 
62.40 At3g60650 R.T.Fw  ATCCAAAGAAGCAGCCTAAATCAG 
62.40 At3g60650 R.T.Rv  TGTAGTGGGCTGCATATAATCAAGAT 
62.40 At3g60660 R.T.Fw  GGGACCAAGTTTGAAACTAGACAACA 
62.40 At3g60660 R.T.Rv    CAAGGTGGCGAAGAACAGTAAGTATT 
63.16 At1g08670f GGTTCGATTGTGGTCTAAAGGTTC 
63.16 At1g08670r AAACATGTCGTCTTCAAGCAATCT 
63.16 At1g08680f CCATTTGATCTCCCCTATGATTCT 
63.16 At1g08680r CCTTGTAACGAACTCATGTCCAAG 
63.17 At2g19600f GTGGTTCGTGCAGTAGCTATTCCAG 
63.17 At2g19600r GTTATTCCACTCAAGCACATGAACA 
63.17 At2g19610f GAGTCTTACCTGAAATCTGACGCG 
63.17 At2g19610r GAACACTTTTTCCATCCTTGTGTCT 
63.17 At2g19620f TAACAGGAGACATGACTTAACTGATGG 
63.17 At2g19620r GGTCGCCAACAAAGATGAGTGTA 
63.67 At5g65690F CGACGAGCTTCACAGTCTCC 
63.67 At5g65690R GGCGCTGCCATCTCTAAGA 
63.67 At5g65683F TCAAGATCAACCGGAGGCAGT 
63.67 At5g65683R TGGTAGACACGACGAACGGA 
63.67 At5g65687F GGCTTCTTCAACTGTTTTGATCC 
63.67 At5g65687R CCTGCATTTTCCCATAAAGTGG 
64.02 At1g07175f TTATGCAATTCGGCTGTGTTTATG 
64.02 At1g07175r TCATCTTTTCGTTTTCTGAAAATGA 
64.02 At1g07180f GGCTACTATTGGGAGATACAAAGCTC 
64.02 At1g07180r CCATTGATATTCCTTTCCCTTCCT 
64.02 At1g07190f CTGGGAGACTCACTCTAACTGGAAA 
64.02 At1g07190r GGTCAGCTTCCGGGAATATTATAGT 
64.15 At5g11530f TATGTCAGCCGGATATTGAGTACAA 
64.15 At5g11530r TGATCAGAGTCACAACTTTTGGAAG 
64.15 At5g11520f GGACAACCTGAGCTCTCTTTATGCAT 
64.15 At5g11520r CAAGATGAGAGAAAACAGAACCACC 
64.22 At2g19893f ATTTCTTGTCTTCCTCTGCCTTTC 
64.22 At2g19893r CAATCGTTCATCTGGCAACTAATATC 
64.22 At2g19890f GCCTACTTGATCGAGGAATCCTTATC 
64.22 At2g19890r GCTACAAGCACAAGTCTCATCATGTT 
64.47 At1g20490F TTTCAAGGATATGCGTTGACTGAG 
64.47 At1g20490R TTTCAGACTCTCCTCCACAGATTCC 
64.47 At1g20500F AACCAAGAAGCTACAAATGAAACCA 
64.47 At1g20500R TCGATGTAGCAAAGATCTCCAGTT 
64.47 At1g20510F AAGGAAAACTGGGAGCAGCTTATC 
64.47 At1g20510R TGTATGGTGCTACTTGTTTCGCTAC 
64.48 At1g70970f GCAACCCTACCACCCGAAC 
64.48 At1g70970r CCGGGAATACATCTTTCCTCTTTAC 
64.48 At1g70980f AAGTGTAGCAAAGGCGAGTTTAGC 
64.48 At1g70980r CATTCTTAGGTAGTCCAGGCTTAAGC 
64.59 At2g38300f GATCAAACGTTGTCCTTGTCGCTAT 
64.59 At2g38300r TCATCTTTCATCAGTCGGCTCTTT 
64.59 At2g38290f CTGGAATGTGGTGTCGACTACTATCA 
64.59 At2g38290r CCTCAGCCATTCTCAATGGTATGA 
64.77 At3g60966F CTTTGATCGTCACAAGTCCATGG 
64.77 At3g60966R GTTTTCCGCCGCTCTCCAC 
64.77 At3g60970F CTCCAATGTCATATTTCGATTCAAC 
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64.77 At3g60970R GACACTTTGATCTGTGGATGCC 
65.32 At1g63820 RL_Fw GATCTCTACTGCAACAATCCTTATCTCA 
65.32 At1g63820 RL_Rv CTTTCAAAGAAACTAAGAGATTGATGATCAT 
65.32 At1g63810 RL_Fw ATTTATGTCGCCTGGAGATTTGAA 
65.32 At1g63810 RL_Rv GCTCGAAGTCCACCATTAGCTTATT 
65.32 At1g63820 TGCATGAGGAAGAAGAAGCTTGTG 
65.32 At1g63820 CATTTGCAACTGAGGCTGAGACT 
65.32 At1g63810 ATTTATGTCGCCTGGAGATTTGAAG 
65.32 At1g63810 GCTCGAAGTCCACCATTAGCTTATT 
67.31 At2g45650f AAAACCTTTCAAGACTTATGGGCAA 
67.31 At2g45650r GGAAATTCAGAATTGTTTGGATCC 
67.31 At2g45660f AAATTGAGCAGCTCAAGCAAAAGG 
67.31 At2g45660r TCCCCACTTTTCAGAGAGCTTCTC 
67.31 At2g45670f CTCGGAGAAGCTCTCAAAAACACAA 
67.31 At2g45670r AGCAAATGGTACATTCCTCGAATCT 
67.51 At1g47813f TCAATGGTGATACTCATAATGTTCAAGAT 
67.51 At1g47813r GGTTTCACAGGAGAAGCATCATC 
67.51 At1g47810f CCACTATATGAGCCAAACTCACTGG 
67.51 At1g47810r TCCCCAACTAGAGCTTCAAATTT 
67.74 At3g04570F CCGGTGTATAATATGCCGGGA 
67.74 At3g04570R TGGCCGCTCATCTGTCCTC 
67.74 At3g04560F AGAGAACAAATGAAGATCCAGATGC 
67.74 At3g04560R AATCAAAGCTTCTCTTTTTGACCTGA 
67.74 At3g04580F CTTAGGCATGTGTAGAAAACTTGCA 
67.74 At3g04580R TGTCCATGCGATTTAGGTGATATC 
68.24 At1g71000 RL_Fw CAGAACCAATCAATGCAAATGAATT 
68.24 At1g71000 RL_Rv GCGGTAGAGACATCTGTGAATGC 
68.24 At1g71002 RL_Fw C-Ter TGATCATAAGAAGGATGGATGAATG 
68.24 At1g71002 RL_Rv C-Ter TCTCGATCTCTCCTCAAAACCCTA 
68.24 At1g71002 RL_Fw N-Ter TCAGAAATCAAAAGTTTCGATCGTC 
68.24 At1g71002 RL_Rv N-Ter AACGTACATGGTTTATCGGTTTGTT 
68.41 At5g41740 RL_Fw TTTGAGTTCAGCCACACTAAAATCG 
68.41 At5g41740 RL_Rv GCTCCCTCTGTCATGATCTGTACAC 
68.41 At5g41730 RL_Fw CAAGATCATCGCCAAAAGTATCAC 
68.41 At5g41730 RL_Rv TCGATTATCCTTCCTTGCTTTAATG 
68.41 At5g41750 RL_Fw GGTGGAGCTTCCCTTTTCTATTTT 
68.41 At5g41750 RL_Rv AGCATAGAGCAGTTTTCAACATTCA 
70.24 At5g59330F TGGTACCGGATCTGTGTTGTG 
70.24 At5g59330R TGTAGGCATCGGCATGGTT 
70.24 At5g59340F TTCACTCAGATTTGACAGATTTGCC 
70.24 At5g59340R TGGAATTGACGTTAATGTCCTCAC 
70.70 At5g49120F GAAGAAAGCTTGAGAAGAGAGTATTGTT 
70.70 At5g49120R TTTCTCGGATCTCGACGGTAA 
70.70 At5g49130F TCAGACCATTAGCTGTGGAATCTTAC 
70.70 At5g49130R CGTAGAAATTAATCTTGGCCCCTAT 
70.70 At5g49140F TGAAGAAGTGGATGTGATACGGTT 
70.70 At5g49140R ATTTGTACACCACATTCCGTAATCTC 
71.12 At2g30200F AGGATCCCAGTGATCTCGAATGTC 
71.12 At2g30200R CACCTGGCGTGCAAGTATCTT 
71.12 At2g30210F CTTATTTGACCCACCAGAGAGGAAC 
71.12 At2g30210R CGACGAACCGAATTGCCAC 
71.12 At2g30220F CTTGTCCGAATCATTCGGATCACT 
71.12 At2g30220R TAGGTATTTGTAAGCTGCCTCGGAG 
71.34 At3g03470F TTATTTGTTGGCTCTGATGTGTTTC 
71.34 At3g03470R CATTTGGTACTGAGCTTCTTCGATC 
71.34 At3g03480F TTCAGTGACCGCCCTAATGG 
71.34 At3g03480R CCGATATTATGTAGTTCCCTGATGC 
71.34 At3g03490F AGGAGCTTGGCGCAAGATATCC 
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71.34 At3g03490F GTGAATATCGTTTGTAGTCTTCTTTGCTT 
71.36 At3g04100f TCGAGTTACGTGATAACTTATGCGA 
71.36 At3g04100r AGATGAACCACCACAGTCTTTTCC 
71.36 At3g04110f AGCTGCTCATGTTCTCGTACTAGC 
71.36 At3g04110r TGGTGCATAGTCGTGATACCTCTT 
71.72 At5g67411f CTACATGTGGATTCCTTACGATACCG 
71.72 At5g67411r CATACCACTGTCTTTGCTCGCTAC 
71.72 At5g67420f ACCGTCGATGAACTCAGAGGAC 
71.72 At5g67420r ACACATCACCCTTGTCACAAAAC 
72.14 At1g02930f TTTGAAGATGGAGACTTCAAGATTTT 
72.14 At1g02930r TCTGAGAATTCATGAGCTATGTATTGAGTAA 
72.14 At1g02940f TTGGCTAGTAACAGCTTCACAATG 
72.14 At1g02940r TGTGTGTCCATAAGGTATTGTATATTAGGA 
72.14 At1g02950f CGAAGAAATTGTTCGAAAAAAGATC 
72.14 At1g02950r CCAAGCCTCTCTACTCGTAATCTCAT 
72.29 At3g59580F ACAAGAATCGAGCGAGGTAATGGA 
72.29 At3g59580R GATGAATCCGACATGCTACTTGATAT 
72.29 At3g59590F GTGTCCACCTCACTGCTCTCG 
72.29 At3g59590R GGTGAATGGTTAGGAAACGAATAATA 
72.29 At3g59600F GCAGAGTTATATGTTTCGTTCGGG 
72.29 At3g59600R CGAAGTGAGAAATATGAGCTGGATC 
72.67 At4g37580F TTACATGTGGCCAAAAACTCGAT 
72.67 At4g37580R TTTAGTGTAAAGAGGCTTAACGACATC 
72.67 At4g37570F GGAAAATCTCGGGTTTACG 
72.67 At4g37570R CATAAACCCGTGATTTTCC 
72.67 At4g37560F AAAGTTCCAACAGGAGCTCGGATAG 
72.67 At4g37560R GGAAGTTTTCCATCATATGTGCTCTT 
73.63 At1g05660 RL_Fw GAAAACCCAATCATAATCGACCAA 
73.63 At1g05660 RL_Rv ACCCCAGAATACTCATTAGGGCA 
73.63 At1g05670 RL_Fw TGTCTGTTGATTCTTGCAACGTG 
73.63 At1g05670 RL_Rv TGATTGCTGTTGCAGTTTTATAGCA 
73.63 At1g05650 RL_Fw CGGATTCGTTAGAAACGTCTTCTTT 
73.63 At1g05650 RL_Rv GGTCGATTATGATAGGGTTTTGGAC 
75.66 At3g13900 RL_Fw GCTTACAGTTCCCAGCACTGTACC 
75.66 At3g13900 RL_Rv CCCGATGATTCTGTACCAGTCAA 
75.66 At3g13910 RL_Fw AGACGCAGTGAAAGGTTACAACAG 
75.66 At3g13910 RL_Rv AATCGTTCGTTTGACTCTGATCG 
75.66 At3g13890 RL_Fw AAACTCAACGTGTTTGTGACACCA 
75.66 At3g13890 RL_Rv GCCTTCGAGAACTTCTCCACATAA 
79.23 At3g27510 RL_FW AATAGCTCTTCACGACCACTTTGC 
79.23 At3g27510 RL_RV TCTGCCCTAAGAATGAAGGAACC 
79.23 At3g27520 RL_FW GAGAAGATGCTTCTAAGTCGCCGT 
79.23 At3g27520 RL_RV CGCTTCTTGTCTTTCCACCGTAA 
79.23 At3g27503 RL_FW GTAATGGAACATGTGGGCCTAACA 
79.23 At3g27503 RL_RV GGGAGAAGGAGGATTTTTCCAAA 
79.23 At3g27500 RL_FW TTTGTGAAAGAGAGACCAATCCAA 
79.23 At3g27500 RL_RV AACATGTAAAGTGACCCCGCA 
81.21 At5g46540 RL_FW AGGGACAATATTACCAATCGTCCA 
81.21 At5g46540 RL_RV GTCGCATAGGATACCGGAAACTA 
81.21 At5g46550 RL_FW AGGAACAGATGGAAAGAGCACAA 
81.21 At5g46550 RL_RV CAACCTTAGCAGCTCTCATCTCG 
81.21 At5g46530 RL_FW CACTTTTAGCCATGGGATTTGGT 
81.21 At5g46530 RL_RV CATTGTCCTCAGACGAGCATTTC 
81.77 At2g37440 RL_Fw TTATCGCCAAATGAGCTCGAG 
81.77 At2g37440 RL_Rv TCTGAGAGGCCTGAGAAGCTG 
81.77 At2g37450 RL_Fw AGATGTACCTCGGAAGGGCTCTT 
81.77 At2g37450 RL_Rv TTTGCCCCATATCACAAGGTATAG 
81.77 At2g38290 RL_Fw TGGAATGTGGTGTCGACTACTATCA 
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81.77 At2g38290 RL_Rv TCCTCAGCCATTCTCAATGGTAT 
81.77 At2g38300 RL_Fw GATCAAACGTTGTCCTTGTCGCTA 
81.77 At2g38300 RL_Rv TCATCTTTCATCAGTCGGCTCTTTT 
82.20 At3g01080 RL_Fw TTGATAACTTCCCTGACGTCTTGA 
82.20 At3g01080 RL_Rv CGAGGTGAGAAGATGAGTAAACGAC 
82.20 At3g01070 RL_FW ACCTAACAAGAACAGTGCAAGAAGAA 
82.20 At3g01070 RL_RV CTACTGGAATAAGAAACTGATAGGCAAA 
84.27 At5g65630 RL_Fw GAGATCGAAAGAGATGGTACTGCA 
84.27 At5g65630 RL_Rv CTGGAACTGCCTGAAGAACTAGAAC 
84.27 At5g65640 RL_Fw AATAGCAACAATTCACATCACTCTAAGCT 
84.27 At5g65640 RL_Rv ACCAGAGGTTCGTTCGCATTAA 
84.63 At1g61270 RL_FW AGAAACAACACCTCAGTGCCATT 
84.63 At1g61270 RL_RV TGACCTGCATACGCAAAAGC 
84.63 At1g61260 RL_FW AGATCTGGTTGAATCCGATGTCAT 
84.63 At1g61260 RL_RV TCTCAATCGGAGGAAGATTCTCC 
84.63 At1g61280 RL_FW ATCAAGAAGTACACGGACCAAAAAC 
84.63 At1g61280 RL_RV GGCAACAACAATCGAAATAGATCC 
84.64 At5g59730 RL_FW CCGAAACTTAGGGACCAGATTAAA 
84.64 At5g59730 RL_RV CGGTAAAACTCGGTACAAACCAG 
84.64 At5g59740 RL_FW GGCTGAGCCAGAATTAGTAAACGG 
84.64 At5g59740 RL_RV CGGAAACTGCGAATACACCTTTC 
84.75 At4g30350 RL_Fw CAGCGAAAAACGTTGCTTCTATC 
84.75 At4g30350 RL_Rv GTCTTAACTCCCATCCTTTGTTCAC 
84.75 At4g30360 RL_Fw TCCTAGAACAAAGATGAACCTTGGA 
84.75 At4g30360 RL_Rv ACACCGCGTCTTGTATTAGCTGC 
86.25 At5g46980 RL_Fw AAATACCTCAAAACACTGGATTACGAGA 
86.25 At5g46980 RL_Rv GCTCTTGGTTTACCTTTTGCCAT 
86.25 At5g46990 RL_Fw AATTGCGGGATTTCGATAAAGTC 
86.25 At5g46990 RL_Rv CATTTCACACTCTCTCGGAACAACT 
86.56 At3g02000 RL_FW GATCATACAAGATGAGCAGCTTAGGA 
86.56 At3g02000 RL_RV GGACTCTATACGAAGCAGACCAGTG 
86.56 At3g02010 RL_FW TAGGCGTCTTAACTGCATGTAGTCA 
86.56 At3g02010 RL_RV AGACATTGCCTGGAAATATTCTGTT 
86.56 At3g01990 RL_FW CGCGAGAGGGTAAGGCTAAAGAC 
86.56 At3g01990 RL_RV GATTTTTGATTCAACCGGGTTTC 
86.71 At5g11320 RL_Fw GACTGGGTATAAGAGTAATGTACCCGATT 
86.71 At5g11320 RL_Rv TTGGCATTCCTTCTTTTGTGAAAA 
86.71 At5g11330 RL_Fw ACTCGGAAACAGTTAGTGGGATTAA 
86.71 At5g11330 RL_Rv CACCGAGATCAAAATACAAGCATT 
86.76 At5g28370 RL_Fw TTGTTGCAGCGTCAGTAATGTAGAG 
86.76 At5g28370 RL_Rv GAGAACAACCAGCTTCCAACATTT 
86.76 At5g28380 RL_Fw GATTCCGAGACGGTTGGCATAATA 
86.76 At5g28380 RL_Rv CGCTCAAACGGGATAGTCTTTTC 
87.09 At1g62886 RL_FW TTTGTGAAGCCATATGCTGAGGAG 
87.09 At1g62886 RL_RV GCGTAAGAGTTTTCGTCCCTGAA 
87.09 At1g62880 RL_FW GGAGAGGTCTGGACATGGATTATTT 
87.09 At1g62880 RL_RV AGCTGATAGACGATGAGTCCGAG 
87.17 At1g30840 RL_FW ACGTTAAGCTCTGTTTTGTTGGCT 
87.17 At1g30840 RL_RV ATACTTGGTTTTGGTTAAACCGGAC 
87.17 At1g30845 RL_FW AGAATCGTTATCGTTTCGTTGGTT 
87.17 At1g30845 RL_RV CGACTTACTGAGGATAAGAACTCCG 
87.17 At1g28300 RL_FW GTCCAAGTGAGTTGGTTGATTCAA 
87.17 At1g28300 RL_RV CGGAGATCTGCACGTTATTTTTC 
87.17 At1g28320 RL_FW GGGAAGTAAATTTTGGGAACAGAAG 
87.17 At1g28320 RL_RV CAGACGAATAATGATTTCGTGGAG 
87.17 At1g28307 RL_FW GCCGAGCTGGGCCAG 
87.17 At1g28307 RL_RV AACATCTTTTATGGGTCGAGGC 
87.42 At1g15757 RL_Fw CGTGTTTGCCTGAAGTCGGA 
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87.42 At1g15757 RL_Rv GGCCTGTTGTAAACTTCATTCTTGA 
87.42 At1g15750 RL_Fw AAGATCAAGCTCACTTCCTCGTTGT 
87.42 At1g15750 RL_Rv GCATTCG AGCTTGGTAGTTTCGTA 
87.42 At1g15760 RL_Fw GGAACAAGAGATCTGTGATGCCG 
87.42 At1g15760 RL_Rv TGGTCAACAACAACCTCTCTTGCT 
87.58 At5g10180 RL_Fw ACGGTTATAATCTGGCTATCAAACG 
87.58 At5g10180 RL_Rv TGAAGTGGATTTGACTCGTCCTC 
87.58 At5g10190 RL_Fw TCAAACGGATATCTGTAATCGACG 
87.58 At5g10190 RL_Rv CACGAATTTTTCGGTATATGCCA 
87.59 At2g41860 RL_FW ACATTCAAATATTGATGGACGCG 
87.59 At2g41860 RL_RV TGGCTACAAATTCATTGACGTCTAA 
87.59 At2g41870 RL_FW ACAACGAACTAATGACTCGTGACGT 
87.59 At2g41870 RL_RV CGTGGATTCTCATCAACTCGTCT 
87.59 At2g41850 RL_FW ATCACGGGATTGAGAAGTTTTGTAA 
87.59 At2g41850 RL_RV CCAAAATCAGAAACACTAACGGTG 
88.05 At5g35770 RL_FW TCACCCTCTCAGACCTCTACTTAGC 
88.05 At5g35770 RL_RV GTTGTTTAAAAGAAAAAGCCGGAC 
88.05 At5g35760 RL_FW TGCAAAACTCATGAAGCCTCTATC 
88.05 At5g35760 RL_RV CCCTCCACATCTCCTTGATTTTAG 
88.36 At5g22500 RL_FW CAGGCAATATATCATGTTGGTTCGT 
88.36 At5g22500 RL_RV GCCGTGAAATCGTGAAGTTGTC 
88.36 At5g22510 RL_FW GGCCAAGCTCCTCTTAGCAAATC 
88.36 At5g22510 RL_RV TTCTCAAATCCGAATCCTCTTCAC 
88.36 At5g22490 RL_FW TTTCTCACCGGATTGTGTCTTTG 
88.36 At5g22490 RL_RV CGTCGTTGATAGTCATTTCCATAGC 
89.01 At3g60160 RL_FW TGCTTGTGCCATTCATAATATTGG 
89.01 At3g60160 RL_RV CATGCCATCCAGTAATTGCTAGC 
89.01 At3g60164 RL_FW CCTCCGTTGCTGTCTTCTCTGTA 
89.01 At3g60164 RL_RV AGTGCGGTGGCGATACCAT 
89.29 At5g55880 RL_FW GTTGAATACATGGATGCTGACGA 
89.29 At5g55880 RL_RV GTAAGATCACCAACGATGGAGGAT 
89.29 At5g55890 RL_FW TACCACGCATGTTTTTCCCTAACA 
89.29 At5g55890 RL_RV GGCTAGATTGAAATATCCGTCTTCG 
89.68 At3g12900 RL_FW GAAGTACAAAAGTGCGGAGCATAG 
89.68 At3g12900 RL_RV TGAAAATGGGCACAGAGACTCTT 
89.68 At3g12915 RL_FW AGGTCAGCTAAGGGCTGCAA 
89.68 At3g12915 RL_RV ACATCATGTCCCAATGGTCAAAC 
89.68 At3g12910 RL_FW TGGCCCTACACACTCTAACCCTAC 
89.68 At3g12910 RL_RV AATATCCGGCATAACGTCCATACT 
89.68 At1g79110 RL_FW GGTTACTACGCCGATGGTGCTAC 
89.68 At1g79110 RL_RV CTTGAGCGTTTTCTCGTTGGTAAAG 
89.68 At1g79120 RL_FW ACGAGAGGATAGGTTATCCCGTG 
89.68 At1g79120 RL_RV TTGTGATCCTGACCCTCTTTCTG 
90.36 At3g10114 RL_Fw AAGAGAGCACAAGCGAGG 
90.36 At3g10114 RL_RV CGCCGTAAGCTAACCCTAATAAAGC 
90.36 At3g10116 RL_FW TTAGAGAAGAACATGACGACCTTGC 
90.36 At3g10116 RL_RV TTAGATTAGCTCGGCCAACATCA 
90.36 At3g10113 RL_FW TCAACACCCATTTCAAGCATTACTC 
90.36 At3g10113 RL_RV GGATGGTTTGTGAGATTCTTCCG 
90.36 At1g01610 RL_FW TGTTGCTCTGACCCGAGACC 
90.36 At1g01610 RL_RV CCAAATCACCTTTCTCGAGGAGTT 
90.36 At1g01620 RL_FW AGAAGAGGATGTTCGAGTGGGA 
90.36 At1g01620 RL_RV CCGTCTGAGCCGATGTACCTA 
90.36 At1g01600 RL_FW TCCGGGACATAAAGTGGAGC 
90.36 At1g01600 RL_RV ACAGATTCACCAGAAGTCCGTTC 
90.46 At5g09530 RL_Fw CACTAATGAAGAAGAGTCTCTCTGCTG 
90.46 At5g09530 RL_Rv CAATGCGATAAGACATATGATCAGAA 
90.46 At5g09520 RL_Fw AATTTCCCAAGTTCGATTTTCCA 
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90.46 At5g09520 RL_Rv AAACGCCGGCACTTTGGTT 
90.46 At5g09540 RL_Fw GATACCGACATTTCCGGAGCTAC 
90.46 At5g09540 RL_Rv GCAACTCTAGCTTCGGAAATTCG 
90.54 At3g15500 RL_FW GGTTCGTCGACATCTTCTTCGTC 
90.54 At3g15500 RL_RV TCTGTTGTCAATCTCATGCAACG 
90.54 At3g15510 RL_FW AGATCACGACAATAACGCTGACGT 
90.54 At3g15510 RL_RV TTCGCCATCATCATAGGACCTG 
90.63 At1g77200 RL_Fw AGTTACGATGAGTCATTGAGCGAG 
90.63 At1g77200 RL_Rv AATATACCAAGGCGAACTAGGTGG 
90.63 At1g77210 RL_FW CGTCGCTTATCTCGTCTACCATTAC 
90.63 At1g77210 RL_RV CAGCTGAATACATAGACATGATCGC 
90.63 At1g77180 RL_FW GAAGAGCAAGATCACCAGAGACAGA 
90.63 At1g77180 RL_RV CAGTAGATGCCATTCCAAGAGCA 
90.64 At2g45050 RL_FW CAAGAAGCAAACGATCAAGAGCT 
90.64 At2g45050 RL_RV GCTCGGATTCCAGTGGCA 
90.64 At2g45040 RL_FW TATCGAAGCTCGAAATCCATCTCA 
90.64 At2g45040 RL_RV CGTTTGATTTCCGGTATAGAGACGT 
90.64 At2g45060 RL_FW CTTCTCGATTCCGCACTCAAATA 
90.64 At2g45060 RL_RV CTTTGTCAAAGCGTTTCTCTCTTG 
94.12 At3g63540 RL_Fw GTGACTGTGATCAGGCTGTGCTT 
94.12 At3g63540 RL_Rv GACGAGACAGGGCAGGTCTACTAT 
94.12 At3g63530 RL_Fw CTCTTAACTACGATCATGCCGCAA 
94.12 At3g63530 RL_Rv TGCATTGGTATTCATGGTCCAGTA 
94.31 At4g40010 RL_Fw AGTGCAAGCATCTCTTGTCTCGTAT 
94.31 At4g40010 RL_Rv TTCGATTTCCGGTACAGTTATTCTC 
94.31 At4g40020 RL_Fw TGGTGAAGGAAACTCTCCAAGTTC 
94.31 At4g40020 RL_Rv TGGCGTCTCTGCTATATCAAAGATC 
94.31 At4g40000 RL_Fw AACTAGCCTTGGGATCTTGCGTTA 
94.31 At4g40000 RL_Rv CACTTTGAATTGTTCTGACCCGA 
94.31 At4g40011for AATAATATTGACGGCCCAACAGTC 
94.31 At4g40011rev CATACGTACAGATACAGTCAGCACCA 
94.48 At1g75440 RL_FW AGAACATTATCCTATGGAATCGCC 
94.48 At1g75440 RL_RV TGTAAATGTGAGGATGCAGAGGAG 
94.48 At1g75450 RL_FW ATGAACAAAGACAAATGGGACGAG 
94.48 At1g75450 RL_RV GCCACCAGATAGAAAACTTCCTCA 
95.19 At3g01870for TTTAATTGTTAACCATGTGTGTTGGA 
95.19 At3g01870rev TGCTCACTGCTGTAGAATTCACATC 
95.19 At3g01860for GTTCGTGTGTCTCCTCTTCTCAAA 
95.19 At3g01860rev GGTTTAGAGATGAAAGAGGCAAGC 
95.19 At3g01880for GCAGAAACTGGAACTAACCCTTTG 
95.19 At3g01880rev GGATATTTGAATGGATACCCTAAAGAATT 
95.31 At4g11911for TGGTCTCATTCTCATGGCTGC 
95.31 At4g11911rev TTGGTCAATAGATTCCCTCCG 
95.31 At4g11910for CTGATGAGTGCAAGTGTTGCTTTC 
95.31 At4g11910rev CGGTATGTTGATAATGACGATGAGA 
95.31 At4g11920for TCAGCTGAATCTTCCACCGTC 
95.31 At4g11920rev CGATTAAACGGTTGATTCGTGAC 
95.36 At1g11920for TACGGAAGAGCAGAGCGGTTT 
95.36 At1g11920rev GGACCGGCGGATGAAGTAAG 
95.36 At1g11915for AATTTCCAGTGACAATGAAGTGCCT 
95.36 At1g11915rev CGTGTCCTCGTATTAAACCCACAA 
95.36 At1g11925for GTTTGCTGCAACGGATATTGTGTAA 
95.36 At1g11925rev CGATCTCCCTTTCTTGCACTTCTT 
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Table S7: List of oligonucleotide primers used for quantitative expression analyses with real time PCR 
gene primer sequence (5’-3’) 
CHS (At5g13930) rtAt5g13930for TGTTGAGCGAGTATGGAAACATGTC 
  rtAt5g13930rev TGACTTCCTCCTCATCTCGTCTAGT 
FLS (At5g08640) rtAt5g08640for GATTTAGCTTTAGGTGTACCGGCTC 
  rtAt5g08640rev GGAACTTCGTTAGGAACAAGAAGAGT 
DFR (At5g42800) rtAt5g42800for CTCCAAATTTCTCAGGCCAAAATAC 
  rtAt5g42800rev GATTCTCATCAACACCTTCAAACG 
CHI (At3g55120) rtAt3g55120for AATTAGGGCTTTATACGGACTGTGA 
  rtAt3g55120rev ATGTTTCTTCCTTGAAGATCTCCAA 
F3H (At3g51240) rtAt3g51240for GAGTCTCTTACCAATGCATGCGTC 
  rtAt3g51240rev TGAGGGCATTTTGGGTAATAATTAA 
F3'H (At5g07990) rtAt5g07990for GAGAGCTGTGAGATCAACGGCTAC 
  rtAt5g07990rev GCTATGGCCCATATGTTCGTCAAT 
PAL1 (At2g37040) rtAt2g37040for GTGAGCTTCATCCTTCTCGCTTCT 
  rtAt2g37040rev TGTGTAGACTTGTTCACGGTCTACAA 
PAL2 (At3g53260) rtAt3g53260for GTCACAAGCCATGTTCAATCAGCT 
  rtAt3g53260rev CGAGACGAGATCAAACCAAGAGAGT 
MYB13 (At1g06180 ) rtmyb13for AATTGGGAGGGCTCACTAGATAGAAA 
  rtmyb13rev AGATGGTCAAACCAAAACTCCATG 
MYB20 (At1g66230 ) rtmyb20for ATATGATGAGCCTGTGGGAAATTAG 
  rtmyb20rev GGAAGAACTCTCATCATTAAGCAGC 
MYB11 (At3g62610) rt2_myb_11_for ATTCGGTTTTGTCGAGGCTGTTAG 
  rt2_myb_11_rev GTCGTTGGAGTCCCTTTGTCTGAT 
  RT_ MYB11_At3g62610_FWD TCGATTCTTGTTTTCTATTGGACGAC 
  RT_ MYB11_At3g62610_REV TTTTACGTTGTTCGACTCACATGA 
MYB12 (At2g47460) rt2_myb_12_for ACGCAGACTTGGGAGAACGAGTAG 
  rt2_myb_12_rev TCGTTTTACGAGTTTTTGTTCTGTGG 
  RT_ MYB12_At2g47460_FWD TGGAGTCGTTTCTCAACTACGACC 
  RT_ MYB12_At2g47460_REV ACAATCCCAATCGATAAACTCATC 
MYB111 (At5g49330) rt2_myb_111_for GAGGGAAGTTTTTTAAGTTCGAATTC 
  rt2_myb_111_rev GAATTACATAGACCAACCCACCAAT 
  RT_ MYB111_At5g49330_FWD GGTTGATGAGGAGTTGCTTGATTG 
  RT_ MYB111_At5g49330_REV GATCCCATAGATCATCACTTTGACA 
MYB28 (At5g61420 ) RL_MYB28sh_Fw TCCCTGACAAATACTCTTGCTGAAT 
  RL_MYB28sh_Rv CATTGTGGTTATCTCCTCCGAATT 
MYB51 (At1g18570 ) MYB51_RL_Fw CTACAAGTGTTTCCGTTGACTCTGAA 
  MYB51_RL_Rv ACGAAATTATCGCAGTACATTAGAGGA 
Actin (At3g18780) Act_Foward ATGGAAGCTGCTGGAATCCAC 
  Act_Reverse TTGCTCATACGGTCAGCGATG 
 
Table S8: List of oligonucleotides (for semiquantitative PCR and T-DNA insertion line control PCR) 
gene primer sequence (5'-3') 
At3g09260 WiscDsLox461-464F2for AGGAAATATTCTTGGCCATGC 
  WiscDsLox461-464F2rev TTGATTAATATGGCCTGGCTG 
 At3g62610 myb11_ln_for CCCAAAAATGCCGGGCTAAAGAGATG 
  myb11_ln_rev TTCGTCAATATCCAACGGTTCTCCAAAGT 
 At5g49330 myb111_ln_for ATATTCAGACCAATGGTGAAGGTT 
  myb111_ln_rev CCCATAGATCATCACTTTGACAAG 
At3g18780 Actin lg F  TAACTCTCCCGCTATGTATGTCGC 
  Actin lg R CCACTGAGCACAATGTTACCGTAC 
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1151                                          1200 
At3g54830 mit att sites  (1151) GAATTTGTACTCTTATGTATGCGGGTGTTGCTGTTATGGGATATAGCATG 
         Sequence Klon 6 (1151) GAATTTGTACTCTTATGTATGCGGGTGTTGCTGTTATGGGATATAGCATG 
         Sequence Clone 5(1151) GAATTTGTACTCTTATGTATGCGGGTGTTGCTGTTATGGGATATAGCATG 
  sequence V2.9          (1151) GAATTTGTACTCTTATGTATGCGGGTGTTGCTGT---------------- 
              Consensus  (1151) GAATTTGTACTCTTATGTATGCGGGTGTTGCTGTTATGGGATATAGCATG 
                                1201                                          1250 
At3g54830 mit att sites  (1201) TTTGGAGAATCAACAGAATCACAGTTTACTCTTAACTTGCCTCAAGATTT 
         Sequence Clone 6(1201) TTTGGAGAATCAACAGAATCACAGTTTACTCTTAACTTGCCTCAAGATTT 
         Sequence Clone 5(1201) TTTGGAGAATCAACAGAATCACAGTTTACTCTTAACTTGCCTCAAGATTT 
  sequence V2.9          (1185) -------------------------------------------------- 
              Consensus  (1201) TTTGGAGAATCAACAGAATCACAGTTTACTCTTAACTTGCCTCAAGATTT 
                                1251                                          1300 
At3g54830 mit att sites  (1251) GGTTGCATCTAAGATTGCTTTGTGGACTACAGTTGTTAATCCATTTACCA 
         Sequence Clone 6(1251) GGTTGCATCTAAGATTGCTTTGTGGACTACAGTTGTTAATCCATTTACCA 
         Sequence Clone 5(1251) GGTTGCATCTAAGATTGCTTTGTGGACTACAGTTGTTAATCCATTTACCA 
  sequence V2.9          (1185) -------------------------------------------------- 
              Consensus  (1251) GGTTGCATCTAAGATTGCTTTGTGGACTACAGTTGTTAATCCATTTACCA 
                                1301                                          1350 
At3g54830 mit att sites  (1301) AATATCCTTTATCAAGAAATATTCAGAGACTTTTCATTTATCTCT----- 
         Sequence Clone 6(1301) AATATCCTTTATCAAGAAATATTCAGAGACTTTTCATTTATCTCTGTAAT 
         Sequence Clone 5(1301) AATATGCTTTGACATTATCTCCAGTTGCAATGAGTCTTGAGGAGT----- 
  sequence V2.9          (1185) -------------------------------------------------- 
              Consensus  (1301) AATATCCTTTATCAAGAAATATTCAGAGACTTTTCATTTATCTCT      
                                1351                                          1400 
At3g54830 mit att sites  (1346) -------------------------------------------------- 
         Sequence Clone 6(1351) TTTGTCATAAGCTTATTCATAATATAAACTGAAAATTGTGTGGCCTTAAT 
         Sequence Clone 5(1346) -------------------------------------------------- 
  sequence V2.9          (1185) -------------------------------------------------- 
              Consensus  (1351)                                                    
                                1401                                          1450 
At3g54830 mit att sites  (1346) ------------------------------------TTGCAATGAGTCTT 
         Sequence Clone 6(1401) AGAAAGAAAGCACATATGCTTTGACATTATCTCCAGTTGCAATGAGTCTT 
         Sequence Clone 5(1346) ----------------------------------T--------------- 
  sequence V2.9          (1185) -------------------------------------------------- 
              Consensus  (1401)                                     TTGCAATGAGTCTT 
                                1451                                          1500 
At3g54830 mit att sites  (1360) GAGGAGTTAATACCATCAAACTATGGGAAGTCACGTTTCTACGCAATCGC 
         Sequence Clone 6(1451) GAGGAGTTAATACCATCAAACTATGGGAAGTCACGTTTCTACGCAATCGC 
         Sequence Clone 5(1347) --------AATACCATCAAACTATGGGAAGTCACGTTTCTACGCAATCGC 
  sequence V2.9          (1185) -------------------------------------------------- 
              Consensus  (1451) GAGGAGTTAATACCATCAAACTATGGGAAGTCACGTTTCTACGCAATCGC 
                                1501                                          1550 
At3g54830 mit att sites  (1410) CATTAGAAGTGCATTAGCCATCTCTACTCTGCTCGTTGGTCTTGCGATTC 
         Sequence Clone 6(1501) CATTAGAAGTGCATTAGCCATCTCTACTCTGCTCGTTGGTCTTGCGATTC 
         Sequence Clone 5(1389) CATTAGAAGTGCATTAGCCATCTCTACTCTGCTCGTTGGTCTTGCGATTC 
  sequence V2.9          (1185) -------------------------------------------------- 
              Consensus  (1501) CATTAGAAGTGCATTAGCCATCTCTACTCTGCTCGTTGGTCTTGCGATTC 
                                1551                                          1600 
At3g54830 mit att sites  (1460) CCTTCTTCGGCCTTGTCATGTCACTGATTGGATCATTCTTGACAATGCTC 
         Sequence Clone 6(1551) CCTTCTTCGGCCTTGTCATGTCACTGATTGGATCATTCTTGACAATGCTC 
         Sequence Clone 5(1439) CCTTCTTCGGCCTTGTCATGTCACTGATTGGATCATTCTTGACAATGCTC 
  sequence V2.9          (1185) ----------------CATGTCACTGATTGGATCATTCTTGACAATGCTC 
              Consensus  (1551) CCTTCTTCGGCCTTGTCATGTCACTGATTGGATCATTCTTGACAATGCTC 
1601                                          1650 
At3g54830 mit att sites  (1510) ATTTTTCTGGACACAGACGCTGATACTACCGCCAGCTTGTTTCTTGAGCA 
         Sequence Clone 6(1601) AT-----T--------ACGCTGATACTACCGCCAGCTTGTTTCTTGAGCA 
         Sequence Clone 5(1489) ATT-------------ACGCTGATACTACCGCCAGCTTGTTTCTTGAGCA 
  sequence V2.9 (1219)          ATT-------------ACGCTGATACTACCGCCAGCTTGTTTCTTGAGCA 
              Consensus  (1601) ATT    T        ACGCTGATACTACCGCCAGCTTGTTTCTTGAGCA 
Fig. S7: 3’ end of the At3g54830 sequence of clones 6, 5 and 2.9. 
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8 Abbreviations 
Abbreviation Full name 
A. thaliana Arabidopsis thaliana 
-1D dominant 
1MO-ascorbigen 1-methoxyindol-3-ascorbigen 
1MO-I3M 1 methoxy indol-3-ylmethyl glucosinolate 
1MO-IAN 1-methoxyindol-3-acetonitrile 
2,4 D 2,4-dichlorophenoxyacetic acid 
4-MSOB-ITC 4-methylsulphinylbutyl isothiocyanate 
4HO-I3M 4-hydroxy- indol-3-ylmethyl glucosinolate 
4MO-ascorbigen 4-methoxyindol-3-ascorbigen 
4MO-I3M 4 methoxy indol-3-ylmethyl glucosinolate 
4MO-IAN 4-methoxyindol-3-acetonitrile 
5-MSOP-ITC 5-methylsulphinylpentyl isothiocyanate 
7-MSOH-ITC 7-methylsulphinylheptyl isothiocyanate 
7MSOH 7-methylthioheptyl glucosinolate (glucosibarin) 
8-MSOO-ITC 8-methylsulphinyloctyl isothiocyanate 
8MSOO 8-methylsulfinyloctylglucosinolate (glucohirsutin) 
A. tumefaciens Agrobacterium tumefaciens 
AA amino acid 
ABA abscisic acid 
ASML2 Activator of Spomin::LUC2 
AT-medium Arabidopsis thaliana medium 
ATP adenosine triphosphate 
BCA bicinchoninic acid 
BFA brefeldin A 
BSA bovine serum albumin 
CaMV Cauliflower mosaic virus 
CCT CONSTANS, CONSTANS-like, TOC1 
cDNA complementary deoxyribonucleic acid 
CDP-ME 4-diphosphocytidyl-2-C-methyl-D-erythritol 
CE capillary electrophoresis 
CHI chalcone isomerase  
CHS chalcone synthase  
CoA Coenzyme A 
Col-0 Columbia 
cp chemoprotective 
Ct cycle threshold 
CYPs Cytochrome-P450-dependent mono-oxygenases 
DAVID Database for Annotation, Visualization and Integrated Discovery 
DEPC diethylpyrocarbonate 
DFR dihydroflavonol 4-reductase 
DMAPP dimethylallyl diphosphate 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
dNTPs deoxyribonucleotide triphosphates 
DPBS Dulbecco's Phosphate Buffered Saline 
DTT dithiothreitol 
DXP 1-deoxy-D-xylulose 5-phosphate 
E. coli Escherichia coli 
EDTA Ethylenediaminetetraacetic acid 
EpRE electrophile response element 
ER endoplasmatic reticulum 
ERF ethylene-responsive binding factor 
ESI electro spray ionization 
et al. et alia 
EtBr ethidium bromide 
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EtOH ethanol 
F3’H  cytochrome P450 monooxygenase 
F3H flavanone-3-hydroxylase  
FAD flavin adenine dinucleotide 
FBS fetal bovine serum 
Fig figure 
FLS flavonol synthase  
FPP farnesyl diphosphate 
FTICR Fourier transform ion cyclotron resonance 
GAP glyceraldehyde-3-phosphate 
GC gas chromatography 
GFP green fluorescent protein 
GH3.5 Gretchen Hagen 3.5 
GLL GDSL lipase-like protein 
GST glutathione-S-transferase 
GUS Beta-glucuronidases 
h hour 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HIG-1D HIGH INDOLIC GLUCOSINOLATE1-1DOMINANT 
HMG-CoA 3-hydroxy-3-methylglutaryl-CoA 
HO-1 heme oxygenase-1 
HPLC high performance liquid chromatography 
HY5 ELONGATED HYPOCOTYL 5 
Hz Hertz 
I3C indole-3-carbinol 
I3M indol-3-ylmethyl glucosinolate (glucobrassicin) 
IAA indole-3-acetic acid 
IAN indole-3-acetonitrile 
IPP isopentenyl diphosphate 
ITC isothiocyanate 
JAL jacalin-related lectin 
kb kilobases   
KEAP1 Kelch-like ECH-associated protein 1 
kV kilo Volt 
LB-medium Lysogeny broth medium 
LC liquid chromatography 
LIT linear ion trap 
Lux luciferase 
M molar 
m/z mass-to-charge ratio 
mA milliampere 
MALDI matrix assisted laser desorption/ionization 
MeOH methanol 
MEP methylerythritol phosphate pathway 
MES 2-(N-morpholino)ethanesulfonic acid 
min minute 
MIR858a MicroRNA858a gene 
miR858a mature microRNA858a 
MMLV Moloney Murine Leukaemia Virus 
mRNA messenger RNA 
MS mass spectrometry 
MS-medium Murashige & Skoog-medium 
MTT 3-(4,5-dimethylthiazo2-yl)-2,5-diphenyltetrazolium bromide 
N. benthamiana Nicotiana benthamiana 
n.d. not determined 
NAD Nicotinamide adenine dinucleotide 
NADPH Nicotinamide adenine dinucleotide phosphate 
NASC Nottingham Arabidopsis Stock Center   
ng nanogram 
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nm nanometer 
Nrf2 nuclear factor-erythroid-2-related factor 2 
OD optical density 
OPC8 3-oxo-2(2’-[Z]-pentenyl)cyclo-pentane-1-octanoic acid 
OxIAA-Glc oxindole-3-acetyl-glucose ester/glucoside 
PAD3 phytoalexin deficient 
PAL1 phenylalanine ammonia-lyase 1 
PAL2 phenylalanine ammonia-lyase 2 
PBP1 PYK10-binding protein 1 
PCI phenol/chloroform/isoamylalcohol 
PCR polymerase chain reaction 
PEN2 PENETRATION 2 
pGWB gateway binary vector 
QIT quadruple ion trap 
QR NAD(P)H quinone oxidoreductase 1 
QTOF quadrupole-time of flight 
RNA ribonucleic acid 
ROS reactive oxygen species 
rpm revolutions per minute 
RQ relative quantification 
RT reverse transcription 
s second 
SA salicylic acid 
SAM shoot apical meristem 
SAP shrimp alkaline phosphatase 
SDS sodium dodecyl sulfate 
SOB-medium Super optimal broth medium 
SOC-medium Super optimal broth with Catabolite Repression  
SU sulfonylurea 
SV-0 supervirulent 
T-DNA transfer- DNA 
TAE Tris-acetate-EDTA 
TAIR The Arabidopsis Information Resource 
TAMARA transposable element mediated activation tagging mutagenesis in 
Arabidopsis TE Tris-EDTA 
Tm melting temperature 
TOF time of flight 
tRNA transfer ribonucleic acid 
u unit 
UPLC ultra performance liquid chromatography 
UV ultra violet 
V Volt 
v/v volume per volume 
w/v weight per volume 
WOX2 WUSCHEL-related homeobox 2 
YEB Yeast extract and beef medium 
!F microfarad  
!g microgram 
!L microliter 
!M micromolar 
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9 Abstracts 
9.1 Abstract 
Many plant secondary metabolites have anti-cancerogenic and anti–mutagenic effects 
in higher organisms including humans. These compounds can induce the expression 
of phase II and detoxification enzymes, which inactivate carcinogens in mammalian 
cells. The genes encoding for phase II enzymes are regulated by electrophile response 
elements (EpRE) in their promotor region. In order to identify chemoprotective 
compounds, EpRE-based reporter systems have been developed in human and murine 
hepatoma cells, such as the HepG2-GFP and the Hepa1c1c7-Lux cells, respectively. 
The aim of this work was to identify novel chemoprotective plant secondary 
metabolites and the genes involved in their biosynthesis in Arabidopsis thaliana (A. 
thaliana). To this end, the effect of extracts of different activation tagged mutants 
(TAMARA lines) on the reporter cells was examined. In a previous screening with 
HepG2-GFP cells, 470 mutants had been selected out of 5,000 tested TAMARA lines. 
Here, these mutants were re-screened using the more sensitive Hepa1c1c7-Lux cell 
line. The screening and subsequent mapping of the T-DNA insertion sites led to the 
identification of 87 independent mutant lines. The relative expression of the genes 
flanking the insertion site was determined in comparison to the gene expression in 
wild-type plants. 32% of the detected genes encode for enzymes, 13% for 
transcription factors, 11% for transporters, 26% for proteins of unknown function, and 
18% are genes belonging to other categories. The selection of mutants for further 
studies was based on the putative or known gene function and metabolite profiles 
from mass spectrometry analyses. Six different gene products that are overexpressed 
in independent mutant lines were selected for detailed characterization. These were 
encoded by the following genes: At3g09260 (ß-glucosidase PYK10), At3g54830 (a 
putative amino acid transporter), At1g63820 (an unknown protein), 
At5g55880/At5g55890 (an unknown protein), At4g27260 (AtGH3.5) and At1g71002 
(MiR858a micro RNA). 
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9.2 Zusammenfassung 
Viele pflanzliche Sekundärmetabolite besitzen antikanzerogene und antimutagene 
Eigenschaften in tierischen Organismen. Diese Wirkstoffe können in Säugerzellen 
die Expression von Phase II und detoxifizierenden Enzymen, welche zum Abbau von 
Zellgiften dienen, induzieren. „Electrophile response elements” (EpRE), lokalisiert in 
den Promotorregionen von Phase II-Enzymen, regulieren die Expression dieser Gene. 
Zur Identifizierung neuer chemoprotektiver Wirkstoffe wurden auf EpRE-basierende 
Reportersysteme in humanen (HepG2-GFP) und murinen Zelllinien (Hepa1c1c7-
Lux) entwickelt. Zielsetzung dieser Arbeit war die Identifizierung neuer 
chemoprotektiver pflanzlicher Sekundärmetabolite in Arabidopsis thaliana. 
Außerdem sollten die an der Biosynthese dieser Pflanzenstoffe beteiligten Gene 
identifiziert und charakterisiert werden. Zu diesem Zweck wurde die Wirkung von 
methanolischen Extrakten aus verschiedenen Arabidopsis-Mutanten (TAMARA 
Linien) in den Reporterzellen untersucht. In früheren Experimenten mit HepG2-GFP-
Zellen wurden bereits 470 aus insgesamt 5000 untersuchten TAMARA-Linien mit 
putativ chemoprotektiven Eigenschaften ausgewählt. In dieser Arbeit wurden diese 
Mutanten in den empfindlicheren Hepa1c1c7-Lux-Zellen erneut untersucht und 
ausgewählte Mutanten kartiert. Dies führte zur Identifizierung von 87 unabhängigen 
Linien. Die relative Genexpression der in direkter Nachbarschaft zur Insertionsstelle 
liegenden Gene wurde im Vergleich zur Genexpression in Wildtyppflanzen 
bestimmt. 32% der entdeckten Gene mit veränderter Expression kodieren für 
Enzyme, 13% für Transkriptionsfaktoren, 11% für Transporter, 26% für Proteine 
noch unbekannter Funktion und 18% gehören anderen Kategorien an. Sechs 
verschiedene Gene wurden für weitere Charakterisierungen ihrer Funktion auf 
Grundlage ihrer vermuteten Rolle in der Biosynthese von pflanzlichen Metaboliten 
bzw. aufgrund eines durch Massenspektrometrie ermittelten veränderten 
Metabolitenprofils ausgewählt. Bei diesen Genen handelt es sich um At3g09260 (ß-
Glukosidase PYK10), At3g54830 (ein putativer Aminosäuretransporter), At1g63820 
(ein unbekanntes Protein), At5g55880/ At5g55890 (ein unbekanntes Protein), 
At4g27260 (AtGH3.5) und At1g71002 (MiR858a mikroRNA). 
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